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People with dementia living in residential care homes often experience multiple symptoms and 
concerns associated with dementia and co-morbidities. As dementia progresses, individuals may 
experience increasing difficulties expressing their wishes and concerns. The complexity of 
symptom presentation and declining communication mean the assessment and management of 
symptoms and concerns is often challenging. Poor detection results in symptoms and concerns 
being untreated, increasing distress and compromising quality of life. A systematic review 
identified no comprehensive measure to support assessment and management of symptoms and 
concerns by care home staff for people with dementia. 
 
Aim 
To develop and then conduct a preliminary evaluation of the Integrated Palliative care Outcome 
Scale for Dementia (IPOS-Dem) to improve assessment and management of symptoms and 
concerns for people with dementia in residential care homes. 
 
Methods 
Design: A three-phase mixed methods study informed by the Medical Research Council guidance 
for developing and evaluating complex interventions. The study was underpinned by a theoretical 
model of the expected mechanisms of action of a measure used in routine care to improve 
assessment and management of symptoms and concerns.  
Setting and participants: Three residential care homes in a borough in South London. Participants 
were people with dementia/cognitive impairment in residential care homes, their family members, 
care home staff, and health care professionals including general practitioners and district nurses.  
Pre-clinical scoping review phase: A systematic scoping review of the literature to identify 
common symptoms and concerns experienced by people with dementia to develop IPOS-Dem 
Version 1, adapted from the Integrated Palliative care Outcome Scale (IPOS). 
Development phase: A qualitative phase comprising focus groups and semi-structured interviews 
with family members, care home staff, and health care professionals to explore content validity, 
expected mechanisms of action, acceptability, feasibility, and implementation requirements of 




cognitive interviews to determine the acceptability and ease of comprehension of IPOS-Dem to 
care home staff.  
Evaluation phase: A qualitative study with embedded quantitative component. IPOS-Dem was 
implemented in routine care of people with cognitive impairment in residential care homes. 
Qualitative data collection comprised focus groups and semi-structured interviews with family 
members, care home staff, and health care professionals, and non-participation observations of 
health care professional consultations with care home staff to explore the mechanisms of action, 
acceptability, feasibility, and implementation requirements of IPOS-Dem in the care home 
context. Quantitative data comprised IPOS-Dem scores at baseline and final time point at 12 
weeks. Qualitative data were analysed using directed content analysis and quantitative using 
descriptive statistics. Qualitative and quantitative data were analysed separately and then 
integrated on key areas to inform the final theoretical model. 
 
Results 
Pre-clinical scoping review phase: Five additional items were identified and five existing IPOS 
items were amended to reflect symptoms and concerns experienced by people with dementia 
and multi-morbidities, resulting in IPOS-Dem Version 1. 
Development phase: Six family members and 20 care home staff and health care professionals 
participated in focus groups (n=4) or semi-structured interviews (n=3). Ten care home staff 
participated in cognitive interviews. Five additional symptoms and concerns to ensure 
comprehensive assessment were identified resulting in Version 2. Refinements from cognitive 
interviews included the use of lay terms and item descriptors and formed Version 3. The 
development phase output was IPOS-Dem Version 3 with a pre-implementation understanding of 
the care home context, likely mechanisms of action, acceptability, feasibility, and implementation 
requirements ready for the evaluation phase. 
Evaluation phase: Thirty-two residents with cognitive impairment received IPOS-Dem as part of 
routine care with 30 completing the full 12 weeks evaluation. Seven family members, and 11 care 
home staff and health care professionals participated in focus groups (n=2), semi-structured 
interviews (n=7), and/or non-participant observations (n=3). Findings informed a theoretical model 
to demonstrate the key mechanisms of action and potential benefit, measurement properties, and 
implementation requirements. Mechanisms of action included, for example, improved observation 




communication. Potential benefit was improved symptom management and comprehensive care, 
and increased family empowerment and engagement. IPOS-Dem was acceptable and feasible, 
with participants reporting that it supported care processes and was quick and easy to use. 
Missing data decreased from 2.1% at baseline to 1.1% at final time point. Leadership was 
essential in implementing IPOS-Dem into routine care processes. 
 
Conclusion 
IPOS-Dem addresses a gap in the comprehensive assessment and management of symptoms 
and concerns experienced by people with dementia in care homes. It incorporates key symptoms 
and concerns that older people with dementia and multi-morbidities, and their family members 
may experience; and is developed for care home staff knowledge, skills and remit within the care 
home context. It is acceptable and feasible for use in routine care, and may improve care 
processes resulting in potential benefit to people with dementia and their family members. IPOS-
Dem is now ready for future research on the psychometric properties and a feasibility trial to test 
the methods for a full trial of effectiveness on improving care outcomes. 
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Glossary of terms 
Care homes- 24-hour staffed accommodation providing care to people who are no longer able 
to live independently and who may require support during the day and night (1). 
Nursing homes- care homes registered to provide nursing care and staffed with 24-hour 
onsite registered nursing staff for people who may have nursing needs (1). 
Residential care homes- care homes registered to provide residential care with no 
requirement for onsite registered nursing staff (1). 
Complex interventions- Complex interventions are defined by a number of characteristics: they 
may have a number of different components that may interact, may require behaviour changes, 
may be directed at multiple groups, have multiple outcomes, and may vary in the degree of 
flexibility of delivery (2). 
Context- Context is anything external to the intervention, which may either impede or assist 
implementation or its consequences (3). 
Feasibility study- a study which occurs prior to a full trial of effectiveness and which provides 
the opportunity to examine components of the intervention (such as acceptability, feasibility), and 
aspects of the testing procedures (such as recruitment and retention and effect size) (2). 
Feasibility testing may also provide valuable insights and understanding of the context of 
intervention delivery (4). 
Implementation- ‘the process through which interventions are delivered, and what is delivered 
in practice’, including what is delivered and how it is delivered (5). 
Implementation requirements of the intervention- this includes important features of the 
intervention that maximise its implementation such as training and additional resources, and the 
mechanisms which may support implementation. 
Measures/Outcome measures 
Measure- a standardised and validated patient-reported or proxy-reported measure 
designed to capture concerns important to patients, or in this study, people with dementia 
living in care homes.  
Outcome measure- a standardised and validated measure of change in patient health 
status as a result of an intervention or health care delivered (6). 
Patient-centred outcome measure (PCOM)- Patient-reported or proxy-reported 
outcome measure that designed to capture concerns important to patients (7). 
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Patient-reported outcome measure (PROM)- an outcome measure completed by 
patients to measure their own perspectives of health status, functional status or wellbeing 
(8). 
Proxy-reported outcome measure- an outcome measure to measure concerns 
important to patients, but not completed by patients usually because they are too unwell 
or have significant cognitive impairment to self-report (7). 
Measurement properties 
 Validity: the degree to which an instrument measures what it purports to measure (9). 
Reliability: ‘the degree to which the measurement is free from measurement error’ (9). 
Responsiveness: the ability of a measure to detect change over time in the construct to 
be measured (9). 
Interpretability: the degree to which one can assign qualitative meaning, or clinical 
connotations, to a measure’s score(s) or change in score(s) (9). 
Acceptability: whether patients (for patient-reported measures) or staff/health care 
professionals are prepared to and willing to use the measure (10), and its suitability for 
intended use in clinical practice (11). 
Comprehension: how patients or staff/health care professionals understand, interpret 
terms, and choose their responses (10). 
Feasibility: whether patients or staff/health care professionals are able to use the 
measure in their respective setting or context (10). 
Availability was added to capture the requirement for measures, and additional training 
and resources, to be easily and freely accessible (12, 13). 
Palliative care- ‘an approach that improves the quality of life of patients and their families facing 
the problem associated with life-threatening illness, through prevention and relief of suffering by 
means of early identification and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual’ (14). 
Process evaluation- ‘A study which aims to understand the functioning of an intervention, by 
examining implementation, mechanisms of impact, and contextual factors. Process evaluation is 
complementary to, but not a substitute for, high quality outcomes evaluation’ (5). 
Residents: Residents of nursing or residential homes, with or without dementia. The term 






CANE Camberwell Assessment of Need 
CCC Concordance Correlation Coefficient 
CI Confidence Interval 
CMAI Cohen-Mansfield Agitation Inventory 
CQC Care Quality Commission 
CRN SL Clinical Research Network South London 
DCM Dementia Care Mapping 
DeNDRoN Dementias and Neurodegenerative Diseases 
EoLC End of Life Care 
EOLD-CAD End of Life in Dementia – Comfort Assessment in Dying 
EOLD-SM End of Life in Dementia – Symptom Management 
EOLD-SWC End of Life in Dementia – Satisfaction With Care 
EORTC QLQ-C30 European Organisation for Research on Cancer Treatment Quality of Life 
Questionnaire  
DN District Nurse 
ENRICH Enabling Research in Care Homes 
FAST Functional Assessment Staging 
FATE(-S) Family Assessment of Treatment at the End of life (- Short version) 
FPCS Family Perceptions of Care Scale 
FPPFC Family Perceptions of Physician-Family caregiver Communication 
GDS Global Deterioration Scale 
GP General Practitioner 
IPOS Integrated Palliative care Outcome Scale 
IPOS-Dem Integrated Palliative care Outcome Scale for Dementia 
MCA Mental Capacity Act 
MDS Minimum Data Set 
MIDOS Minimal Documentation system for Palliative care 
MORECare Methods Of Researching End of Life Care 
MRC Medical Research Council 
MSSE Mini Suffering State Examination 
NHS National Health Service 
NIHR National Institute for Health Research 
NRES National Research Ethics Service 
POS Palliative care Outcome Scale 
PCOMs Patient-Centred Outcome Measures 
PIC Participant Identification Centre 
PPI Patient and Public Involvement 
PROMs Patient-Reported Outcome Measures 
QUALID Quality of Life in Late-Stage Dementia 
QODD Quality of Dying and Death 
QOD-LTC Quality of Dying in Long Term Care 
QOD-LTC-C Quality of Dying in Long Term Care – Cognitively Intact 
(m)QOLC-E (modified) Quality of Life Concerns in End of life questionnaire 
RAI-PC Resident Assessment Instrument for Palliative Care 
R&D Research and Development 
RCTs Randomised Controlled Trials 
REC Research Ethics Committee 
RGF Research Governance Framework 
SD Standard Deviation 
SMMSE Standardised Mini-Mental State Examination 
STAS Support Team Assessment Schedule 
TIME Toolkit of Instruments to Measure End of life care 
UK United Kingdom 
US United States 
WHO World Health Organisation 






Dementia is an international public health priority (15). It is the leading cause of disability and 
dependency in chronic illnesses (16), and has profound physical, emotional and financial effects 
on those with the illness, their families and wider society (15). Dementia is progressive and 
terminal (17, 18), and there is currently no cure nor any treatment to stop its progression (15). As 
a consequence, the World Health Organisation (WHO) has emphasised the requirement to 
improve the lives of people with dementia and their families through optimising health and 
wellbeing, assessing and treating comorbidities and symptoms, and providing information and 
support to family carers (19). Central to this is improved management of distressing symptoms 
and concerns experienced by people with dementia and their families (20-22) to improve quality 




Dementia is predominantly a disease of older age (16). The incidence of dementia doubles with 
every 6.3 year increase in age from 3.9 per 1000 person-years for the age group 60-64 to 104.8 
per 1000 person-years for aged 90 years and over (23). Increased life-expectancy is resulting in 
a global ageing population, which in turn is increasing the prevalence of dementia (24). In 2015, 
the estimated prevalence was 46.8 million, and this is anticipated to increase 131.5 million by 
2050; with an estimated incidence rate of 9.9 million new cases of dementia worldwide each year 
(23). The median survival from onset of disease has been estimated from between 3.3 to11.7 
years, with the majority of studies reporting a median survival of between 7-10 years (25). In 2015, 
dementia became the leading cause of death in England and Wales accounting for 11.6% of all 
deaths registered (26). While a recent study conducted to estimate population palliative care need 
in England and Wales based on past trends (27), projected the expected number of deaths as a 
result of dementia to rise from 59,199 in 2014 to 219,409 deaths per year in 2040.  
 
1.2.2 Dementia: definition, presentation and disease trajectory 
Dementia is a term that describes a group of diagnoses characterised by progressive decline in 
cognition resulting from neurodegeneration (28). As dementia progresses, all aspects of cognition 




are affected including memory, orientation, verbal and nonverbal communication, ability to learn 
new information, and executive functioning (29). Dementia is staged according the degree of 
cognitive and functional abilities using measures such as the Standardised Mini-Mental State 
Examination (SMMSE) (30), Global Deterioration Scale (GDS) (31), or Functional Assessment 
Staging (FAST) (32). In the early stages of dementia or mild dementia, people may require 
support for instrumental activities of daily living such as shopping and cooking, and may start to 
have difficulties with word or name finding (32). Those with moderately severe dementia typically 
require support with personal activities of daily living including dressing, bathing, and toileting; 
while severe or advanced stage dementia is characterised by minimal or no verbal 
communication, urinary and faecal incontinence, inability to walk, and complete dependence in 
all areas of functioning (32). 
 
People with dementia may also experience psychological symptoms and behaviours that 
challenge which may cause distress to them and their families, or those close to them. These 
symptoms may also complicate care provision. They can occur at any stage of the illness 
trajectory and include, amongst others depression, hallucinations, delusions, aggression, 
irritability, and wandering (20, 33).  
 
1.2.3 Dementia, multi-morbidity and frailty 
Many people with dementia also have other common conditions of older age (34), notably frailty 
(35). As a consequence of dementia, multi-morbidities, disability, and polypharmacy (36-38), 
people with dementia may experience high physical symptom burden, and emotional and social 
concerns. People with advancing dementia may have challenges expressing their wishes and 
concerns (39, 40) and symptoms and concerns may therefore be undetected and untreated, 
leading to reduced quality of life and avoidable distress. Distress can manifest as behavioural 
changes that may challenge, for example aggression, irritability, and wandering, making the 
provision of care increasingly complex and demanding, and depleting already-stretched 
resources (41). 
 
1.2.4 Family carers: the impact of dementia and challenges to sustaining the caring role 
Complex care needs, high dependency, high symptom burden, and behaviours that challenge 
place considerable demand on family carers, or those close to the person with dementia. In 




addition, the main carer is often a spouse of advanced age who may be living with multi-
morbidities themselves (42).  The complexity of care needs, and the health and wellbeing of family 
carers means many people with dementia move into a care home (43), particularly in the 
advanced stages; with cognitive impairment being a prominent predictor of care home transition 
(44). In particular, worse cognition, higher dependency, behaviours that challenges, and carer 
burden all increase the risk of care home transition (43, 45, 46). It is estimated that approximately 
36.5% of those with dementia live in care homes increasing from 27.8% of those in those aged 
65-74 to 60.8% in those aged 90 and over (47). In 2012-2014, 58% of all deaths of people with 
dementia occurred in the care home setting (34). 
 
While a move into care homes may increase support for family members, it is also a time of loss; 
and may result in a different type of carer stress (48). Many family members would like to retain 
a caring role when a relative moves to a care home (49, 50) but frequently feel excluded from this 
(48). This can result in a sense of loss, frustrations due to a lack of control, and difficulties 
adjusting to their change in role (48). 
 
1.2.5 The care home context: residential care homes 
Care homes offer 24-hour staffed accommodation and care to people who are no longer able to 
live independently and who may require support during the day and night (1). The most common 
reasons for admission to care homes are clinical (48.7%) followed by frailty (28.8%) (51).  
 
There are different types of care homes in the United Kingdom (UK) and internationally, 
categorised by staffing (52). Care homes in England are registered with the Care Quality 
Commission (CQC) (1). Type of care home and registration comprise two main types: nursing 
homes (those with 24-hour onsite registered nursing staff for people who may have nursing 
needs) and residential care homes (those with no onsite registered nursing staff) (1). Both nursing 
and residential homes may also be registered to provide care for specific age groups e.g. people 
65 years and older, and conditions e.g. dementia (1). Even though there are differences in the 
staffing requirements and registration, the two types of care home often provide care for similar 
groups of people with complex care needs. In 2009, Bupa, with the Centre for Policy and Ageing, 
carried out a census of all their care homes in the UK, Australia, New Zealand, and Spain with a 
95% response rate, and incorporating 15,477 care home residents in the UK. The average age 




of residential care home residents in the UK was 85.0 (n=3,829) compared to an average of 82.0 
(n=11,575) of nursing home residents (51). The most common conditions were similar for 
residential care home residents (n=3,829) and nursing home residents (n=11,575) comprising: all 
neurological impairments – including dementia and stroke (65.5% versus 78.3%), incontinence 
(65.0% versus 77.2%), dementia (40.9% versus 45.0%), arthritis (19.7% versus 18.0%), heart 
disease (15.6% versus 22.3%), and stroke (11.9 versus 23.1%) (51). 
 
The total number of care home beds in England is over 450,000. The two types of care homes 
have a similar total bed capacity, but with nursing homes tending to be larger. In 2017 the number 
of residential care home beds was 239,902 compared to 220,815 nursing home beds in England 
(53). The number of residential care homes in England registered with the CQC (1) was 10,858 
compared to 4,042 nursing homes (53). Residential care homes are typically small (1-10 beds: n-
4,408, 41.0%) or medium (11-49 beds, n=5762, 53.1%). Larger residential care homes of 50 beds 
or more are less common (n=688, 6.3%) (53). The majority care home services in England are 
predominantly provided by independent organisations (private or voluntary) (54). These 
organisations are largely responsible for employment, training, pay, and terms and conditions for 
their employees (54).  
 
The adult care sector in England is under increasing pressure. There is a growing demand for 
services, with an ageing population and complexity of care needs associated with longevity and 
commonality of multi-morbidity (27, 55). The increasing demand is further compounded by 
workforce challenges notably high staff turnover (27.8% in 2016-2017), high staff vacancies (6.6% 
in 2016-2017), and increasing demand for care exceeding growth in jobs. Workforce challenges 
relate in particular to care work being perceived as low skilled with limited opportunities for career 
progression, low pay, and leadership problems with high vacancy rate of managements (11.3% 
in 2016-2017) (54). In addition, the care sector is under significant financial pressure with the 
majority of its income from public funding (65%). In the past six years, local authority spending on 
care has decreased by 5.3% in real terms and is further expected to decrease by 0.2% in the next 
two years. This, with the increasing demand in care, mean there is a significant spending 
pressures and a lack of certainty about future funding being sufficient, resulting in further impacts 
on workforce planning. 
 




The workforce employed in adult residential care homes in England is relatively large (305,000 
jobs), and comprises mainly women (83%) with an average age of 43 years (56). Most posts are 
direct carer jobs (225,000 approximately) (56). Around half the posts are full-time (53%) with the 
remainder part-time (40%), or with no set hours (8%) (56). The majority of the residential care 
home workforce in England are British (85% in 2016/2017), and only 15% non-British. However, 
the proportion of non-British workers in the London region is much higher with 39% being non-
British across the adult social care sector in England (57).  
 
Few staff hold a formal social care qualification. In 2017, across the adult social care sector 51% 
of direct care staff held no social care qualifications. A small proportion held qualifications at level 
2 (25%) or level 3 (18%) (58). Around half of direct care staff (57%) in residential care homes 
complete or partially complete the Care Certificate within two years of moving into the sector. This 
is lower than in nursing homes (67% of direct care staff) (57). The Care Certificate is 
predominantly targeted as those new to the care sector and comprises 15 standards,  for 
example, duty of care; equality and diversity; awareness of mental health, dementia and learning 
disability; and safeguarding adults (59).   
  
Overall, residential care homes face many challenges. They care for a population with 
increasingly complex care needs, have challenges with workforce recruitment and retention, and 
most staff members hold no formal training. They are also not required to employ registered 
nurses (nurses) and therefore rely on community and primary care services to meet residents’ 
health care needs (60, 61). This means that residential care home staff are required to detect and 
monitor changes in symptoms and concerns, and access health care on the individual’s behalf. 
This is despite the fact that the majority (or frequently all) do not hold a clinical qualification such 
as nursing. 
 
Access to health care for people living in care homes depends on integrated working between 
residential care homes and health care providers (60, 62). However, there are barriers to 
integrated working between these sectors. These include (i) different work cultures, priorities, 
infrastructures and funding sources; (ii) hierarchies and power dynamics; (iii) poor training 
opportunity with high staff turnover in care homes (60, 62-65); and (iv) a lack of clearly defined 
roles (60). In this context, some care home staff may face challenges in communicating and 




sharing their assessments of residents with health care professionals. They may not feel listened 
to or understood by health care professionals, or feel that their skills are not respected (64). 
Access to specialist health services for people living in care homes compared to those living at 
home is often inequitable (63, 66-70), including access to palliative care (71). 
 
1.2.6 Palliative care and dementia 
Palliative care is defined as, 
‘an approach that improves the quality of life of patients and their families facing the problem 
associated with life-threatening illness, through prevention and relief of suffering by means of 
early identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual’ (14) 
 
There is international consensus that palliative care, with its aim to improve quality of life through 
comprehensive and timely assessment, and treatment of distressing symptoms and concerns 
may benefit people with dementia (22). However, there is a lack of consensus about when in the 
disease trajectory palliative care should be introduced or provided (22). A goal-directed model of 
care to address this has therefore been proposed (Figure 1) (22, 72). This model is based on the 
suggested premise that there are three main goals of providing medical care: ‘prolongation of life’, 
‘maintenance of function’, and ‘maximisation of comfort’. It is proposed that palliative care is most 
aligned to the goals of ‘maintenance of function’ and ‘maximisation of comfort’, which starts at the 
onset of dementia but increases as dementia progresses (72). Palliative care and arguably all 
high-quality dementia care aims to improve quality of life (14) and maintained function and living 
without discomfort are essential components of good quality of life (73, 74). Improving quality of 
life for people with dementia throughout the disease trajectory is indisputably an essential part of 
good quality dementia care. It is therefore difficult to argue against an approach that emphasises 
early and impeccable assessment and treatment of physical, emotional, social and existential 
concerns, as well as family concerns in this population (14). There is evidence that introducing 
routine assessment of quality of life into clinical care may improve quality of life in other 
populations with serious illness, notably cancer (75, 76).  
 





Figure 1 Dementia progression and suggested prioritising of care goals (22) 
 
 
The projected increase in dementia deaths, the long illness trajectory, and the potential capacity 
for people with dementia to benefit from palliative care pose a substantial challenge to the 
palliative care discipline (27). Currently, specialist palliative care does not have the capacity to 
meet this need, and huge training of specialist palliative care professionals would be required to 
do so (27). There is therefore an urgent requirement to find a better model of care delivery to 
meet this need. A possible and more feasible model is for those providing the majority of care to 
people with dementia, or generalist palliative care providers, to continue to do so with the support 
of specialist palliative care for more complex patients (77). However, this requires that those 
providing the majority of care have the necessary skills to assess and manage symptoms and 
concerns, and access health care services and specialist palliative care services when required. 
For people with dementia in care homes and residential care homes in particular, those providing 
the majority of care are care home staff without a clinical qualification. Care home staff are well-
placed to assess symptoms and concerns due to their frequent close contact and good knowledge 
of the residents they care for (78). On the other hand, this means it is essential for them to be 
able to detect and address symptoms and concerns in a timely way, and access health care to 
support the treatment and management of distressing symptoms. Given the paucity of evidence-
based interventions for this population in this setting (71, 79-81), there is therefore an urgent 
requirement for interventions that support assessment and management of symptoms and 
concerns by care home staff without a clinical qualification for this population. 





1.3 Measures used in routine care for people with dementia 
1.3.1 Patient-reported outcome measures and proxy-reported outcome measures 
Patient-reported outcome measures (PROMs) are standardised and validated questionnaires, 
which are completed by patients to measure their perceptions of their own health status (8). 
Traditionally designed to measure outcomes as a result of research studies, there is increasing 
recognition of their potential benefit as an intervention in routine clinical care as a means of 
improving the provision and outcomes of patient-centred care (7, 11). This is because PROMs 
intend to measure and capture concerns held by patients, which may inform care and treatment, 
and enable the review of outcomes of the care and treatment provided (82). There is an increasing 
policy emphasis on the use of PROMs in health and social care to ensure that the outcomes of 
care are patient-centred, and commissioning is increasingly being based on care outcomes rather 
than care processes (83). As a consequence, there is a growing use of PROMs in palliative care 
to support assessment and evaluation of physical, emotional, social and existential concerns 
important to the patient (7, 84), and to demonstrate effective care and improved outcomes for 
patients with complex needs and their family members (85). 
 
PROMs have been used successfully with people with dementia to measure, for example, quality 
of life (86). However, it becomes increasingly challenging for people with advancing dementia and 
difficulty expressing their wishes or concerns to complete a PROM; and proxy-reported measures 
may be used instead (86). Proxy-reported measures may also measure patient-centred concerns, 
but are completed by a person who knows the patient well, often a family member or a 
professional providing care (87). However, there are threats to the validity of using proxy-reported 
measures in people unable to express their wishes or concerns; with regards to the degree to 
which the proxy account reflects the concerns of the person. This is particularly the case for 
subjective symptoms or concerns such as pain and depression (88). Proxy assessment may be 
conducted through clinical examination, or through observation of behaviour or signs, a method 
which many of the pain assessments developed for this population utilise (89). Good knowledge 
of the person and regular close contact with the person may enhance assessment by providing 
the opportunity for close observation and detection of any changes to presentation and 
behaviours (78). Used as part of routine care, PROMs and proxy-reported outcome measures, 




together known as patient-centred outcome measures (PCOMs) are means of assessing and 
monitoring symptoms and concerns important to the patient in order to improve patient-centred 
care and patient-centred outcomes, and are therefore complex interventions (7). This is due to 
the interacting components involved e.g. assessment, communication, change of care delivery; 
the requirements for behaviour change and flexible delivery; and potential for multiple outcomes 
(2). 
 
1.3.2 Theory of change 
This study uses a theory of change to inform the intervention development. The study commenced 
with developing a theoretical model to inform how a PCOM used in routine care may change care 
processes to improve outcomes for people with dementia living in residential care homes. Using 
the theory of change informed the theoretical model underpinning the study to provide a 
theoretical understanding of how the complex intervention of a PCOM may work. The theoretical 
model also underpinned the study design and methods including the use of mixed methods, 
methods of data collection and data analysis, and implementation requirements for using a PCOM 
in routine care. 
 
Theory of change is a ‘theory of how and why an initiative works’ (90). It presents a hypothetical 
causal pathway in which each step can be tested. The theory is presented in diagrammatic format 
to demonstrate the expected causal mechanisms of action in which an intervention is expected 
to achieve its intended outcomes (91). It provides a pragmatic and flexible framework in unpacking 
the ‘black box’ of a complex intervention, and allows for multiple pathways without a pre-defining 
structure (91) and may be developed from research evidence or constructed by stakeholders (92). 
Theory of change has been proposed as a means of strengthening the application of the Medical 
Research Council guidance for developing and evaluating complex interventions (MRC guidance) 
(2, 93) throughout all the phases (91, 94). For example, and in this study,  theory of change in the 
development of a complex intervention supports stakeholder engagement, makes explicit the 
likely mechanisms of action, and helps adapt and tailor the intervention to the context (91, 94). 
While, in feasibility testing, it helps identify any implementation barriers and applicability, and 
acceptability of the intervention (91, 94). A criticism of theory of change is that it remains relatively 
superficial and does not provide the in-depth understanding of how an intervention may work 




within the context (95) while its strength is that it provides a theoretical means of managing 
complexity, and multiple components of an intervention (95).  
 
1.3.3 Patient-centred outcome measures used in routine care of people with dementia in 
care homes: theoretical underpinning of a complex intervention 
Few studies have tested the effectiveness of using PCOMs in routine care for people with 
dementia, and specifically for those living in care homes (7). Those that have been conducted 
have predominantly utilised pain assessment to examine whether this improved detection and 
management of pain (96) rather than comprehensive assessment of all physical, emotional, social 
and existential concerns that people with dementia may experience. However, there is some 
qualitative evidence that the use of a palliative care symptom assessment tool may support care 
processes and improve quality of care of people with dementia in care homes (97). In this study, 
the Minimal Documentation system for Palliative care (MIDOS) tool was used in the care of people 
with advanced dementia in care homes to assess physical and psychological symptoms. Care 
home staff perceived using this PCOM as beneficial in supporting comprehensive assessment, 
and supporting communication within the care home (97). 
 
An underpinning theoretical model is an essential component of a complex intervention to 
understand the linkages between the problem and the intended outcomes (2). To understand how 
using a PCOM in routine care may work to change care processes i.e. the mechanisms of action, 
and improve outcomes (potential benefit) for people with dementia, it is important to have a 
theoretical model. A theoretical model makes explicit the causal assumptions of the intervention. 
Understanding the assumptions is essential in understanding the intervention, evaluating 
uncertainties, and extending the understanding of the intervention including how it is to be 
delivered and implemented within the context. By making the assumptions explicit, the 
intervention can be evaluated against the theory and refined accordingly (2, 3, 5, 93). Theory 
further provides a conceptual organisation to the overall study, including the planning and conduct 
of the design, methods, and analysis and interpretation of data. In mixed-methods research, an 
underpinning theory provides a means of structuring, organising, and integrating the data from 
both qualitative and quantitative methods to understand the phenomena under study (98, 99). 
 




This study therefore draws upon the use of outcome measurement in clinical care to develop a 
theoretical model of how a PCOM used in routine care may support assessment and management 
of symptoms and concerns to potentially benefit people with dementia living in residential care 
homes. 
 
Theoretical models of the likely mechanisms of action of using PCOMs in routine clinical care 
have been developed. Slade (100) addressed the use of routine outcome assessment in clinical 
care and proposed a testable model of the expected mechanisms of action. This model, 
developed for mental health services, proposes the use of routine patient- and staff-reported 
outcome measures, and feedback of the data to both groups. Completing the outcome measure 
and/or receiving feedback may prompt mental health professionals or patients to reflect on the 
process or content of care, resulting in changes to process and/or content of care, and improved 
patient outcomes including reduced unmet need and improved quality of life (100) (Figure 2). 
However, there are limitations to applying this model to the care of people with dementia in care 
homes. The role of family members (including friends or others close to the person with dementia) 
is not taken into consideration in this model. Palliative care aims to intervene to address the 
concerns of people with a life-limiting or chronic illness and their family members (14, 101). It is 
important that the model incorporates family members’ roles in the care of people with dementia, 
and also understand how using a PCOM may benefit family members. Another limitation is that 
the model is developed for the health care setting and therefore does not take into account the 
requirement for care home staff to access health care on behalf of people with dementia and the 
challenges associated with this.   

























*Staff model, the same processes may occur for patients 
 
Assessment plus feedback 
Patient Assessment Feedback Staff Assessment 
Staff receive feedback 
Staff read feedback 
Staff reflect on 
process of care 
Staff reflect on 
content of care 
Staff behaviour 
changes 
Care plan is discussed and 
changed 
Process of care 
changes 
New care is provided 
Improved alliance Improved collaboration/ 
negotiation 
Improved outcomes – fewer unmet needs and increased quality of life 
 
Figure 2 Mechanisms of action for staff involved in routine outcome assessment and feedback (100) 
 
Greenhalgh and colleagues (102) proposed a theoretical model to demonstrate how PROMs used 
in routine clinical care may improve patient outcomes. In this model, a series of hypotheses, with 
the strength of evidence based on trial results are proposed demonstrating the mechanisms of 
action of using and feeding back information from PROMs to health care professionals. 
Mechanisms of action include improved communication between health care professionals and 
patients, detection of unrecognised problems, monitoring of treatment response, and changes to 
health care professionals and patient behaviour; resulting in improved patient satisfaction and 




improved health outcomes (102) (Figure 3). Once again, there are limitations to applying this 
model to the care of people with dementia in care homes, including the role of family members, 
and the challenges of integrated working between care home staff and health care professionals. 
In addition, this model is developed to understand the use of PROMs in routine care. The 
mechanisms of action of using a care home staff reported PCOM are likely to be different to those 
of PROMs used in clinical care. 
Figure 3 Outcomes and hypotheses in the trials evaluating the impact of health status measures on clinical 
decision-making (102) 
 
These models are useful to identify the expected mechanisms of action of using a PCOM 
intervention in routine care, and the anticipated patient outcomes. However, adaptations are 
required to take into consideration: 




(i) The likely mechanisms of action of using a care home staff reported outcome 
measure instead of a PROM. 
(ii) The requirement for family members to be included in the assessment, monitoring 
and care of people with dementia in care homes, and an understanding of potential 
benefit to family members. 
(iii) The requirement for integrated working between care home staff and health care 
professionals so that care home staff can access health care on behalf of people with 
dementia. 
 
Consequently, a decision was made to develop a theoretical model that outlines expected 
mechanisms of using a measure in routine care of people with dementia living in care homes, 
drawing upon the two existing models (100, 102) but adapting it for this population and setting. In 
particular, the model was developed with the following considerations: 
(i) Terminology: the term ‘patient-centred’ reflects a clinical setting. Care homes are 
people’s homes and are not clinical settings. The term ‘patient-centred’ or PCOM was 
therefore not used for the purposes of this study. In addition, to reflect the use of the 
outcome measure as a care intervention, rather than as an instrument to measure 
outcomes for research purposes, the term ‘measure’ is used rather than ‘outcome 
measure’. Accordingly, the term ‘measure’ is used henceforth in this thesis. 
(ii) The theoretical model reflects that the measure aims to assess symptoms and 
concerns in people with dementia who may be unable to express their symptoms and 
concerns verbally. 
(iii) Many agencies may be involved in assessment, decision-making and management 
including the person with dementia, family members and friends of the person with 
dementia, care home staff (including support staff, night staff, keyworkers and 
managers), and health care professionals (50, 62-64, 103). Communication between 
all agencies is an essential process that needs to be incorporated at all stages. 
 
The theoretical model developed for this study draws upon both models (100, 102) and takes into 
account these three considerations. Figure 4 overviews the theoretical model underpinning this 
thesis. The model details the expected mechanisms of action of the use of a measure in routine 




care to support assessment, timely delivery of care and treatment, and review and improve 
outcomes. The key expected mechanisms of action comprise: 
(i) Routine use of the measure in care home staff’s day-to-day care and review of people 
with dementia. Routine use means that care home staff are prompted at regular points 
in a person’s care to assess and monitor symptoms and concerns. This includes gaining 
an account from the person with dementia either verbally or through observation when 
providing care, speaking to family members and colleagues, and reading case notes. 
(ii) Completing the measure supports care home staff to detect symptoms and concerns 
in people with dementia. Scores on the measure may help care home staff prioritise 
treatment of symptoms and concerns.  
(iii) If required, the completed measure facilitates integrated working by supporting care 
home staff to communicate symptoms and concerns to health care professionals. The 
completed measure provides a documented summary of the symptoms and concerns 
experienced by the person. This provides a means of communicating information to 
health care professionals in an easily accessible format. In addition, scores on the 
measure support communication of severity and urgency of symptoms and concerns to 
support health care professionals in prioritising treatment. 
(iv) The process of using the measure, detecting symptoms and concerns and 
communicating assessments to health care professionals prompts shared decision-
making and care planning between family members, care home staff, and/or health 
care professionals. Where possible, people with dementia too may be enabled to 
participate in shared decision-making in care planning, particularly when they are able 
to express their wishes and concerns. A comprehensive assessment that can be easily 
shared between all agencies supports communication and prioritisation of care needs, 
thus supporting shared decision-making and care planning. 
(v) Shared decision-making and care planning may result in changes to care provided by 
care home staff. Care home staff may identify symptoms and concerns that they are 
able to address through changes in the care provision. This may be, for example, 
tailoring activities to enable and support the person to engage in activities. 
(vi) Shared decision-making and care planning may result in changes to health care 
management by health care professionals. This improves treatment of symptoms. 




(vii) Referrals to other services including secondary or specialist services such as mental 
health teams, specialist palliative care, or therapy services results from shared decision-
making and care planning. 
(viii) As a consequence of shared decision-making and care planning, people with 
dementia and family members change behaviour. People with dementia may feel 
that their symptoms and concerns are being better addressed, and have increased 
satisfaction or engagement with care. A reduction in behaviour that challenges, resulting 
from psychological distress, may also occur if distressing symptoms and concerns are 
adequately addressed. Behaviour that challenges resulting from physiological causes 
may also be addressed, through improved treatment and management from care home 
staff, family members and health care professionals. Family members too may feel 
better able to engage in the care, and therefore may take an active role in the care of 
people with dementia. 
(ix) Changes to care provision, to health care management and behaviour of people with 
dementia and family members; and referrals to other services result in improved 
outcomes for people with dementia and family. This includes reduced unmet need, 





















Change to health care management 
Health care staff change health care 
provision 
 
Referral to other services 
including secondary health 
care, therapy services, 
specialist palliative care 
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decision making and 
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satisfaction with care 
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Care home staff use measure to 
communicate problems to health 
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- care home staff 
- people with dementia 
- family members 
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Detection of symptoms and 
concerns 
Symptoms and concerns detected 
by care home staff.  Scores support 
prioritisation. 
Routine use of measure 
- Implemented in routine care to 
assess and monitor for symptoms 
and concerns over time  
- Improved communication between 
care home staff and people with 
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- Improved observation in care 
provision 
- Improved communication between 
care home staff and family members 
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Figure 4 Theoretical model of expected mechanisms of action of measure used in routine care of people with dementia in care homes    












1.3.4 Measurement properties for use in routine care in care homes 
Also included in the theoretical model are the particular requirements of measures used in routine 
care to support its use and changes to care processes; as well as the consideration of 
implementation into routine care.  
 
Outcome measures developed for use in research may have less utility when used in routine 
care, with barriers to their use. Some of these barriers are related to resources, but many are 
related to the properties of the measure. Table 1 identifies measure-related barriers to using 
measures in routine clinical care (11, 12), and requirements of measures identified in palliative 
care and mental health literature to overcome these barriers (11-13). These requirements are 
categorised in Table 1 according to the following commonly accepted definitions from the 
literature on clinical measurement (9-13), although the same requirements are important in non-
clinical care home settings (104). 
 
Validity: the degree to which an instrument measures what it purports to measure (9). 
Reliability: ‘the degree to which the measurement is free from measurement error’ (9). 
Responsiveness: the ability of a measure to detect change over time in the construct to be 
measured (9). 
Interpretability: the degree to which one can assign qualitative meaning, or clinical connotations, 
to a measure’s score(s) or change in score(s) (9). 
Acceptability: whether patients (for patient-reported measures) or staff/health care professionals 
are prepared to and willing to use the measure (10), and its suitability for intended use in clinical 
care (11). 
Comprehension: how patients or staff/health care professionals understand, interpret terms, and 
choose their responses (10). 
Feasibility: whether patients or staff/health care professionals are able to use the measure in 
their respective setting or context (10). 
Availability: the requirement for measures, and additional training and resources, to be easily 
and freely accessible (12, 13). 
 
  




Table 1 Barriers, measurement requirements and properties of measures used in routine clinical care 
Measure-related barriers (i.e. 
not staff-related or resource-
related) 
Requirements of measure to 
minimise barriers 
Measurement property 
Lack of validated version for 
setting and/or population (12) 
Valid and reliable for 
population and setting (11) 
Validity and reliability 
The measure is not able to 
detect changes when the 
construct being measured has 
changed (10) resulting in 
limitations in monitoring 
symptoms and concerns, and 
changes in symptoms and 
concerns over time 
Responsive to change: the 
measure detects clinically 
meaningful changes (11) 
Responsiveness 
Interpreting what the score 
means clinically may be 
challenging. This is particularly 
the case for multi-item 
measures where the result is 
not immediately obvious (10) 
The results of the measure can 
be interpreted clinically and are 
relevant (11). Staff are able to 
make decisions about care 
based on the scores (105) 
Interpretability  
Lack of available training or 
guidance on how to use the 
measure and interpret the 
scores (12) 
 
Require trained researchers to 
administer (11) 
Measures are easy to use, 
simple, and easy to score (11, 
13) 
 
Simple instructions, do not 
require formal training (13) 
Acceptability and 
comprehension: easy to 
use and score, any training 
is easy to understand and 
simple 
Not clinically relevant to the 
population (11) 
Relevant and suitable for its 
intended use in clinical practice 
or care (11) 
 
Relevant to the intended 
population with familiar 
language and concepts, 
avoiding jargon, with relevant 
choice of language (13) 
Acceptability and 
comprehension: relevant 
to population and to 
clinical purposes, 
language is relevant and 
easy to comprehend 
The costs of using the 
measure outweigh the 
perceived benefits, and the 
information obtained from 
completing the measure (13) 
Value to care: the benefits to 
use outweigh the relative costs 
(13) 
Acceptability: providing 
value to care 
Burdensome for staff (12) 
 
Too lengthy for clinical care 
(11) 
Brief, quick to complete (11, 13) 
 
 
Feasibility: brief and quick 
to complete 
Not able to access information 
on measure (12) 
 
Limited access to measure 
(12) 
 
Costs for using measure (12) 
 
Measure not available in 
language (12) 
 
Lack of training on how to 
analyse measure data (12) 
 
Access to measure information 
and training (12) 
 





training and resources are 
freely available to health 
care professionals, 
translated versions 
available for international 
use 
 




1.3.5 Implementation requirements 
As with all complex interventions, it is important to consider the process of implementing in 
practice (3). Implementation is defined as the process through which an intervention is delivered 
and what is actually delivered in practice (5). This study is not an implementation study and it is 
beyond its scope to examine the implementation of measures into routine care. Nonetheless, in 
developing any intervention, it is important to consider implementation from the outset (2). 
Implementation requirements of the intervention, in this case a measure used in routine care, 
include important features of the intervention that maximise its implementation such as training 
and additional resources, and the mechanisms which may support implementation. 
 
1.4 Summary of key points 
Changing demographics mean that there is growing number of people living with and dying from 
dementia. Due to dementia, multi-morbidities, and polypharmacy, people with dementia may have 
multiple symptoms and concerns. In addition, they may have increasing difficulty expressing their 
wishes and concerns resulting in challenges to assessment. Undetected and therefore untreated 
symptoms and concerns may lead to avoidable distress, reduced quality of life and wellbeing, and 
behavioural complications. 
 
Many people with dementia may move into care homes due to the requirement for increased 
support and complex care needs. Residential care home staff, the majority of whom do not have 
a clinical qualification, need to be able to detect and manage symptoms and concerns in people 
with dementia, and access health care when required. This is despite the challenges of assessing 
symptoms and concerns in people with dementia, and challenges to integrated working with 
health care. Family members (including friends and others to close to the person) frequently wish 
to retain their caring role but often feel excluded from the care of people with dementia resulting 
in feelings of loss and frustrations, and difficulty adapting to the transition. There are few evidence-
based interventions to support assessment and management of symptoms and concerns of 
people with dementia in care homes, and their family members. 
 
Measures used in routine clinical care may support comprehensive assessment of symptoms and 
concerns, and change care processes resulting in patient benefit. However, there are gaps in 




knowledge of how they may work to improve assessment and management of symptoms and 
concerns of people with dementia living in care homes; and how they may be best implemented 
into routine care. It is also important that the measurement properties of such measures are 
maximised for a non-clinical environment and for residential care home staff without a clinical 
qualification to use in routine care, in particular, the validity, reliability, responsiveness, 
interpretability, acceptability, comprehension, and feasibility; and availability to care homes with 









2. Existing measures for people with dementia in care homes 
[PUBLICATION 1] 
This chapter presents a systematic review published in 2016. The systematic review aimed to 
identify measures to assess symptoms and concerns experienced by people with dementia in 
care homes. In particular, the review identified measures that care home staff without a clinical 
qualification are able to use to assess people who have difficulty or are unable to verbally express 
their wishes and concerns due to dementia. They are therefore measures that do not rely on a 
clinical examination, rather they use observation of signs and behaviours.  
 
The systematic review identifies the measures and evaluates them according to measurement 
































































































Additional file 1: PRISMA checklist  
 








Additional file 2: Full search strategy1,2 
1. exp Dementia/ 
2. Delirium/ 
3. Wernicke Encephalopathy/ 
4. Delirium, Dementia, Amnestic, Cognitive Disorders/ 
5. dement*.mp. 
6. alzheimer*.mp. 
7. (lewy* adj2 bod*).mp. 
8. deliri*.mp. 
9. (chronic adj2 cerebrovascular).mp. 
10. ("organic brain disease" or "organic brain syndrome").mp. 
11. ("normal pressure hydrocephalus" and "shunt*").mp. 
12. "benign senescent forgetfulness".mp. 
13. (cerebr* adj2 deteriorat*).mp. 
14. (cerebral* adj2 insufficient*).mp. 
15. (pick* adj2 disease).mp. 




20. Long-Term Care/ 
21. exp Nursing Homes/ 
22. Assisted Living Facilities/ 
23. Homes for the Aged/ 
24. long term care.mp. 
25. nursing home*.mp. 
26. care home*.mp. 
27. residential care home*.mp. 
28. OR/1-27 
29. Geriatric Assessment/ 
30. Needs Assessment/ 
31. Health Impact Assessment/ 
32. exp Nursing Assessment/ 
33. Symptom Assessment/ 
34. exp nutrition assessment/ 
35. Psychometrics/ 
36. Pain Measurement/ 
37. psychomet*.mp. 
38. assess* instrument.mp. 
39. assess* tool.mp. 
40. (observ* adj5 assess*).mp. 
41. OR/29-40 
42. Palliative Care/ 
43. exp Terminal Care/ 
44. Terminally Ill/ 
45. Hospice Care/ 
46. palliative care.mp. 
47. palliative treatment.mp. 
48. palliative medicine.mp. 
49. terminal care.mp. 
50. terminally ill.mp. 
51. end-of-life care.mp. 
52. hospice care.mp. 
53. exp Pain/ 
54. exp Pain Management/ 
55. pain.mp. 
56. exp Dyspnea/ 







60. exp Deglutition Disorders/ 
61. swallow*.mp. 
62. (swallow* adj3 problem*).mp. 
63. Constipation/ 
64. constipat*.mp. 
65. (mouth adj3 pain*).mp. 
66. Toothache/ 
67. (dent* adj3 pain*).mp. 
68. Accidental Falls/ 
69. fall*.mp. 
70. mobil*.mp. 
71. Pressure Ulcer/ 
72. (pressure adj3 ulcer).mp. 
73. (pressure adj3 sore).mp. 
74. (skin adj3 breakdown).mp. 









84. exp Depressive Disorder/ 
85. exp Anxiety/ 
86. exp Anxiety Disorders/ 
87. anxiety.mp. 
88. anxious.mp. 
89. "Quality of Life"/ 




94. "Activities of Daily Living"/ 
95. ADL*.mp. 






102. exp Sleep/ 
103. (sleep adj3 disorder*).mp.  
104. OR/42-103 
105. 28 and 41 and 104 
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functioning in people with dementia. Cochrane Database Syst Rev 2012, 2:CD005562. doi: 
005510.001002/14651858.CD14005562.pub14651852. 
2. Hall S, Kolliakou A, Petkova H, Froggatt K, Higginson IJ. Interventions for improving palliative 
care for older people living in nursing care homes (review). Cochrane Database Syst Rev 
2011(3):CD007132. doi:007110.001002/14651858.CD14007132.pub14651852. 





































































Additional file 4: Psychometric evaluation of measures 
 
 




































Additional file 5: Summary of measure details, methods of administration, and feasibility and applicability in care
 
 



















































































2.1 Summary of key points and gaps  
This systematic review found that there are no comprehensive assessment measures developed 
specifically for care home staff without a clinical qualification to assess physical symptoms and 
emotional, social and existential concerns for people who have difficulty expressing their wishes 
and concerns due to dementia. It is proposed that such a measure could address an important 
gap in the care of people with dementia living in care homes through facilitating prompt detection 
and management of potentially distressing symptoms and concerns, and in turn, reducing 
avoidable distress and improving quality of life.  
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3. Identification of a comprehensive measure to develop as an 
intervention for use in routine care of people with dementia 
in care homes 
3.1 Introduction 
This chapter starts by discussing the benefits of adapting an existing comprehensive measure 
versus developing a completely new measure. Having presented the argument for adapting an 
existing measure, a review of measures used in palliative care is conducted to identify potentially 
suitable measures and compare their relative strengths and limitations of adapting for this purpose 
and population. A rationale is provided for the selected measure, and the chapter concludes with 
a brief summary of this measure, and next steps on how to adapt it to use in routine practice for 
people with dementia in care homes. 
 
3.2 Developing a new measure or adapting an existing measure? 
A decision needed to be taken as to whether to develop a new measure or adapt an existing one.  
The systematic review [chapter 2: publication 1] identified 32 measures to assess individual 
symptoms or groups of symptoms. In addition, there is a plethora of measures developed for 
research and/or clinical care for people with dementia including those that measure quality of life 
(107-110), functional ability (111-113), and behaviours that challenge (114-120). Results of a pan-
European survey of measures used in palliative and advanced disease care found that 
respondents used 116 measurement tools in clinical care and audit, and that 99 of these were 
cited less than 10 times (84). Based on the results of this survey, the authors recommended that 
the number of tools be rationalised, and that new measurement tools are not developed but rather 
existing ones refined (84). The decision was therefore taken to identify a comprehensive measure 
of symptoms and concerns with robust psychometric properties, and established for use in routine 
clinical care, to adapt for use as an intervention in the routine care of people with dementia in 
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3.3 Selecting an existing measure to adapt for people with dementia 
No comprehensive measure developed for care home staff to use as an intervention as part of 
routine care was identified from the literature [Chapter 2: Publication 1]. Palliative care, with its 
aim to provide comprehensive assessment of all physical symptoms and emotional, social and 
existential concerns experienced by people with life-threatening and chronic illness, and their 
families (14, 101), is advocated for people with dementia (22). An established palliative care 
measure developed for use in routine clinical care is therefore well-suited for adaptation for this 
population and purpose.  
 
As part of the PhD preparation, a scoping review on measures used in palliative care for people 
with dementia was conducted (see Appendix A for methods). This initial scoping review identified 
four reviews/evaluations of measures, all published in the previous two years. These included a 
systematic review of measures used to assess the quality of palliative care provided in care home 
settings (121), and a series of studies to identify palliative and end of life measures used in care 
home settings and evaluate their properties (104, 122, 123). The identified measures from these 
reviews and evaluations were appraised to identify the most suited measure for adaptation, rather 
than repeating or updating a systematic review. 
 
3.3.1 Aim 
To identify the most suitable comprehensive measure for adaptation to support assessment and 
management of physical symptoms and emotional, social and existential concerns by care home 
staff without a clinical qualification for people with dementia living in care homes who may have 
difficulty in verbally expressing their wishes and concerns. 
 
3.3.2 Methods 
3.3.2.1 Study design 
This was a review of reviews/evaluations of measures for people with dementia living in care 
homes identified in the scoping review (Appendix A). The identified reviews/evaluations are 
detailed above and reported in more detail below. The identification and appraisal of suitable 
measures included in the reviews/evaluations incorporated two stages. In stage one, all measures 
identified from the reviews and evaluations were examined against eligibility criteria informed by 
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the theoretical model and measurement properties detailed in chapter one. Those measures not 
meeting the eligibility criteria were excluded. In stage two, the remaining measures were 
examined in greater detail, and their relative strengths and weaknesses for adaptation were 
compared and contrasted. Reference list searches of the four reviews/evaluations was conducted 
to identify relevant papers cited. Publications were included if in English, reporting a review or 
original study on the psychometric properties, acceptability and feasibility for use in care homes, 
and/or translations or cross-cultural validations of any of the measures meeting the stage one 
eligibility. Conference abstracts and grey literature were excluded.  
 
3.3.2.2 Eligibility criteria for measures 
The theoretical model and measurement properties detailed in chapter one were utilised to 
develop a set of criteria to examine each of the identified measures. 
Stage one eligibility: 
(i) Measures that are proxy-reported rather than patient-reported. As the measure is 
developed to support assessment of people who may have challenges expressing 
their wishes and concerns, patient-reported measures were excluded from 
consideration. 
(ii) The aim of the measure i.e. what the measure was developed to assess. Measures 
that aimed to assess predominantly quality of care, quality of life, single symptoms or 
single care processes e.g. communication did not meet the criteria for adaptation and 
were excluded from consideration. 
(iii) Whether the measure was developed to be used pre-death. Measures developed for 
administering post-death to evaluate quality of dying were excluded as the measure 
is required to inform care prospectively and be relevant for all people with 
dementia in care homes not just those at the dying phase. However, those measures 
that had been developed for post-death but had also been used or evaluated before 
death and may therefore have some relevance pre-death, were included for 
consideration as a potential measure for adaptation. 
(iv) Whether the measure had been undergone psychometric evaluation in people with 
dementia in care homes. Those measures that had not undergone psychometric 
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evaluation in this population were excluded to ensure that only measures with some 
evidence of validity and reliability in this population were included for consideration. 
Stage two eligibility: 
(i) Whether the measure was developed to assess comprehensive symptoms and 
concerns. Those that were developed to assess comprehensive symptoms and 
concerns experienced by people with dementia throughout the disease trajectory 
were considered preferable so as to maximise relevance and therefore content 
validity and acceptability to all people with dementia living in care homes (124). 
(ii) Evidence on how well-established it is as a clinical assessment measure, including 
ease-of-use of the measure and any training to inform whether it is acceptable and 
feasible for routine care. 
(iii) Whether the measure requires a clinical qualification to complete it. Those measures 
explicitly stating that they were developed or tested when used by health care 
professionals with a clinical qualification were considered to require a clinical 
qualification to administer. This informed acceptability and comprehension for 
proxies without a clinical qualification. 
(iv) A detailed review of the psychometric properties of the measure in people with 
dementia in care homes to determine validity, reliability, responsiveness and 
interpretability. 
(v) Evidence on how well-established and available the measure is, including 
translations, cross-cultural validations, evidence of use in routine clinical care and 
any data on access and charges. 
 
3.3.2.3 Data extraction  
Stage one data extraction: 
Data extraction of the reviews/evaluations included name of lead author, date and country of 
publication, the aim of the study, study design, and inclusion criteria of measures. Data extracted 
on the measures included name of the measure, date of publication, country it was developed in, 
whether the measure self-reported or proxy-reported, what the measure aimed to assess, when 
the measure was designed to be completed i.e. pre-death or post-death, whether the measure 
had been psychometrically evaluated in people with dementia living in care homes, whether the 
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measure had been specifically developed for people with dementia, and if so, which stages of 
dementia, and whether it had been developed for people living in care homes. 
 
Stage two data extraction: 
Data extraction in stage two was from the four reviews/evaluations and additional identified 
studies from the reference list searches. Data extracted included the measure items, the methods 
of psychometric evaluation, the psychometric properties of the measures, methods of assessment 
of feasibility and acceptability, and feasibility and acceptability data. In addition, any data reporting 
how established and accessible the measure and any training is, and data on translations and 
cross-cultural validations. Both qualitative and quantitative data were extracted. 
 
3.3.2.4 Assessment of quality and data synthesis 
Methods and quality of psychometric testing was assessed using established quality criteria 
(106). Data on the psychometric properties, acceptability and feasibility of the measures used in 
routine care were compared and contrasted for each measure to determine the relative strengths 
and weakness of adaptation. 
 
3.3.3 Results 
The four reviews/evaluations included a systematic review of measures of quality of palliative care 
for use in care home settings to identify and assess the psychometric properties and feasibility of 
measures used to assess the quality of care in palliative care (121), a literature search and 
qualitative content analysis (123), psychometric evaluation (122), and comparison of the 
psychometric properties and feasibility (104)  of measures to assess the quality of care and quality 
of dying for people living in care homes, including those with dementia or cognitive impairment. 
Table 2 provides details on the four reviews and the measures identified in each.  
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assess the quality of 
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To evaluate the 
content of measures 
to assess the quality 
of care and quality 
of dying for 




content analysis of 
measures 
Measures were included if: 
- Used to assess quality of     
dying and/or care when 
dying 
- Used in care home settings 
- Developed, validated or 
widely used in populations 
that include people with 
dementia or cognitive 
impairment 



















To assess and 
compare the validity 
and reliability of 
measures of 
perceived quality of 
care and quality of 
dying for residents 
dying with dementia 




identified in van 
Soest-Poortvliet et 
al (2011) (123) 
Measures were included if: 
- Used to assess quality of     
dying and/or care when 
dying 
- Used in care home settings 
- Developed, validated or 
widely used in populations 
that include people with 
dementia or cognitive 
impairment 

















and US (104) 
To compare 
measures to assess 
quality of care and 
quality of dying for 
people with and 
without dementia 
dying in care homes, 
and provide an 
overview of 
feasibility, validity 
and reliability in the 







carers of people 
who died with 
dementia in the 
Netherlands and 
with and without 
dementia in the 
US (122, 123, 
137) of measures 
identified in van 
Soest-Poortvliet et 
al (2011) (123) 
Measures were included if: 
- Used to assess quality of     
dying and/or care when 
dying 
- Used in care home settings 
- Developed, validated or 
widely used in populations 
that include people with 
dementia or cognitive 
impairment 













EOLD: End of Life in Dementia; EOLD-SM: Symptom Management; EOLD-SWC: Satisfaction With Care; EOLD-CAD: 
Comfort Assessment in Dying; FATE: Family Assessment of Treatment at the End of life; FATE-S: Family Assessment of 
Treatment at the End of life - Short version; FPCS: Family Perceptions of Care Scale; FPPFC: Family Perceptions of 
Physician-Family caregiver Communication; MSSE: Mini Suffering State Examination; POS: Palliative care Outcome 
Scale; QODD: Quality of Dying and Death;  QOD-LTC: Quality of Dying in Long Term Care; QOD-LTC-C: Quality of Dying 
in Long Term Care – Cognitively intact; QOLC-E: Quality Of Life Concerns in End of life questionnaire; mQOLC-E: 
modified Quality Of Life Concerns in End of life questionnaire; RAI-PC: Resident Assessment Instrument for Palliative 
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Sixteen measures were identified from the reviews: End of Life in Dementia – Comfort 
Assessment in Dying (EOLD-CAD) (125), End of Life in Dementia – Symptom Management 
(EOLD-SM) (125), End of Life in Dementia – Satisfaction with Care (EOLD-SWC) (125), Family 
Assessment of Treatment at the End of life (FATE) (126), Family Assessment of Treatment at the 
End of life –Short version (FATE-S) (134), Family Perceptions of Care Scale (FPCS) (127), Family 
Perceptions of Physician-Family caregiver Communication (FPPFC) (135), Mini Suffering State 
Examination (MSSE) (136), Palliative care Outcome Scale (POS) (87), Quality of Dying and Death 
(QODD) (128), Quality of Dying in Long Term Care (QOD-LTC) (129), Quality of Dying in Long 
Term Care – Cognitively Intact (QOD-LTC-C) (129), Quality of Life Concerns in End of life 
questionnaire (QOLC-E) (130), modified Quality of Life Concerns in End of life questionnaire 
(mQOLC-E) (131), Resident Assessment Instrument for Palliative Care (RAI-PC) (133), Toolkit of 
Instruments to Measure End of life care (TIME) (132). Table 3 shows the properties of identified 
palliative care or end of life measures that were identified from the publications (104, 121-123). 
 
Two measures were excluded as they were patient-reported. These were the QOLC-E (130) and 
the mQOLC-E (131). The majority of measures (n=10) were developed and have been assessed 
as measuring the quality of care received (123), rather than comprehensive symptoms and 
concerns. They were therefore identified as not suitable for amending. These included EOLD-
SWC (125), the FATE (126), the FATE-S (134), the FPCS (127), the FPPFC (135), the QODD 
(128), the QOD-LTC (129), the QOD-LTC-C (129), and the nursing home version of the TIME 
(132). The EOLD-CAD (125) was developed to assess comfort at dying in people with advanced 
dementia. As it specifically measures the comfort during dying and is completed post-death, and 
not as a clinical assessment tool, it was excluded for adaptation in this study. The RAI-PC (133) 
was excluded on the basis that no psychometric evaluation had been conducted in people with 
dementia. 








country of origin 
Purpose of measure: what 
does it aim to assess? 
Developed for data 






















perceptions of symptom 
intensity and conditions 
common in dying 
Post-death: developed as a 
post-death family-reported 
outcome measure 






No – developed for 







perceptions of frequencies 
of physical and emotional 
symptoms 
Post-death: developed as a 
post-death family-reported 
outcome measure. Has also 
used pre-death 





(last 90 days 
of life, also 
used in last 
month and 
last week) 
No – developed for 







satisfaction with the quality 
of care provided 
Post-death: developed as a 
post-death family-reported 
outcome measure. Has also 
used pre-death 





(last 90 days 
of life, also 
used in last 
month and 
last week) 
No – developed for 






perceptions of quality of care 
Post-death: developed as a 
post-death family-reported 
outcome measure 




No – developed for 






perceptions quality of care 
Post-death: developed as a 
post-death family-reported 
outcome measure 




No – developed for 






perceptions of quality of care 
Post-death: developed as a 
post-death family-reported 
outcome measure 
Yes No Yes  Not 
applicable 
No – developed for 






perceptions of physician 
communication during dying 
Post-death: developed as a 
post-death family-reported 
outcome measure 
Yes No Yes Not 
applicable 
No – developed for 





Health care professionals’ 
perspective of dying in end-
stage dementia 
Pre-death: developed to be 
used as part of routine care 
by health care professional 
pre-death 




Yes - physician 
completed 







country of origin 
Purpose of measure: what 
does it aim to assess? 
Developed for data 




















Palliative care symptoms 
and concerns 
Pre-death: developed to be 
used as part of routine care 
completed by patients, 
carers or staff 
Yes No No – palliative care 
settings including 
inpatient, outpatient, 
day care, home care 
and primary care 
Not 
applicable 









perceptions of quality of 
dying 
Post-death: developed as a 
post-death family-reported 
outcome measure 





No – developed for 





Family members’ and staff 
perceptions of psychosocial 
quality of dying 
Post-death: developed as a 
post-death family- and staff-
reported outcome measure 
Yes Yes Yes All No – developed for 





Family members’ and staff 
perceptions of psychosocial 
quality of dying 
Post-death: developed as a 
post-death family- and staff-
reported outcome measure 
No No Yes Not 
applicable 
No – developed for 





Patients’ perceptions of 
quality at end of life 
Pre-death: developed as a 
patient-reported outcome 
measure 
No No Yes Not 
applicable 
No – developed for 




Patients’ perceptions of 
quality at end of life 
Pre-death: developed as a 
patient-reported outcome 
measure 





No – developed for 






Palliative care needs Pre-death: developed to be 
used as part of routine care 
completed by staff 












perceptions of dying process 
Post-death: developed as a 
post-death family-reported 
outcome measure 
Yes No Yes Not 
applicable 
No – developed for 
completion by family 
members 
EOLD: End of Life in Dementia; EOLD-SM: Symptom Management; EOLD-SWC: Satisfaction With Care; EOLD-CAD: Comfort Assessment in Dying; FATE: Family Assessment of Treatment at 
the End of life; FATE-S: Family Assessment of Treatment at the End of life - Short version; FPCS: Family Perceptions of Care Scale; FPPFC: Family Perceptions of Physician-Family caregiver 
Communication; MSSE: Mini Suffering State Examination; POS: Palliative care Outcome Scale; QODD: Quality of Dying and Death;  QOD-LTC: Quality of Dying in Long Term Care; QOD-LTC-
C: Quality of Dying in Long Term Care – Cognitively intact; QOLC-E: Quality Of Life Concerns in End of life questionnaire; mQOLC-E: modified Quality Of Life Concerns in End of life questionnaire; 
RAI-PC: Resident Assessment Instrument for Palliative Care; TIME: Toolkit of Instruments to Measure End of  life  care; UK: United Kingdom; US: United States 
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Three measures remained as potentially suitable for adaptation: EOLD-SM (125), the MSSE 
(136) and the POS (87). They warranted further examination as to their suitability for adaptation 
to assess comprehensive symptoms and concerns in people with dementia living in care homes 
by care home staff. Reference searches identified 12 additional papers for inclusion in the review 
(Table 4). One potentially eligible study was not included as it was published in Dutch (138), and 
two were excluded as they were conference abstracts (137, 139). 
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EOLD-SM: Symptom Management; MSSE: Mini Suffering State Examination; POS: Palliative care Outcome Scale; UK: 
United Kingdom; US: United States 
 
The EOLD-SM (125) is a nine-item scale, with a six-point Likert scale response option from 0 to 
5 comprising: daily, several days a week, once a week, 2 or 3 days a month, once a month, or 
never. EOLD-SM was developed for completion by family members and therefore does not 
require a clinical qualification. It measures symptom burden experienced at the end of life for 
people dying with advanced dementia, and exploratory factor analysis in people in care homes 
who died with dementia (n=105) revealed two subscales: psychological symptoms (including 
‘Calm’, ‘Depression’, ‘Fear’, ‘Anxiety’, ‘Agitation’, and ‘Resistiveness to care’)’, and physical 
symptoms (including ‘Pain’, ‘Shortness of breath’, and ‘Skin breakdown’) (125).  Cronbach’s alpha 
of the total measure and psychological symptoms scored positively (106) at 0.78 and 0.81 
respectively. However, Cronbach’s alpha of physical symptoms was poor at 0.47 (106). To test 
validity, EOLD-SM total scores and subscale scores were compared to EOLD-SWC and EOLD-
CAD total and subscale scores. Correlation coefficients ranged from 0.20 to 0.66 (106). However, 
without a priori hypotheses on the expected strengths of associations, it is difficult to interpret 
these results (106). EOLD-SM has also been psychometrically evaluated pre-death in people with 
advanced dementia living in care homes (n=189) (146). In this study, trained research assistants 
administered EOLD-SM to nurses with primary care responsibility at baseline and quarterly for 18 
months, and post death if the person with dementia died during the study period. Cronbach’s 
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alpha for the total scale was 0.68 (n=176). Validity testing was conducting by examining the 
strength of association between EOLD-SM and the Quality of Life in Late-Stage Dementia 
measure (QUALID) (150) administered to nurses at baseline (n=174). Pearson and Spearman 
correlation coefficients were -0.64 and -0.63 respectively. No a priori hypotheses were stated, 
and EOLD-SM was not tested against any other measures. As a consequence, it is not possible 
to determine the strength of validity from this study (106). Another study examined EOLD-SM 
scores of nurses and family members of people who died with dementia in nursing homes (n=48). 
Concordance correlation coefficients (CCC) between nurses and family members was 0.42, with 
family members reporting slightly higher symptom management than nurses (148). The EOLD-
SM has also been used to compare family members’ post-death evaluations of end of life of 
people with dementia in nursing homes in the Netherlands (n=54) and US (n=76). Although not a 
validation study, the authors found small but consistent and systematic differences between 
countries and conclude that this may suggest validity and sensitivity of EOLD-SM to detect 
differences between countries or timeframes (147). EOLD-SM has been translated into Dutch and 
validated in both United States (US) (104, 125, 146) and the Netherlands (122, 148). Its limitations 
are that it aims to assess physical and psychological symptoms but not the full range of physical 
symptoms and emotional, social, existential, and family concerns that people with dementia may 
experience; it was developed for people dying with advanced dementia rather than throughout 
the disease trajectory; and primarily as an outcome measure for research purposes, to be 
completed post-death, rather than for use in routine care by care home staff. 
 
The MSSE (136) was also developed for people with advanced dementia. The MSSE aims to 
assess suffering and as such does not assess the full extent of comprehensive symptoms and 
concerns to inform management of these. It comprises 10 dichotomous items including ‘Not calm’, 
‘Screams’, ‘Pain’, ‘Decubitus ulcers’, ‘Malnutrition’, ‘Eating disorders’, ‘Invasive action’, ‘Unstable 
medical condition’, ‘Suffering according to medical opinion’, ‘Suffering according to family 
opinion’. The MSSE was originally developed to be used by physicians to inform clinical care in 
hospital settings. As such, its use by care home staff without a clinical qualification is less 
established. In addition, one of the items ‘Malnutrition’ requires objective laboratory data to inform 
the response, thus limiting its suitability for completion by care home staff. It has, however, 
undergone psychometric evaluation with family members (122) in the Netherlands, and in another 
Chapter 3. Identification of a comprehensive measure to develop as an intervention for use in 




study, its terminology was adapted for use by family members (144). It was originally developed 
and psychometrically evaluated in a hospital setting in Israel (136). In this study, 103 patients with 
end-stage dementia were recruited, and two physicians independently examined patients and 
completed the MSSE. Cronbach’s alpha for each of the physicians was 0.74 and 0.72 indicating 
strong internal consistency (136). Total score kappa between both physicians was 0.79, with 
individual item kappa of 0.62 to 0.97. MSSE correlation with EOLD-CAD total scores was -0.80 
and with EOLD-CAD subscales of wellbeing: r=0.72, emotional distress: r=-0.65, physical 
distress: r=-0.76, dying symptoms: r=-0.50. The MSSE has been translated and psychometrically 
evaluated in care homes in the Netherlands (122) and in the US (104, 136), and has been used 
in two prospective studies to evaluate suffering and palliative care need in people with end stage 
dementia in general hospitals (140, 141).  
 
The POS was originally developed for people with cancer, and was developed for both research 
and clinical purposes with established clinical utility (87). It has been used in people with dementia 
in care homes and found to be appropriate and feasible for the majority of participants except for 
those with severe dementia, with the authors concluding that POS is suitable for people with 
dementia in care homes (143). POS comprises 10 items including ‘pain’, ‘other symptoms e.g. 
nausea, coughing or constipation’, ‘anxiety or worry about illness or treatment’, ‘family anxiety or 
worry’, ‘information for patient or family’, ‘ability to share feelings’, ‘life worth living’, ‘feeling good 
about themselves’, ‘time wasted on appointments’, ‘practical matters resulting from illness’. The 
items are rated from 0 to 4 with higher scores reflecting worse problems. Originally, a patient and 
a staff/health care professional version were developed and these measures were 
psychometrically evaluated in multiple community and inpatient palliative care settings in 
predominantly people with cancer, but also people with stroke and motor neurone disease (87). 
In this development and psychometric evaluation, item weighted kappa agreement between 
patient- and staff/health care professional-completed measures at first assessment (n=145 
matched assessments) ranged from 0.22 to 0.56, second assessment (n=97 matched 
assessments) ranged from 0.32 to 0.58, and third assessment (n=66 matched assessments) 0.28 
to 0.58. Test-retest reliability was limited by a small sample size (n=34) (106) with item kappa 
ranging from -0.08 to 0.62. Internal consistency for the patient-completed measure (n=128) was 
0.65 and for the staff/health care professional-completed measure (n=308) was 0.70. Construct 
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validity was examined through correlation between staff/health care professional-completed POS 
and the Support Team Assessment Schedule (STAS) (n=43) and patient-completed POS and the 
European Organisation for Research on Cancer Treatment Quality of Life Questionnaire (EORTC 
QLQ-C30) (n=29). POS items were grouped into subscales with expected correlations between 
subscales and total scores on the STAS and EORTC QLQ-C30. Spearman’s rho correlation 
coefficients ranged from 0.43 to 0.53 between patient-completed POS and EORTC QLQ-C30 
(n=29) and from 0.51 to 0.80 between staff/health care professional-completed POS and STAS 
(n=43). However, the validity testing is limited by the small sample sizes (106). The mean time 
taken to complete POS for staff/health care professionals was 5.7 minutes which decreased to 
under 4 minutes by the third assessment, with none taking longer than 10 minutes. In the identified 
studies from this review, POS has been translated and cross-cultural validated into German in 
Germany and Austria (142), and Spanish in Argentina (145), although not in populations of people 
with dementia. The limitations of POS is that it was not developed for people with dementia in 
care homes, and therefore includes items that may be of less relevance to people with dementia 
living in care homes (143). This indicates a requirement for a disease-specific version for people 
with dementia generally, and specifically for those living in care homes. It has, however, 
undergone psychometric evaluation for people with dementia living in care homes in the 
Netherlands and US (104, 122).  
 
In a validation study conducted in the Netherlands all three measures were translated into Dutch. 
The MSSE (136) was found to be the most valid and reliable at assessing quality of death in 
nursing home residents with dementia, with correlation coefficients with other quality of death 
measures (EOLD-CAD, EOLD-SM, POS, QOD-LTC) ranging from r=0.36-0.581 for family-
completed measures (n=70) and r=0.32-0.701 for professional-completed measures (n=103). 
MSSE correlation with ‘gold-standard’ physician-completed before death discomfort and pain 
measures, the Discomfort Scale – Dementia Alzheimer’s Type (DS-DAT) (151) and the Pain 
Assessment in Advanced Dementia (PAINAD) (152) were r=0.09 and r=0.141 (n=24) respectively. 
In comparison the POS was assessed as the weakest measure to assess quality of death with 
correlation coefficients with other measures (EOLD-CAD, EOLD-SM, MSSE, QOD-LTC) ranging 
from r=0.38-0.591 for family completed measures (n=70) and r=0.41-0.561 for professional 
                                                     
1 Directions not shown but both positive and negative values due to different scoring directions 
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completed measures (n=103). POS correlation with DS-DAT (151) was r=0.08 and PAINAD (152) 
was r=0.03 (n=24). Without clear a priori hypotheses stating expected strengths of correlations, 
it is difficult to interpret these results (106). They are, however, perhaps not unsurprising as POS 
measures a much more comprehensive construct than either discomfort or pain, has not been 
developed with dementia specific items for this population, and was not developed to be 
completed retrospectively post-death.   
 
In terms of reliability, there was no significant difference between family and professional 
completed measures for MSSE (p=0.88) with CCC (95% confidence interval (CI)) of 0.50 (0.25-
0.68), Cohen’s d effect size=0.02 (n=54). Similarly, there was no significant difference between 
physician and nurse completed measures for MSSE (p=0.08), CCC (95% CI) of 0.40 (0.08-0.64) 
(n=33). There was no significant difference between family and professional-completed measures 
for POS (p=0.82) with CCC (95% CI) of 0.23 (-0.09-0.50), Cohen’s d effect size=0.18 (n=54). 
There was, however, a significant difference between physician and nurse completed measures 
for POS (p=0.03), CCC (95% CI) of 0.25 (-0.07-0.54) (n=33). Overall, CCC reliability estimates 
for EOLD-SM, MSSE and POS were fair to moderate (0.21-0.50) (122). In this same study (104, 
122), average percent missing data for EOLD-SM was 17.8% and 2.9% missing for family and 
health care professionals respectively; for MSSE 6.9% and 3.2% respectively; and for POS 16.3% 
and 4.8% respectively.  
 
A study utilising data from the Netherlands validation study reported above (122) and a validation 
study conducted in US sought to identify the best instruments to measure quality of end of life 
care and quality of dying in care homes (104). In this study, the measures were rated as positive, 
intermediate or negative against criteria to determine feasibility, validity and reliability. In both 
studies, measures were administered post-death. Unlike the Netherlands study, in the US study 
measures were only administered to family members and not completed by health care 
professionals, and residents who had died were both cognitively intact and cognitively impaired. 
In terms of feasibility, the MSSE scored positively in the Netherlands and US for ‘relevance and 
ease of use’, ‘level of completion’ and ‘suitability for target population’. The EOLD-SM and POS 
had similar levels of intermediate and positive ratings, with EOLD-SM scoring higher for ‘level of 
completion’ than POS, and POS scoring higher on ‘relevance and ease of use’ than EOLD-SM. 
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In terms of convergent validity in relation to overall rating of quality of dying, all three measures 
scored intermediate (r=0.30-0.50) in the Netherlands while in the US, POS scored intermediate 
and EOLD-SM and MSSE scored negatively (r≤-.30). In terms of convergent validity in relation to 
other measures of a similar construct, in the US all measures scored positive (total score 
correlates r≥0.50 with total score of two or measures of the same construct), while in the US, the 
MSSE and POS scored positive and the EOLD-SM scored intermediate (total score correlates 
r≥0.50 with only one other measure of the same construct).  
 
There are limitations to this review. The first is that it is not a systematic review and some 
measures may have been missed. However, as recent reviews had been published, conducting 
a full systematic review was not justified. In addition, the aim of this review was to identify and 
critically appraise the most established measures, rather than identify all measures used with this 
population. Conducting reference searches of the reviews allowed identification of further data on 
the psychometric properties and feasibility and acceptability in routine care. However, using this 
method may have resulted in some studies being missed. Another limitation is that only English-
language papers were included in this review meaning that any additional data on the measures 
used in other countries and languages were not included (138).  
 
3.3.3.1 Final selection of measure: 
Table 5 Summary of measures meeting the stage 2 criteria for selection 
Eligibility criteria EOLD-SM MSSE POS 
i. Comprehensive assessment of symptoms and concerns x x  
i. Relevant throughout the dementia disease trajectory x x x 
ii. Established as a clinical assessment measure x   
iii. No requirement for a clinical qualification  x/   
iv. Psychometric evaluation in setting and population x/ x/ x/ 
v. Established internationally and cross-culturally    
v. Freely accessible and available N/K N/K  
 - meets criterion, x – does not meet criterion, x/ - mixed evidence or partially meets criterion, N/K from review or 
measure description 
 
Table 5 shows how each measure is rated against the five stage 2 criteria detailed in section 
3.3.2.2. For clarity, criteria two and five are separated.  Based on the review and evaluations, 
POS was selected as the measure for adaptation as it was the measure that meets the most 
criteria. All three measures have relative strengths and weaknesses. Importantly, POS is the only 
measure that has been developed to assess comprehensive physical symptoms, and emotional, 
social, existential and family concerns.  (87). Another important strength was that it was originally 
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developed for use in, and is now well-established in practice to inform and aid care, and that it 
was not just developed for research purposes (87, 153). Unlike the EOLD-SM and MSSE, the 
POS has not been developed specifically for people with dementia. This is both a strength as a 
measure for generic palliative care populations with additional disease-specific items allows for 
comparisons between populations (84); and may also be more suited to older people with 
dementia and multi-morbidities. However, it is a disadvantage in that it does not incorporate 
dementia-specific symptoms and concerns experienced by this population. Conversely, the 
EOLD-SM and the MSSE have just been developed for the end-of-life for people with advanced 
dementia, and not for the full dementia trajectory. None of them are therefore developed to be 
used for people with dementia and multi-morbidities throughout the disease trajectory and all 
would require some adaptation and psychometric evaluation in this population. MSSE has 
strongest and most established psychometric properties in this population but assesses suffering 
during end stage dementia rather than comprehensive symptoms and concerns experienced by 
people with dementia and multi-morbidities throughout the disease trajectory. This means that it 
is the least suited to adaptation, as it does not aim to assess comprehensive symptoms and 
concerns but instead signs of distress for example, screaming. It would therefore require 
substantial changes resulting in an overall change of the measure aim and of its construct.  
Additionally, although MSSE was also developed for clinical purposes, it was developed for and 
has also predominantly been evaluated in hospital settings completed by physicians (136, 140, 
141). EOLD-SM does assess physical and psychological symptoms and concerns, but a major 
limitation is that it was developed for research purposes as a post-death outcome measure for 
the dying phase. POS was therefore the best suited for adaptation, meeting the most criteria.  
 
3.4 POS and the Integrated Palliative care Outcome Scale (IPOS) 
POS is one of the measures in the POS family of measures, and there are ongoing developments 
(154). A patient, staff/health care professional and carer version have been developed (154) and 
POS has been translated into a number of languages including German (142) and Spanish (145), 
and cross-culturally validated including, for example, the African Palliative Care Association 
African POS (155). As such, the psychometric properties of POS have been extensively tested in 
diverse populations and settings (156). POS, its disease-specific and translated versions, and 
resources are all freely available online (154), thus maximising its availability internationally. 
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POS has been used in an action research project in a nursing home and hospice to examine the 
facilitators and barriers to implementation (157). The results of this study revealed that POS had 
been easily incorporated into routine care in nursing homes, and was quick and easy to use (157).  
In addition, nursing home staff, including those without a clinical qualification, overwhelmingly 
reported that using POS routinely benefitted resident care (157).  
 
The POS family of measures is ongoing development, with new versions and translations 
regularly being developed (153). These are conducted or overseen by the POS development 
group, based at the Cicely Saunders Institute. A strength of adapting the POS was the ability to 
draw upon the scientific expertise of the POS development team in developing and refining the 
measure for dementia, and access to the most recent POS developments. One recent 
development of POS is the IPOS (158). The IPOS was developed following requests from health 
care professionals to combine the POS and POS-symptom module (POS-S). The result is a 10 
question measure that examines a person’s main concerns, common symptoms, and emotional, 
social and existential, and family concerns (158). As the aim of this study was to develop a 
comprehensive measure to assess symptoms, the most recent POS development, the IPOS was 
chosen for adaptation. See Appendix B for copies of POS, POS-S and IPOS. 
 
3.5 Summary of key points, gaps and next steps 
This chapter reviews palliative care measures and their potential to be developed as a 
comprehensive measure to improve assessment and management of symptoms and concerns 
for people with dementia. In particular, the methods used in the chapter identify comprehensive 
proxy-reported measures of physical symptoms and emotional, social, existential and 
family concerns that have been psychometrically evaluated in people with dementia, before 
death.  
 
Three measures, EOLD-SM, MSSE, and POS, were identified and reviewed in detail with regards 
to their validity, reliability, responsiveness, and interpretability. In addition, their 
acceptability and feasibility for use by care home staff without a clinical qualification for people 
throughout the disease trajectory living in care homes were also examined, as well as how well-
established they are cross-culturally and how easily available they are.  
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All three measures were identified as requiring some adaptation to ensure comprehensiveness 
and relevance for people with all stages of dementia living in care homes. The POS, as the only 
measure developed to assess comprehensive physical symptoms, and emotional, social and 
existential, and family concerns as part of routine care, was identified as the most suited measure 
for adaptation. The IPOS is a new development integrating POS and POS–S to assess 
comprehensive symptoms and concerns experienced by palliative care patients, and identified as 
the most suitable version of the POS family of members for adaptation. However, neither POS 
nor IPOS were developed for people with dementia.  
 
To adapt IPOS for people with dementia living in care homes requires examination of the content 
validity to determine items of less relevance requiring adaptation or removal, and possible addition 
of important items to ensure that it is comprehensive for people with dementia and multi-
morbidities (10). 
 
Furthermore, this newly developed measure is being developed as a complex intervention to 
improve comprehensive assessment and management of symptoms and concerns of people with 
dementia in residential care homes and their family members. It is therefore important to gain an 
understanding of the likely mechanisms of action within the residential care home context; the 
potential benefit to people with dementia and their families; its feasibility and acceptability for use 
in routine care; and implementation requirements from early in the intervention development 
phase (2, 5, 93).  




4. Methods: general 
4.1 Introduction 
This chapter presents the study aim and objectives, as well as the study design, the rationale for 
the choice of methods chosen, and ethical issues.  
 
4.2 Aim 
To develop and conduct a preliminary evaluation of the Integrated Palliative care Outcome Scale 
for Dementia (IPOS-Dem) to improve assessment and management of symptoms and concerns 
for people with dementia in residential care homes. 
 
4.3 Objectives 
IPOS-Dem pre-clinical objectives: 
1. To identify common symptoms and concerns experienced by people with dementia, and 
items of low relevance in POS/IPOS to construct the measure, IPOS-Dem Version 1. 
 
IPOS-Dem development/pre-implementation objectives: 
2. To explore the content validity of IPOS-Dem Version 1 to identify additional relevant 
symptoms and concerns, and redundant items, and refine the measure resulting in IPOS-
Dem Version 2. 
3. To determine the acceptability and ease of comprehension of IPOS-Dem Version 2 and 
its manual to care home staff and make necessary refinements based on the results, 
resulting in IPOS-Dem Version 3 ready for evaluation phase. 
4. To gain an understanding of the residential care home context, the likely mechanisms of 
action, implementation requirements, and acceptability and feasibility of IPOS-Dem in the 
development phase to inform its use in routine care in preparation for evaluation phase. 
 
IPOS-Dem evaluation/post-implementation objectives: 
5. To understand the mechanisms of action and potential benefit of IPOS-Dem used in 
routine care of people with dementia within the residential care home context. 




6. To gain an understanding of the implementation requirements of IPOS-Dem into routine 
care of people with dementia. 
7. To test the acceptability and feasibility of IPOS-Dem in routine care of people with 
dementia. 
 
4.4 Study design and overview of methods 
The overall study design used a mixed methods approach with pre- and post-implementation 
phases, informed by MRC guidance (2, 3, 93) and Methods of Researching End of Life Care 
(MORECare) statement (159). The study is a development and preliminary evaluation (process 
and feasibility evaluation) of a complex intervention to refine and understand the intervention 
within the residential care home context in preparation for testing the methods of, and conducting 
a full trial of effectiveness (2, 3, 93). Stages of the overall study design, linked to the study 
objectives, research methods, and outputs are presented in Figure 5. 
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Figure 5 Overview of study design, objectives, methods and study outputs 




4.5 Medical Research Council guidance and Methods Of Researching 
End of life Care statement 
4.5.1 Medical Research Council guidance for developing and evaluating complex 
interventions 
The MRC guidance published in 2000 was developed with the recognition that health care 
services regularly use complex interventions. The guidance proposed a framework of sequential 
phases to guide the process of developing and evaluating a complex intervention, with each 
phase building upon the next (93). However, limitations of this framework were subsequently 
identified and an updated guidance was published in 2008 (2). The updated guidance addressed 
requirements for: (i) more focus on initial piloting and development work (160), (ii) a more iterative 
and less sequential model (161), (iii) integration of process and outcome evaluation (162), (iv) 
recognition that interventions may work best when adapted to contexts (163), (v) and greater use 
of insights from theory of complex adaptive systems (164). Within the new guidance, an updated 
model (Figure 6) was presented. The four phases in the new model are: development, 
feasibility/piloting, evaluation, and implementation. These may not necessarily be linear.  
 
Figure 6 MRC guidance 2008 Key elements of the development and evaluation process (2) 
 
The 2008 MRC guidance recommends that adequate development of the intervention is essential 
before a large-scale evaluation is conducted. Development of an intervention involves three 
components. The first, Identifying the evidence base, includes conducting a systematic review to 
determine what is known about similar interventions. The second involves Identifying and 
developing theory. Essential to this is gaining a theoretical understanding of how the intervention 
is likely to change processes, and is gained from existing evidence and theory. If necessary, 




additional primary research may be carried out to inform theory development. Finally in Modelling 
process and outcomes a number of studies may be required to refine the intervention. 
 
The feasibility/piloting phase allows for the opportunity to examine components of the intervention 
(such as acceptability, feasibility), and aspects of the testing procedures (such as recruitment and 
retention and effect size). Feasibility/piloting may also provide valuable insights and 
understanding of the context of intervention delivery (4). It is essential that intervention 
development, and feasibility/piloting is adequately conducted before proceeding to full-scale 
evaluation (2). 
 
In 2015, further MRC guidance was published to address the need for guidance in conducting 
process evaluations (3). A process evaluation is defined as: 
‘A study which aims to understand the functioning of an intervention, by examining 
implementation, mechanisms of impact, and contextual factors. Process evaluation is 
complementary to, but not a substitute for, high quality outcomes evaluation’ (5) 
 
The process evaluation framework built upon the 2008 MRC guidance (2), but emphasised the 
relationship between implementation, mechanisms of action and context (Figure 7). Delivery of a 
complex intervention is usually tailored to different contexts. By examining what is delivered in 
practice against the intervention theory, greater understanding can be gained as to which aspects 
of the intervention can be modified to fit the context, and which pose a threat to fidelity (165, 166). 
Process evaluations provide the opportunity to examine how interventions are delivered, thus 
providing important data on how the intervention can be replicated in other settings. 
 
Figure 7 MRC guidance 2015: Key functions of process evaluation and relations among them (blue boxes 
are the key components of a process evaluation. Investigation of these components is shaped by a clear 
intervention description and informs interpretation of outcomes) (3) 
 




Furthermore, process evaluations provide the opportunity to examine the hypothesised 
mechanisms of action (3) to gain a greater understanding into complex pathways, and identify 
any unexpected mechanisms of action (167). Finally, they can provide insight into the impact of 
context, defined as anything external to the intervention that may either impede or assist 
implementation or its consequences. Delivery of intervention may vary between contexts. 
However, even if delivery is the same, the context may impact on the effect of the intervention 
(164). Understanding of context and how it interacts with the intervention is essential, both to 
interpret findings and to understand generalisability of the intervention (3). In particular, it is 
essential to understand which aspects of the intervention should be standardised as the 
mechanisms of action and which components and/or delivery of components need to be adapted 
for local contexts (165). 
 
This study was informed by the 2000 and 2008 MRC guidance. The 2015 guidance was published 
after this study was planned and designed. However, objectives of the study were to understand 
the likely mechanisms of action and how these may occur within the context, feasibility and 
acceptability, and the implementation requirements of the intervention. The 2015 process 
evaluation guidance therefore provided a useful framework and language for articulating the 
methods, and to contextualise it within the process of developing and evaluating complex 
interventions. In particular, the 2015 guidance informed how process evaluations are combined 
in feasibility and pilot testing to provide the opportunity to examine the feasibility, acceptability 
and implementation requirements (5). 
 
The aim of this study was, as informed by the MRC guidance, the development and preliminary 
evaluation of a complex intervention, IPOS-Dem, to support assessment and management of 
symptoms and concerns. Preliminary evaluation comprised a feasibility and process evaluation 
of the intervention, prior to testing of methods and full evaluation of effectiveness. The feasibility 
and process evaluation incorporated an examination of the residential care home context, the 
likely mechanisms of action, acceptability and feasibility, and implementation requirements of the 
intervention. In keeping with the 2008 guidance, this study followed a less linear approach, with 
feasibility and process evaluation occurring both during the development/pre-implementation and 
evaluation/post-implementation phases (Figure 5). This crucially allowed examination of the 




context, mechanisms of action and implementation requirements during the development of the 
intervention.  
 
The study started with a pre-clinical (93) literature review which informed the development IPOS-
Dem Version 1 (Objective 1). The pre-clinical phase in the MRC guidance 2000 refers to the first, 
or theoretical, stage of intervention development (93). A development/pre-implementation 
qualitative phase was then conducted to further develop and refine IPOS-Dem, (Objectives 2 and 
3); and explore the likely mechanisms of action within the residential care home context, and gain 
an early understanding of its acceptability and feasibility, and likely implementation requirements 
during the development of the intervention (Objective 4). An evaluation/post-implementation 
mixed-methods phase followed where IPOS-Dem was implemented into routine care of 
participants with dementia to gain a deeper understanding of the likely mechanisms of action and 
how the intervention may work in the residential care home context (Objective 5) as well as an 
understanding of the implementation requirements (Objective 6), and the acceptability and 
feasibility of the intervention (Objective 7). The theoretical model demonstrating likely 
mechanisms of action, requirements for acceptability and feasibility of the intervention, and 
implementation requirements was then refined as a greater understanding was obtained from 
development/pre-implementation and evaluation/post-implementation feasibility and process 
evaluation. The focus of this study is on the development of an intervention and an understanding 
of its mechanisms of action, acceptability, feasibility and implementation requirements for use in 
routine care of people with dementia living in care homes. In doing so, the study seeks to establish 
how the intervention works within context and how it should be adapted to context. Furthermore, 
the study undertakes to understand the complexity of multi-agency working within residential care 
homes and external to residential care homes. This includes the importance of relationships 
between care home staff, and between care home staff, family members, and health care staff; 
taking into consideration known barriers that have previously been identified (60, 62-65).  
 
4.5.2 MORECare statement 
The MORECare collaboration was established by the MRC and National Institute of Health 
Research (NIHR) in response to the challenges of conducting high quality end of life care (EoLC) 
studies. The MORECare statement defines EoLC as:  




‘the total or holistic care of a person during the last part of their life, from the point at which a 
person’s health is in a progressive state of decline, usually in the last months, weeks or days of 
life.’ (159, 168) 
 
MORECare builds upon the MRC guidance to provide guidance on best practice for undertaking 
EoLC research (159). In developing the statement, the MORECare collaboration conducted 
systematic reviews, transparent expert consultations and stakeholder workshops to identify 
challenges in undertaking high quality EoLC research; and to identify best practice. MORECare 
identified five areas in EoLC research that needed addressing: (i) ethics (169), (ii) statistics 
(managing missing data, attrition and response shift) (170), (iii) outcome measurement (124), (iv) 
mixed methods research (171), and (v) health economics (172). In addition, MORECare  identified 
three shortcomings of the MRC guidance (159):  
(i) Moving from feasibility and piloting to implementation without robust evaluation. In 
particular, the requirement that implementation be evaluated at all phases, rather 
than at the end. This ensures that the intervention is feasible with an understanding 
of context, and that implementation processes are known and understood. 
(ii) Failing to evaluate both feasibility of intervention and feasibility of research methods 
at the same time. 
(iii) A lack of theoretical framework underpinning the intervention. 
 
The MORECare statement addresses these problems, recommending a series of steps in the 
development and evaluation of EoLC interventions (Figure 8).  
 





Figure 8 MORECare statement key steps in developing and evaluating EoLC interventions 
 
The MORECare statement also produced a checklist of components requiring consideration when 
designing and conducting EoLC studies. This study drew upon this checklist with a particular 
focus on (i) the study team to ensure that the appropriate experts were consulted in the planning 
and conducting of the study; (ii) ethics – including applying the Mental Capacity Act  (MCA) (173) 
in recruiting and conducting research with people with dementia, (iii) consideration, reporting and 
management of attrition and missing data, (iv) use of mixed methods research, and (v) 
consideration of implementation requirements from the outset. 
 
As the focus of the study is on the development and feasibility and process evaluation of IPOS-
Dem, the study does not aim to test the feasibility of methods for a full evaluation of effectiveness, 
despite the MORECare statement’s recommendation to do so. However, it was beyond the remit 
of this study to do so. 
 
The MORECare statement, with its focus on the challenges and requirements for palliative and 
end of life care research informed methods of this study. The MORECare statement alongside 








4.5.3 How the MRC guidance and MORECare statement informed this study 
The study was a development, feasibility and process evaluation of a complex intervention 
(93). Based on the MRC guidance and MORECare statement, particular attention was paid to the 
following in informing the overall aim, objectives and study design:  
(i) Theoretical model underpinning intervention (159). As detailed in Chapter 1, this 
study commenced with the development of a theoretical model. The model was 
developed based on existing models of how measures used in routine health care 
may improve outcomes (100, 102), detailing the expected mechanisms of action. It 
was also developed based on existing knowledge of the context of residential care 
homes, the population of people with dementia who may be unable to express their 
wishes and concerns, and the many groups of people who may be involved in care 
(including family members, care home staff, and health care professionals) (50, 63, 
65, 103, 174, 175). Intervention components (acceptability and feasibility) and 
implementation requirements were also considered within the theoretical model. The 
model underpinned the entirety of the study. 
(ii) Modelling and understanding the mechanisms of action and how they may 
impact on outcomes (2, 3, 93, 159). The theoretical model was examined 
throughout the study. Initially through a developmental qualitative phase, and then 
through a mixed-methods evaluation phase where IPOS-Dem was implemented into 
routine care. Expected and unexpected mechanisms of action were identified. The 
theoretical model was refined to detail the mechanisms of action and their potential 
impact on outcomes as a result of the study findings. Attention was also paid to how 
the mechanisms of action worked within the residential care home context. 
(iii) Implementation requirements of the intervention.  The study was not intended to 
be an implementation one and the focus of the study was on developing and 
evaluating the intervention. Nonetheless, the implementation requirements of IPOS-
Dem were considered from the outset and throughout the study (3, 159). The 
implementation requirements of IPOS-Dem were incorporated into the initial 
theoretical model and were examined throughout the study phases, taking into 
account the residential care home context.  
(iv) The impact of the care home culture on the on delivery of the intervention and 
outcomes (3, 159). Froggatt and colleagues (176) suggest that traditional qualitative 




and quantitative methodologies could be criticised for not taking the care home 
culture into consideration and that there is therefore little attention to how the 
knowledge that has been produced from research translates into improved care and 
residents’ experiences. The authors also describe the challenge of carrying out high 
quality research in care home settings that is both relevant to this sector and that 
engages with the people involved including residents, family members, and care 
home staff. As such, the study was designed to incorporate key stakeholders’ 
(including family members, care home staff, and health care professionals) views, 
experiences and expertise in the development and refinement of the intervention. 
Taking this approach provided a deeper understanding of the care home culture 
meaning that IPOS-Dem was designed for the care home setting. Furthermore, 
implementation barriers could then be anticipated and potentially overcome during 
the development stages, and considered in relation to the design of the study. 
However, care homes are not homogenous and include different types of ownership, 
funding, size, and resident profiles (1, 177, 178). There is also wide variety in how 
residential care homes work with health care providers and in leadership styles (178). 
This study made the attempt to recruit a mix of residential care homes to develop and 
examine the intervention in different care home setting types and cultures.  
(v) Understanding of components of intervention including acceptability, 
feasibility (3). Key features of acceptability and feasibility of measures used in 
routine care were identified in the literature (Chapter 1) and IPOS-Dem was 
developed to maximise these. Evaluation of these was conducted throughout the 
study, and refinements and intervention recommendations made based on the 
results. 
(vi) Expert consultation with patient and public involvement members, care home 
staff and health care professionals (3, 159). Expert consultation with patient and 
public involvement (PPI) members, care home staff, senior multi-disciplinary health 
care professionals and academics were conducted at all stages of the study including 
study design, and development of study materials. Expert consultation was also 
utilised in the development and refinement of IPOS-Dem.  
 




PPI involvement comprised an older adult mental health and dementia service user 
and carer advisory group who were consulted on the study design and study material. 
This group was also consulted on the development of IPOS-Dem and provided 
feedback on its versions in the process of development. Regular presentations were 
made to this group of approximately 15-30 service user and carer representatives. 
Presentations were followed by feedback and discussion.  
 
A PPI member with carer experience also supported the study (Appendix C). 
Consultation with this individual involved designing and refining the study aim and 
study design, and improving the clarity and language of the study materials in order 
to improve readability, relevance and comprehension (179).  
 
Senior palliative care health professionals and academics were consulted on the 
intervention development. Early collaborations with mental health, palliative care, and 
general practice health care professionals not directly involved in the study were 
developed to understand how IPOS-Dem may support and complement existing 
health and social care structures and processes. 
 
From the time of the approaching care homes, managers and care home staff were 
consulted on the conduct of the study. During the study set-up and preparation, 
regular meetings and visits to the care homes took place to discuss the study. Care 
home staff were invited to share ideas on how the study should be conducted and on 
the development of IPOS-Dem. The same consultation took place with General 
Practitioners (GPs), district nurses (DNs) and senior community nurse managers. 
(vii) Mixed methods research (2, 3, 93, 159). The MRC guidance (2, 3, 93) and 
MORECare statement (159) both advocate the use of mixed methods in developing 
and evaluating interventions. A more detailed discussion of the methodological and 
theoretical considerations of mixed methods research is warranted, and presented in 
the following section. 
 




4.6 Mixed methods research 
The choice of methods must be determined by the study aims and objectives. Qualitative research 
lends itself to exploring and understanding meaning that participants may ascribe to the 
phenomenon under study (180). It is well suited to understanding, moving beyond ‘how much?’ 
or ‘how many?’ to how and why things happen the way that they do (181). Quantitative methods 
on the other hand, provide the means for measuring and for testing the relationship between 
variables (180). Mixed methods research is an approach that combines both qualitative and 
quantitative forms, but is more than simply collecting and analysing both separately (180). 
Instead, mixed-methods is an approach that enables research of more complex phenomena, and 
in health care is well suited to understanding more about interventions and the environment (182). 
Mixed methods research is therefore useful, for example, when the inclusion of a second method 
may enhance understanding, such as in an embedded mixed methods design (183).  
 
This study utilised both qualitative and quantitative methods, using qualitative phase to develop 
IPOS-Dem followed by evaluation utilising an embedded qualitative design. Qualitative data 
provided an in-depth understanding of the requirements of the IPOS-Dem including content 
validity (objective 2), comprehension (objective 3), acceptability (objectives 3, 4 and 7), feasibility 
(objectives 4 and 7), the context and how the mechanisms of action work within the context 
(objectives 4 and 5), and implementation requirements (objectives 4 and 6) both during the 
development/pre-implementation and evaluation/post-implementation phases of the study. 
Quantitative data provided a different level of data about the acceptability (objective 7) and 
feasibility (objective 7) of the intervention by providing numerical data on IPOS-Dem scores in the 
evaluation/post-implementation phase. These data were integrated to provide a detailed and 
enhanced understanding of IPOS-Dem as an intervention in routine care of people with dementia 
living in residential care homes. 
 
An embedded design uses a traditional qualitative design with an embedded quantitative strand, 
or vice versa (183). Priority is given to the primary strand while the embedded strand is utilised to 
answer different questions or study different levels of data relating to the overall study, thus 
enhancing understanding of the primary strand (180, 183). Data collection and analysis of the 
embedded strand may occur before or after (sequential), or during (concurrent) the data collection 




and analysis of the main design. Unlike many other mixed methods designs, the two types of data 
are not merged in order to answer the same question. Instead the results from each method may 
be presented alongside each other to provide composite results of the different research 
questions or levels of data (180). The data are analysed separately and then used as a means of 
triangulation at the interpretation of the study (184). In this way, the findings from both the 
qualitative and quantitative data can be compared to identify areas of convergence, 
complementarity or discrepancy in order to provide a deeper understanding of the question under 
study (184-186). This approach is taken by this study in particular, when utilising both types of 
data in understanding acceptability and feasibility of the intervention (Objective 7).  
 
A challenge of using mixed methods is that it presents and epistemological tension, with 
qualitative approaches being associated with an interpretive paradigm and quantitative 
approaches being associated with positivist paradigm; and that these being considered as 
incompatible and mutually exclusive (187, 188). 
 
4.7 Methodological considerations 
4.7.1 Philosophical basis, positioning and reflexivity 
Originally developed by Bhaskar (189), critical realism is a philosophy which argues that the world 
is complex and multi-dimensional, and that powers, structures, and relations may be observable 
and measurable, but may also remain unobservable until they are triggered in a particular context 
(190). This means that the mechanism of action of an intervention may be hidden or suppressed 
until revealed in a particular context (190). 
 
Realists have argued against the methods proposed by the MRC guidance (2, 93), in particular 
the use of randomised controlled trials (RCTs) in evaluating complex interventions, stating that 
they fail to understand the mechanisms, and under what conditions and contexts the interventions 
may work (188). However, subsequent arguments have been made that realist evaluations, with 
the underpinning philosophy of critical realism, may be well suited to evaluating complex 
interventions; and that in particular, realist evaluations may be synergistic with RCTs to evaluate 
how the mechanisms may operate in context, and which mechanisms may promote or inhibit 
effectiveness (5, 167, 191). The MRC process evaluation guidance draws upon realist evaluation 




to determine how context-mechanisms-outcome configurations work together to understand ‘what 
works’, ‘for whom’ and ‘under what circumstances’ (5). It has also been proposed that realist 
evaluations may work well with theory of change in understanding the complexity of multiple 
mechanisms of action within the real world context (95). 
 
The tension of using mixed methods may be resolved by adopting an anti-conflationist view that 
qualitative and quantitative approaches can be combined if an ontological and epistemological 
position is maintained (187). Critical realists distinguish between three different modes of reality 
or ontological domains. These are the empirical (the visible phenomena that can be experienced), 
the actual (that which occurs whether observed or not), and the real (the underlying structures 
and mechanisms which may generate the actual phenomena) (187, 189). Critical realists take an 
anti-conflationist view, and argue that research aims to go beyond positivist goals to generate 
generalizable laws, or the interpretivist goals to identify the lived experiences of individuals. As 
such, it is necessary to draw upon qualitative and quantitative approaches depending on the 
research question and that mixed methods are frequently required and the most suited (187). 
 
Like qualitative research, post-positivist science recognises that research is not value free, and 
that the researcher brings their experiences, assumptions, and values to the research process 
(192). Reflexivity is a researcher’s internal dialogue and continued self-critique of their own 
assumptions and values; and the active acknowledgement and explicit recognition of how the 
subjectivities and position of the researcher may affect the research process and outcomes (192, 
193). To enhance and facilitate reflexivity, I maintained a diary throughout the course of the PhD 
(181). This provided the opportunity to record reflections of formal and informal meetings and 
discussions with family members, care home staff, and health care professionals; as well as other 
stakeholders such as palliative care teams. I also recorded reflections following focus groups and 
interviews, and used the diary as a means to record some of the practical challenges as well as 
challenges in my own learning and thinking. When analysing the data and interpreting the 
findings, I was able to use these reflections and discussions with supervisors, to gain a deeper 
understanding of the data, and how my own assumptions and values may have had an effect on 
this. 




4.8 Study site recruitment 
4.8.1 Recruitment of residential care homes 
There are known challenges to conducting research in care homes (194). One challenge is 
recruiting care homes to participate in research, with recruitment being resource-intense (194) 
and researchers typically required to approach 40% more care homes than they require for the 
study in order to recruit (195). This study drew upon resources such as NIHR Enabling Research 
in Care Homes (ENRICH) (194), publications and guidance (196) and previous studies (197) to 
inform recruitment of care homes. 
 
Eligible residential care homes were those providing care to people aged 65 and over, and larger 
than 15 beds in order to provide sufficiently large population of residents with dementia. 
Residential care homes were recruited to provide a mix of dementia-registration (to provide a mix 
of residents with complex and non-complex symptoms of dementia), funding and ownership types 
(to provide a mix of organisational management, leadership, priorities and cultures). Residential 
care homes meeting the eligibility criteria were identified from review of the CQC (1) registration 
details. Letters of approach were sent to providers of identified residential care homes and 
followed up with a telephone discussion (Appendix D). If agreement was obtained by the care 
home providers, the manager of the residential care home was approached and the study 
discussed and introduced to the manager and care home staff. If the manager and care home 
staff were in agreement, the residential care home was identified as potentially eligible. Final 
recruitment was made on the basis of agreement by care home providers, residential care home 
managers and staff, and obtaining a mix of funding types. 
 
4.9 Ethical considerations and approvals 
4.9.1 Ethical approvals 
Ethical approval was required from a National Research Ethics Service (NRES) and, for one of 
the participating care homes, from a care home provider ethics committee. Research governance 
approvals were required from National Health Service (NHS) Research and Development (R&D) 
for participating NHS sites, and local authority for recruitment of participants from care homes. 
 




Ethical approval was obtained from the Research Ethics Committee (REC) – London South East, 
a committee flagged for adults lacking capacity [NRES: 13/LO/1339] (18/11/2013). The REC also 
approved Site Specific Assessments (SSAs) for each of the participating care homes (Care home 
A: 24/03/2014, Care home B: 24/03/2014, Care home C: 10/06/2014). NHS approvals were 
obtained to recruit health care professionals employed by the NHS. As only health care 
professionals were identified for participation from NHS sites, and no part of the study was 
conducted within the NHS nor were the NHS sites responsible for the delivery of research 
procedures, NHS Participant Identification Centre (PIC) assurance was given and full study site 
approval was not required. Two NHS PIC sites were involved: (i) provided by South London 
Primary Care R&D Office (R&D reference: 035) for recruitment of GPs to the study (18/12/2013), 
(ii) provided by South East London R&D for the recruitment of DNs to the study (26/03/2014). A 
minor amendment regarding the conduct of focus groups was submitted and approved 
(14/03/2014). A substantial amendment regarding recruitment and informed consent of family 
members and professionals (care home staff and health care professionals), and adding 
members of the research team was submitted and approved (17/04/2014). A third amendment 
(substantial) was submitted to temporarily change the study Chief Investigator (16/12/2014). A 
final substantial amendment was made and approved in order to amend research questions, 
study design and methodology, outcome measures used, study exclusion criteria, and recruitment 
and consent of residents with dementia or cognitive impairment (22/04/2015). The ethics 
application, substantial amendments, and approvals are included in Appendix E. 
 
As the study settings were care homes, local authority Research Governance Framework (RGF) 
approval was also required. This process included submission of the London RGF Alliance 
Common Proposal Form to the local authority (Appendix F), and presentation at the local authority 
research governance board, following which approval was obtained (30/08/2013). All 
amendments which were submitted to the REC were also submitted to the board and approvals 
received.  
 
Finally, one of the care home organisations had their own ethics committee. An organisation 
Application for Ethics Approval was submitted. Following review of the application, the ethics 
group initially decided against supporting the research. However, a response to their concerns 
was submitted, and the organisation’s ethics group then approved the application (07/01/2014). 




All amendments were also submitted to the ethics committee and approvals received. The 
application is included in Appendix G. 
 
4.9.2 Ethical considerations: research with adults who lack capacity 
The Mental Capacity Act (MCA) 2005 
The MCA defines a person as lacking capacity as follows: 
‘a person lacks capacity in relation to a matter if at the material time he is unable to make a 
decision for himself in relation to the matter because of an impairment of, or a disturbance in the 
functioning of, the mind or brain’ (173) 
 
In relation to consenting to participate in research, this means that the person being recruited is 
not able to make an informed decision to consent due to a condition affecting decision-making 
abilities.  
 
There a five key principles to the MCA (173) as follows: 
(i) A person must be assumed to have capacity unless it is otherwise established. 
(ii) A person should not be treated as unable to make a decision unless all steps to have 
been made to assist the decision-making. 
(iii) A person should not be treated as unable to make a decision just because an unwise 
decision is made. 
(iv) An act or decision made on behalf of the person who lacks capacity must be done in their 
best interests. 
(v) In making a decision on behalf of a person who lacks capacity, the least restrictive option 
must be selected. 
 
Assessing mental capacity 
According to the MCA (173), a person is unable to make a decision if unable to: 
(i) Understand the information relevant to the decision. 
(ii) Retain the information. 
(iii) Use or weigh up the information to inform the decision. 
(iv) Communicate the decision, in any way. 
 




A person should be enabled to understand the information in the most appropriate way (including 
visual aids and simple language) and is not considered to lack capacity if requiring support to 
understand the information.  The information relevant to the decision includes information about 
the foreseeable consequences of deciding either way or failing to make the decision. Even if a 
person can only retain the information for a short period, it does not mean that they do not have 
capacity to make the decision. 
 
The MCA (173) and research requirements 
It is a legal requirement that any study that conducts invasive research with people lacking 
capacity obtains the correct approvals prior to the research commencing (173). Invasive research 
is any research that would have required informed consent if the participants had capacity to 
consent (173). Approvals were therefore required from a REC flagged for adults lacking capacity.  
 
The MCA stipulates a number of conditions for research to be conducted in a person lacking 
capacity: 
(i) The research must be conducted into the condition causing impaired capacity, or the 
treatment thereof. 
(ii) The research cannot be carried out as effectively in persons with capacity to consent. 
(iii) The research must have potential to benefit without causing disproportionate burden on 
the person; or provide knowledge of the causes, treatment or care of the same condition. 
(iv) If the research does not have the potential to benefit or provide knowledge into the 
condition, then the risk to the person should be expected to be negligible and the research 
should not be burdensome of interfere with privacy or freedom of action in any way. 
 
This study addressed these requirements as follows. IPOS-Dem is a measure and it is essential 
that measures are developed for and tested in the population that they are intended for (106). 
Furthermore, measures are more valuable if they work along the whole trajectory of the illness 
(from early stages to death) (124) as this ensures relevance to all people with dementia living in 
care homes. It would therefore be inappropriate to develop and evaluate the measure in just 
people with mild cognitive impairment or early stage dementia who retain capacity to consent. 
 




Finally, the purpose of IPOS-Dem is to assess symptoms and concerns in all people with 
dementia in care homes including and, in particular, those who may have difficulties expressing 
their wishes and concerns, and may therefore not be able to communicate symptoms and 
concerns. It was therefore essential to conduct the study incorporating this population in order to 
understand how using the measure supported their care. It would not have been possible to 
sufficiently evaluate the measure in a population without dementia or only with those who are able 
to self-report their symptoms and concerns. 
 
The MCA and recruiting adults who lack capacity 
If the above conditions are met, then the MCA (173) states the process of recruiting people who 
lack capacity to the study. The first step is to identify somebody who is involved in the care of or 
welfare of the person but not in a professional capacity e.g. family member or friend who is 
prepared to be consulted about the person’s participation in research (personal consultee).  If a 
personal consultee cannot be identified, then a nominated consultee who is prepared to be 
consulted and is independent from the research project must be identified and consulted on the 
person’s participation in research. 
 
The personal or nominated consultee must be presented with information about the research and 
asked, based on their knowledge of the person lacking capacity, whether that person would wish 
to take part in the research. 
 
Recruitment of residents with dementia or cognitive impairment to this study 
The study adhered to the MCA (173) in recruiting adults lacking capacity to consent, and a 
detailed recruitment protocol was developed (Figure 9). This study’s recruitment protocol drew 
upon an earlier study protocol of recruiting adults who lack capacity developed by Scott and 
colleagues (198). The MORECare statement also informed the recruitment protocol (169).  
 
The first step in recruitment was to advertise the study in care homes. Posters were displayed 
with my photograph and contact details, as well as details of a coffee morning for residents and 
family members (including friends) (197, 199) (Appendix H). The coffee mornings were conducted 
in each care home to share information about the study, and invite residents and family members 
to ask questions about the study. It also provided the opportunity for residents and family 




members to decline participation if they so wished. The coffee mornings enabled the researchers 
to advertise the study, invite residents and family members to attend, and therefore provided a 
means of having contact with those interested in hearing about the study. The coffee morning 
also facilitated the opportunity for researchers to discuss the study with residents, family members 
and care home staff to gain their perspectives, inputs, and suggestions about the purpose and 
conduct of the study. This enabled the researchers to, within the requirements of ethical 
approvals, incorporate participants’ suggestions into the study methods. Study materials including 
participant information sheets were made available at this time. Appendix I includes examples of 
participant information sheets from each data collection phase of the study. 
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Figure 9 Flow chart of resident recruitment protocol 
 
A meeting was then held with a senior member of the care home staff of each care home to 
identify residents meeting the inclusion criteria. Inclusion criteria were people aged 65 and over, 
for whom the care home formed their permanent residence with a documented diagnosis of 
dementia (any stage) or cognitive impairment. Care was taken to identify eligible residents using 
the least invasive method i.e. not assessing residents’ cognitive abilities. All residents with a 




documented diagnosis of dementia were approached to participate in the study. To identify those 
residents with cognitive impairment, the FAST (32) was used, with residents at stages four to 
seven being included. Stage four was chosen as the cut-off as it is the mildest stage that does 
not require a clinical investigation or interview to identify cognitive deficits. This facilitated inclusion 
of residents with moderate cognitive decline who could be identified by senior care home staff. 
 
Those residents identified as meeting the inclusion criteria by senior care home staff members 
were introduced to a research nurse and me by care home staff. If the resident was in agreement, 
one of us met with the resident to discuss the study with the aid of a single side participant 
information sheet (Appendix I). If the resident comprehended this, it was left with the resident 
along with a more detailed participant information sheet (Appendix I) to give the opportunity for 
family members to read about the study and ask questions if needed. If the resident was assessed 
to have capacity, I returned after one week (or more if requested) to undertake informed consent 
process. Appendix J includes examples of participant consent forms. 
 
It was anticipated that those residents that had capacity to consent, may lose capacity over the 
course of the study. The MORECare statement on ethical issues in palliative and EoLC research 
(169) recommends a ‘belt and braces’ approach to recruiting people who may lose capacity. In 
this way, the MCA (173) can be adhered to if participants lose capacity. This study took this 
approach. As such, advice from a consultee was obtained for all residents who provided informed 
consent, as well as all residents who were assessed not to have capacity, and did not 
demonstrate unwillingness or reluctance to participate (169, 173). As such, if a resident lost 
capacity over the course of the study, they were not withdrawn from the study. Taking this 
approach meant that the least invasive approach was taken in gaining informed consent as 
residents were only approached once, rather than at each data collection point.  
 
Personal consultees were identified by care home staff. They were identified based on residents’ 
pre-specified wishes (i.e. if this was a lasting power of attorney in place) or based on the 
knowledge of care home staff (i.e. a family member of close friend who knows the resident well 
and visits the resident regularly). Senior care home staff sent a letter of approach to identified 
potential personal consultees on my behalf. The letter included brief information about the study, 
and information about the role of the personal consultee. The letter asked the recipient to contact 




me if they would like to be consulted. The letter also made explicit that if no contact was received 
within three weeks, a nominated consultee would be consulted. Two letters were sent to potential 
personal consultees (Appendix K). 
 
The nominated consultee for this study was a research practitioner from the Clinical Research 
Network South London (CRN SL) Division 4 – Dementia and Neurodegenerative Diseases 
(DeNDRoN) speciality. The research practitioner was independent from the study but had 
expertise in research conduct and implications of resident participation and was therefore well-
placed to give advice on participation. The research practitioner used all available information 
available in order to give advice on participation. This included meeting residents, reviewing care 
home notes and discussion with care home staff. Personal and nominated consultees signed a 
consultee declaration form (Appendix J). 
 
4.10 Summary 
In this chapter key guidance, frameworks, and legal documents are presented and discussed in 
relation to how they informed the overall study design, methodology, and conduct. Detailed 
methods relating to the specific phases of the study are presented in respective subsequent 
chapters. 
 
4.11 Presentation of detailed methods and results 
The following chapters describe the specific methods of the study for the different study 
components (Figure 5): 
Chapter 5 – pre-clinical literature scoping review to develop IPOS-Dem Version 1 (study objective 
1) 
Chapter 6: publication 2 – qualitative phase to develop IPOS-Dem Versions 2 and 3 (study 
objectives 2 and 3) 
Chapter 7: publication 3 – qualitative and mixed methods phases to conduct pre- and post-








5. Pre-clinical phase: development of IPOS-Dem Version 1 
5.1 Introduction 
For a measure to have content validity and acceptability (11, 13), it is important that the items are 
relevant and comprehensive to the construct being measured (10). This means that the included 
items must be relevant for the purpose of the measure e.g. to assess symptoms and concerns in 
routine care, and be relevant to the population e.g. people with dementia living in care homes 
(10). It is also important that the measure is comprehensive to ensure that the construct assessed 
is captured by all the items (10). POS/IPOS was developed as a measure for clinical care and 
research, and its purpose to assess all domains of palliative care to support patient care is 
established (87, 158, 200). POS/IPOS was not, however, developed specifically for the care of 
people with dementia in care homes. It was therefore important the items were assessed for 
relevance to this population. It was also important that the measure is comprehensive to ensure 
that all important symptoms and concerns experienced by this population are included. 
 
This chapter details the aim, methods, and results used to inform the development of IPOS-Dem 
Version 1. In particular, to ascertain the relevance of IPOS items to people with dementia in care 
homes and to identify key symptoms and concerns that this population may experience to ensure 
it the comprehensiveness of IPOS-Dem.  
 
This phase was a pre-clinical phase of the MRC guidance (93) drawing upon what is known in 
the literature to develop the intervention. This phase also draws upon the methods for measure 
development to ensure that the measure is developed for the purpose it is intended and for the 
population it is intended. In particular, utilising literature reviewing and expert consultation (10). 
The experts comprised academics and health care professionals in primary, palliative, and mental 
health care, and PPI members. They were consulted regarding decisions about inclusion, 










5.2 Aim and objectives 
5.2.1 Aim 
To develop IPOS-Dem Version 1 by identifying IPOS items that have less relevance to people 




1. To examine the evidence of content validity of POS/IPOS for people with dementia in 
care homes. 
2. To conduct a scoping review to identify common physical symptoms and emotional and 
social concerns experienced by people with dementia in care home settings through the 
course of the illness trajectory. 
3. To construct IPOS-Dem Version 1 based on the amendment or removal of less relevant 
items and identification and addition of important symptoms and concerns experienced 
by people with dementia in care homes. 
 
5.2.3 Objective 1: to examine the evidence of content validity of POS/IPOS for people with 
dementia in care homes 
A systematic review of studies using POS (156) and review of the literature of POS used with 
people with dementia in care homes (Chapter 3) identified one study which provided quantitative 
data on POS item relevance for people with dementia. This study was used to examine the 
evidence of content validity for use in this population. In particular, items of less relevance to this 
population were identified for potential amendment or exclusion. 
 
The identified study examined the use of a Dutch-translated staff/health care professional version 
of POS, completed by physicians or nursing staff for residents in 16 nursing homes (143) in the 
Netherlands. Eligibility criteria were all residents with a life expectancy of six weeks or less, 
admitted for long term care. Residents scoring 5-7 on the GDS (31) were categorised as having 
dementia. The response options ‘Unknown’ and ‘Not applicable’ were added to questions 1-9, 
and ‘Unknown’ was added to question 10 on the POS. 
 




POS data were reported for 195 residents with dementia whose data could be included for 
analysis, of a total sample size of 448 of people with and without dementia. Table 6 shows 
completion rates of each POS item for residents with dementia. The authors concluded that POS 
is suitable for people with dementia in care homes as POS was successfully completed for a large 
subgroup with dementia, particularly those in stages 5 and 6 of the GDS (31).  Nonetheless, the 
results indicate that some items require changing to improve the relevance to this population.  
  





Table 6 Completion rates for POS in people with dementia in nursing homes (143) 
Item Residents with dementia (n=195) 




POS item entered as not 
applicable or unknown 
Not applicable (%) Unknown (%) 
1. Has the patient been affected by 
pain? 
78.1 17.7 4.2 
2. Have other symptoms 75.0 20.8 4.2 
3. Have they been feeling anxious 
or worried about their illness 
40.2 40.2 19.6 
4.Have any of their family or friends 
been worried or anxious  
89.2 3.6 7.2 
5. How much information has been 
given to the patient/ family/ friends 
82.7 16.8 0.5 
6. Has the patient been able to 
share feelings with family/ friends 
40.4 52.7 6.9 
7. Do you think they have felt life 
was worth living? 
23.2 52.1 24.7 
8. Do you think they have felt 
good about themselves? 
18.3 50.8 30.9 
9. How much time do you feel has 
been wasted on appointments 
relating to healthcare? 
67.5 25.3 30.9 
10. Have any practical matters 
resulting from illness been 
addressed? 
50.3 - 49.7 
Bold >50% missing indicated as ‘Not applicable’ or ‘Unknown’ 
 
Implications for this study: 
IPOS-Dem was being developed from IPOS, a more recent development of POS. As such, the 
next step was to map the less relevant POS items identified in the Dutch study (143) against the 
corresponding IPOS items to identify which IPOS items required amending (Table 7). This was 
done in consultation with experts including PPI members, health care professionals, and 
academics. Four items were identified as requiring amendment as more than 50% was rated as 
either ‘Not applicable’ or ‘Unknown’: (i) ‘Have they been feeling anxious or worried about their 
illness?’, (ii) ‘Has the patient been able to share feelings with family/ friends?’, (iii) ‘Do you think 
they have felt life is worth living?’, (iv) ‘Do you think they have felt good about themselves?’. 
 
The first two: (i) ‘Have they been feeling anxious or worried about their illness?’, and (ii) ‘Has the 
patient been able to share feelings with family/ friends?’, had both been changed slightly between 
the POS and IPOS versions, but were still considered to be less relevant to people with dementia 
in care homes and were therefore identified for amending. The third, ‘Do you think they have felt 
life was worth living?’ had been replaced by, ‘Do you think that s/he felt depressed?’ As 




depression is common in people with dementia (33), it was anticipated that this item would have 
relevance in this population and it was therefore retained for further testing. ‘Do you think that 
they have felt good about themselves?’ had been replaced by to ‘Do you think that s/he has felt 
at peace?’ Assessing existential concerns are an important part of palliative care provision (14), 
including for people with dementia in care homes (201). This item was therefore retained for 
further testing in this population. One new IPOS item was identified as potentially having less 
relevance for people with dementia in care homes: ‘Has the patient had as much information as 
s/he wanted?’ which had replaced, ‘How much information has been given to the patient and their 
family or friends?’ This item was therefore also identified for amending. 
 
Table 7 Original POS and IPOS items, and those identified for amending for IPOS-Dem 
Original POS item Corresponding IPOS item Items to retain or amend 
Q1. Has the patient been 
affected by pain? 
Q2. How has the patient 
been affected by each of the 
following symptoms: Pain 
Q2. Retain 
Q2. Have other symptoms Q2. How has the patient 
been affected by each of the 
following symptoms: POS-S 
items 
Q2. Retain 
Q3. Have they been feeling 
anxious or worried about 
their illness 
Q3. Has s/he been feeling 
anxious or worried about 
his/her illness or 
treatment? 
Q3.To be amended 
Q4.Have any of their family 
or friends been worried or 
anxious  
Q4. Have any of his/her 
family or friends been 
anxious or worried about the 
patient 
Q4. Retain 
Q5. How much information 
has been given to the 
patient/ family/ friends 
Q8. Has the patient had as 
much information as s/he 
wanted? 
Q8. To be amended 
Q6. Has the patient been 
able to share feelings with 
family/ friends 
Q7. Has the patient been 
able to share how s/he is 
feeling with his/her family 
or friends as much as s/he 
wanted? 
Q7. To be amended 
Q7. Do you think they have 
felt life was worth living? 
Q5. Do you think that s/he 
felt depressed? 
Q5. Retain 
Q8. Do you think they have 
felt good about 
themselves? 
Q6. Do you think that s/he 
has felt at peace? 
Q6. Retain 
Q9. How much time do you 
feel has been wasted on 
appointments relating to 
healthcare? 
Not included in IPOS Not applicable 
Q10. Have any practical 
matters resulting from illness 
been addressed? 
Q9. Have any practical 
problems resulting from 
his/her illness been 
addressed? (such as 
financial or personal) 
Q9. Retain 
Items in bold represent those identified for amending 




5.2.4 Objective 2: to conduct a scoping review to identify common physical symptoms and 
emotional and social concerns experienced by people with dementia in care home 
settings through the course of the illness trajectory 
To ensure that IPOS-Dem includes common symptoms and concerns experienced by people with 
dementia living in care homes, it was important to identify which symptoms and concerns should 
be added to ensure comprehensiveness. 
 
A scoping review was conducted to identify symptoms and concerns that people with dementia 
may experience. The aim of the scoping review was therefore to identify physical symptoms, and 
emotional and social concerns experienced by people with dementia in care homes. 
 
5.2.4.1 Scoping review methods 
Search strategy: Ovid MEDLINE in process and other non-indexed citations and Ovid MEDLINE, 
PsycINFO, and Embase Classic and Embase from inception to 23 December 2013 were 
searched. A search strategy was developed using a combination of MeSH and key word terms: 
dementia AND symptom AND long term care AND symptom assessment. The following search 
strategy was used and supplemented with reference and citation searches using Scopus: 
 
1. Alzheimer Disease/ or Cognition Disorders/ or Dementia/ or Aged/ 
2. Alzheimer's disease.mp. or Alzheimer Disease/ 
3. 1 or 2 
4. Symptom Assessment/ 
5. symptom burden.mp. 
6. palliative care.mp. or Palliative Care/ 
7. 4 or 5 or 6 
8. Long Term Care/ 
9. long term care.mp. 
10. exp Residential Care Institutions/ or exp Health Care Services/ or exp Nursing Homes/ 
11. care home.mp. 
12. 8 or 9 or 10 or 11 
13. 3 and 7 and 12 
 




Eligibility criteria: The population was people with dementia living in care homes. Mixed 
cognitively impaired and cognitively intact participants were included as long as at least 50% had 
established cognitive impairment or dementia. When the proportion of population with cognitive 
impairment was not reported, the study was excluded. All stages of dementia were included. 
Studies that included multiple settings but reported care home settings separately were included. 
Acute or general hospitals study settings were excluded as it was expected that patients in these 
settings would have additional symptoms due to being acutely unwell. However, long-stay/ 
permanent wards were included. 
 
Studies that aimed to identify the breadth of physical symptoms, and emotional and social 
concerns were included. Therefore, studies that used a range of methods and measures to 
identify a wide range of symptoms and concerns were included (e.g. case note review, resident 
examinations, survey, generic assessment measures).  For the same reason, those studies that 
examined three of fewer symptoms or used dementia-specific measures to identify already-
established common symptoms in dementia  e.g. Symptom Management at the End of Life  in 
Dementia (125) were excluded. As neuropsychiatric symptoms of dementia including depression, 
psychosis, aggression and wandering, are already well-established and documented (20, 117), 
studies that only examined these symptoms were not included. Cause of death studies, co-
morbidity studies, and studies that used medication prescription as a proxy for symptoms were 
all excluded.   
 
Qualitative studies, intervention studies, case studies, theses, reviews and conference abstracts 
were excluded. Studies were included if they were English language. 
 
Study selection: All titles and abstracts were reviewed and those that did not meet the inclusion 
criteria were excluded. Full texts of the remaining articles were screened and those meeting the 
inclusion criteria retained for data extraction. Studies were assessed for risk of bias but not 
excluded on the basis of quality. Risk of bias was reported on in the interpretation of results. 
 
Data extraction: Data were extracted on study design, study setting, population, symptom 
measurement methods, symptoms identified/ measured, symptom prevalence. Physical, 
emotional and social symptoms and concerns were extracted. Diagnoses (such as cancer, 




arthritis) were not extracted. An exception to this were psychiatric diagnoses (such as depression 
and anxiety) in order to capture the prevalence of common neuropsychiatric symptoms in 
dementia (33). Care processes (such as hygiene and cleanliness) and functional problems such 
as incontinence, independence in activities of daily living were not extracted as not in construct 
of measure. Fevers, premortem signs and symptoms, and delirium were not extracted. When 
different severity (such as mild or moderate pain) or frequency (such as pain more than 5 days a 
month) symptoms or concerns were reported, the category that encompassed all levels of severity 
or frequency were extracted. Symptoms identified as present but effectively treated were included 
in the reported prevalence. 
 
Data analysis: A summary of symptoms and concerns were identified, and prevalence tabulated.  
 
5.2.4.2 Scoping review: results  
In total, 1500 papers were identified through the database searches. Following deduplication and 
abstract screening, 81 full texts were screened with 10 studies meeting the inclusion criteria. 
Reasons for exclusion were: not care home population (n=8), not dementia population (n=4), not 
measuring symptom burden (n=15), used a single measure to assess symptoms (n=4), study 
design e.g. qualitative or review, conference abstract, commentaries or editorials (n=40). 
Three additional papers were identified from citation and reference screening resulting in a total 
of 13 included studies.  
 
Table 8 shows the study details of included studies. Five of the included study populations 
comprised residents with dementia only (202-206). Three studies analysed a subgroup of 
residents with dementia separately (18, 207, 208). Four study populations comprised mixed 
cognitively intact and cognitively impaired residents (209-213) with the proportion of those with 
cognitive impairment ranging from 59% (212) to 94% (210). Study populations included all stages 
of dementia or cognitive impairment (208, 209, 212), advanced dementia only (18, 202, 203, 205, 
206) and end-stage dementia only (204). Four studies did not specify which stages of dementia 
were included (207, 210, 211, 213). The populations of the majority of included studies were 
residents with dementia at the end of life (18, 203-205, 207-212). Of these, four studied those 
dying with advanced dementia (18, 203-205). Sample sizes ranged from n=17 (204) to n=40,622 
(209) with mean age of participants ranging from 76.4 years (Standard Deviation (SD) 13.9) (209) 




to 86.5 years (SD 7.8) (208). Methods of data collection comprised review of case/ medical/ 
nursing records (202-204, 210), after-death interviews e.g. with family members or care home 
staff (208, 211, 212), and Minimum Data Set (MDS) assessments (18, 205, 209). One study 
utilised a nursing home physician completed questionnaire (207) and one study utilised multiple 
methods of data collection including case note reviews, nurse interviews and brief physical 
examinations (206). One study used a combination of case note reviews and interviews with 
residents (213). Three studies collected data from family members (208, 211, 212) but only two 
concerned the family’s perspectives on a resident’s symptoms and concerns (211, 212). One 
study reported combined data from family members and care home staff (212) and one analysed 
agreement between family members and care home staff but only for three symptoms (211). Data 
collection time periods ranged from 48 hours (210) to 18 months (206). The majority of studies 
(n=10) (18, 203-205, 207, 208, 210-213) collected data on the last time period of participants’ 
lives, ranging from the last three months (212) to last 48 hours (210) of life.  
 




Table 8 Study details of scoping review papers meeting inclusion criteria 
Author, 
year 
Country Study design Study setting Population Dementia  Dementia 
severity 
Sample size Mean age 
years (SD) 
Data collection method 





3 NHs Residents  All Advanced 123 81.5 (7.1) Baseline data collection: 
review of medical notes 









Residents with life 















considered to be 
cause of limited 




83.5 (8.1) Baseline data collection: 
questionnaire completed 
by NH physician which 
included a list of 25 
symptoms and open 




US Analysis of 
admission 
assessments 






40, 622 76.4 (13.9) MDS admission 
assessments completed 
by trained health care 
professionals, 
completed within 14 





7 geriatric care 
homes 
Residents who died 
in previous 12 
months 
All  Advanced 141 86 (7.7) Data extracted from 
clinical records by two 
independent study 
nurses on residents’ last 






sample of 5 care 
homes 
Residents who died 





Not stated: likely 
all stages 
185 86.2 Audit tool developed by 
authors based on 
literature review with 
common symptoms. 
Data extracted from 
resident charts by two 
auditors for the last 48 








of 230 care 
homes 
Residents who had 








85.4 (9.5) Structured interviews of 
family members and 
care home staff by 
trained interviewers 
about the last month of 
life 






Country Study design Study setting Population Dementia  Dementia 
severity 
Sample size Mean age 
years (SD) 
Data collection method 









Residents who died 





17 83.2 Case notes, nursing 
records and medicine 
charts, for the last two 







643 NHs Residents who died 







Advanced  Subgroup of 
dementia=160 
83.5 (7.1) MDS completed 120 
days within death. Time 










Residents aged 65 
years or older with 
advanced dementia 
who died within one 
year of admission to 
nursing home or 
home care program 
All  Advanced  Subgroup of 
nursing home 
residents=273 
83.4 (7.1) MDS completed within 
120 days of death. Time 






22 NHs Residents over the 
age of 60 with 
advanced dementia 
All Advanced 323 85.3 (7.5) Quarterly chart reviews, 
interviews with nurses, 
and brief physical 
examinations over 18-
month period 
Parker (213) Australia Prospective 
observational 
study 
18 care homes Residents with life 
expectancy of ≤6 
months 
64% diagnosis of 
dementia 
Not stated: likely 
all stages 
69 84  Prospective data 
collection over 10 weeks 










2 NHs Residents who died 59% assessed as 
disorientated to 
time 
All stages 80 82 Family members and 
care home staff 
interviewed on physical 
and emotional 
symptoms in last 3 












homes and 31 
NHs 
Residents who died  Subgroup of 
dementia 
All stages Subgroup of 
dementia=422 
86.5 (7.8) Care home staff 
interviewed to identify 
physical and behavioural 
symptoms in the last 
month of life 
NHs – Nursing homes; MDS- Minimum Data Set; SD – standard deviation; UK: United Kingdom; US: United States






Table 9 shows the symptoms and concerns identified in the included studies. Identified symptoms   
and concerns ranged from 4 (205) to 18 (209).  Identified symptoms and concerns were organised 
into two main groups: (i) physical symptoms, and (ii) emotional, social, and existential concerns.  
(i) Physical symptoms were classified into symptoms or groups of symptoms as follows: 
pain, shortness of breath, skin problems, swallowing problems, food and fluid intake, 
vomiting, nausea, constipation, drowsiness or weakness, mouth or dental problems, 
and other symptoms identified less than three times (oedema, falls, vision problems, 
bleeding, myoclonus and seizures). Pain and shortness of breath were the most 
common physical symptoms, identified in 12 out of the 13 studies.  
(ii) Emotional, social, and existential concerns were classified as follows: depressed, 
anxious/agitated, interaction/lonely, and other concerns identified less than three 
times (hallucinations, restless, activities/ goals, at peace and insomnia). Depressed 
was the most common of the emotional, social, and existential concerns identified in 
five studies out of the 13 studies. 
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Table 9 shows the reported prevalence for each symptom and concern assessed or 
identified in the included studies. The prevalence of symptoms and concerns varies widely 
between studies with pain prevalence ranging from 11.5% (18) to 86% (212), shortness of 
breath prevalence ranging from 8.2% (18) to 75% (212), and depression prevalence 
ranging from 9.1% (18) to 46.3% (209).  
 
There are a number of reasons for the ranges of prevalence in the studies:  
(i) Definition of symptom or concern: Symptoms and concerns were defined 
according to different criteria. Some studies reported any presence of a 
symptom (202-204, 207, 210, 212) while others categorised symptoms 
according to pre-defined frequency or severity (18, 205, 206).  
(ii) Method of assessing symptoms or concerns: assessment is challenging in 
people with advanced dementia, and each assessment method is likely to be 
subject to some source of bias. In addition, informants have different 
perspectives and knowledge about symptoms and concerns in people with 
dementia. Care home staff assess residents based on their close and frequent 
contact with people with dementia (78). Family members may base 
assessment on their long-term knowledge of the person, while health care 
professionals may use clinical examination, discussion with care home staff 
providing direct care, and observation. One study utilised physical 
examinations as part of assessment of symptoms (206). Three studies 
collected MDS assessment data (214-216) which provides guidance on 
utilising all available methods of assessing residents including communication 
with and observation of residents, communication with care home staff and 
health care professionals, communication with family members, and resident 
records (217). The remaining studies depended on physicians, nursing staff, 
care home staff, or family members accurately identifying and recording/ 
reporting symptoms and concerns. Three studies collected data through post-
death interviews with family members and care home staff with the potential 
for recall bias (208, 211, 212).  




(iii) Study designs: the scoping review method was designed to identify the breadth 
of symptoms and concerns experienced by people with dementia in care 
homes. However, the number and type of symptoms and concerns were 
limited by the study designs. Some studies assessed only pre-specified 
symptoms and concerns utilising audit tools (210), questionnaires (207) and 
interviews (208, 211, 212). This means that the number of symptoms and 
concerns was limited to only those that had been pre-specified. Other studies, 
identified all symptoms and concerns identified in case notes (202-204). This 
method had the potential to identify a wider breadth of symptoms and 
concerns, although a limitation is whether they had been detected and 
accurately documented. Data from the MDS were utilised in three studies (18, 
205, 209). The MDS (214-216) is a comprehensive assessment of residents, 
covering multiple domains such as cognition, communication, psychosocial 
wellbeing, diagnoses, health conditions, nutritional status, skin conditions, 
activity and medication (217). The comprehensive nature of the MDS did mean 
that two of the studies examined a wider range of physical symptoms, and 
emotional, social, and existential concerns (18, 209). The limited number of 
emotional and social concerns identified from the scoping review is likely to 
reflect the pre-specified symptoms that the studies aimed to examine and the 
fact that the majority of included studies aimed to examine physical symptoms 
only; rather than a true low prevalence of emotional and social concerns in this 
population (33).  
(iv) Period prevalence: the time period that data were collected over impacts on 
the number of symptoms and concerns identified, with more being identified 
over longer time periods. The included studies assessed symptoms and 
concerns over a range of time periods from 48 hours (210) to 18 months (206).  
(v) Stages of illness: the different study populations mean that it is likely that 
symptom prevalence varied. Symptoms and symptom prevalence for 
populations at the end of life are likely to be different from those not at the end 
of life, and people with advanced dementia may have different symptoms and 
symptom prevalence from those with mild to moderate dementia.  
 





5.2.4.3 Scoping review: strengths, limitations and implications for IPOS-Dem 
development 
A systematic approach was used to ensure rigour in identifying the studies, and extracting 
and reporting the data. However, there are limitations to this scoping review. First, it was 
conducted to scope the literature rather than as a systematic review. Some eligible studies 
may therefore not have been identified and included. The search strategy and inclusion 
criteria resulted in a focus on physical symptoms rather than the full range of physical 
symptoms, emotional and social concerns that people with dementia may experience; and 
in study populations predominantly at the end of life, meaning that the symptom burden 
along the full trajectory of dementia was not fully examined. Extending the search strategy 
and inclusion criteria to include populations not resident in care homes and studies that 
examined neuropsychiatric symptoms only may have resulted in a wider range of 
symptoms and concerns being identified in along the illness trajectory of dementia, but is 
likely to have resulted in symptoms and concerns less relevant to people with dementia in 
care homes, and even greater study heterogeneity. 
 
The scoping review was important to identify symptoms and concerns in people with 
dementia in care homes. Table 10 details the symptoms and concerns identified and maps 
them to IPOS items resulting in corresponding IPOS-Dem items. Symptoms not already 
included in IPOS that were common with high prevalence including ‘Skin breakdown’, 
‘Swallowing problems’ and ‘Weight loss’ were added. The IPOS item ‘Sore or dry mouth’ 
was amended to ‘Mouth or dental problems’ as both these symptoms were identified in the 
scoping review. Symptoms that were already included in IPOS were retained for further 
testing even if they were not identified as common or prevalent in people with dementia in 
care homes. The less commonly identified symptoms including oedema, falls, vision 
problems, bleeding, myoclonus and seizures not in IPOS were not included.  
 
It was anticipated that emotional and social concerns had been under-estimated in the 
scoping review. As such, all of those identified were included in IPOS-Dem (Table 10).  ‘Do 
you think that s/he felt depressed?’ was therefore retained and ‘Hallucinations’ was added 
as an item. At this stage the IPOS item, ‘Has s/he been feeling anxious or worried his/her 




illness?’ was amended to ‘Has s/he been feeling anxious or worried?’ Similarly, the less 
relevant IPOS item, ‘Has s/he been able to share how s/he is feeling with his/her family or 
friends as much as s/he wanted?’ was amended to ‘Has s/he been able to interact positively 
with others?’ to capture ‘Interaction’. To capture the concern ‘Activities/ goals’, another 
item, ‘Does s/he have the opportunity to engage in enjoyable or pleasurable activities?’ 
was added. 
 
IPOS-Dem aims to assess symptoms and concerns that are distressing to people with 
dementia. As it is not intended as a measure of behavioural change or behaviours that 
challenge, the symptoms and concerns, ‘Agitation’, ‘restlessness’ and ‘Insomnia’ were not 
included in IPOS-Dem Version 1. 
 
Additional items: 
Additional emotional and social concerns were identified for inclusion: 
(i) A depression screening item, ‘Do you think that s/he is still able to enjoy things 
in life?’ was included. This item has been tested in palliative care populations 
and had a sensitivity of 79.1% (95% CI 63.5-89.4) and a specificity of 72.6% 
(95% CI 63.7-80) using a gold standard of diagnosis of major depressive  
Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSM 
IV) (218). 
(ii) Delusions is a common symptom in mild cognitive impairment and dementia, 
with prevalence estimate of 18% in this population (33). Delusions was 
therefore identified as an additional item for inclusion. 
(iii) ‘Have any care matters been addressed [hearing aids, foot care, dental, 
glasses]’. This was identified as important to address some of the other care 
concerns that people with dementia in care homes may be likely to experience 
and that is not sufficiently captured in the IPOS item, ‘Have any practical 
problems resulting from his/her illness been addressed? (such as financial or 
personal). 
(iv) ‘Are priorities and preferences for care reviewed and documented?’ was 
identified as an important care need for people with dementia in care homes, 




and one that could potentially result in fewer hospital admissions and care 
transitions (219).  





Table 10 Identified symptoms and concerns mapped to IPOS items and corresponding IPOS-Dem 
item 
Symptom identified Original IPOS item  IPOS-Dem item 
Pain Q2. Pain  Q2. Pain 
Shortness of breath/ 
dyspnoea/ respiratory 
distress 
Q2. Shortness of breath Q2. Shortness of breath 
Skin problems/ skin 
disorders/Pressure ulcers 
Not included Q2. Skin breakdown 
Aspiration/ difficulty  
chewing or swallowing/ 
choking/ dysphagia 
Not included  Q2. Swallowing problems 
Poor food and fluid intake/ 
cachexia/ anorexia/ 
dehydration/ weight loss 
Q2. Poor appetite Q2. Poor appetite 
Weight change Not included Q2. Weight loss 
Vomiting  Q2. Vomiting (being sick) Q2. Vomiting (being sick) 
Nausea/ feeling sick Q2. Nausea (feeling like 
you are going to be sick) 
Q2. Nausea (feeling like 
you are going to be sick) 
Constipation Q2. Constipation Q2. Constipation 
Somnolence/ Extreme 
tiredness/ drowsiness/ Less 
alert/ Fatigue 
Q2. Drowsiness Q2. Drowsiness 
Generalised weakness Q2. Weakness or lack of 
energy 
Q2.Weakness or lack of 
energy 
Dental problems/ mouth 
problems/ oral thrush 
Q2. Sore or dry mouth Q2. Mouth or dental 
problems 
Oedema Not included Not included 
Falls Q2. Poor mobility  Q2. Poor mobility 
Vision problems Not included Not included 
Bleeding Not included Not included 
Myoclonus Not included Not included 
Seizures Not included Not included 
Mood/ very sad/ depressed Q5. Do you think that s/he 
felt depressed? 
Q5. Do you think that s/he 
felt depressed? 
Anxiety/ very anxious or 
agitated 
Q3. Has s/he been 
feeling anxious or 
worried about his/her 
illness or treatment? 
Q3. Has s/he been feeling 
anxious or worried? 
Hallucinations Not included Q2. Hallucinations 
Restlessness Not included Not included 
At ease interacting/ very 
lonely/ compassionate 
touch 
Q7. Has s/he been able 
to share how s/he is 
feeling with his/her 
family or friends as 
much as s/he wanted? 
Q7. Has s/he been able to 
interact positively with 
others? 
 
At ease in self-initiated 
activities 
At eases in planned/ 
structured activities 
Establishes own goals 
Accepts group activities 
Pursues involvement in life 
of facility 
Not included Q9. Does s/he have the 
opportunity to engage in 
enjoyable or pleasurable 
activities? 
 
Peace Q6. Do you think that s/he 
has felt at peace? 
Q6. Do you think that s/he 
has felt at peace? 
Insomnia Not included Not included 
  





Amendments of items of less relevance: 
The less relevant IPOS item ‘Has the patient had as much information as s/he wanted?’ 
was changed to ‘Has his/her family had as much information as wanted?’ to reflect the 
family members’ requirement for information (48, 220, 221). 
 
Language: 
To reflect that the care home setting is not a clinical one, the term ‘patient’ in IPOS was 
changed to ‘person’. 
 
5.3 Construction of IPOS-Dem Version 1 
Table 11 shows the amendments made to IPOS to form IPOS-Dem Version 1 based on 
the identification of less relevant items, the scoping review and expert consultation 
(Appendix O). 
  





Table 11 Original IPOS items, required amendments and corresponding IPOS-Dem items 
Original POS/POS-S/IPOS 
item 
Amendments IPOS-Dem Version 1 
Q1.What has been the 
patient’s main problems over 
the past week? 
None Q1. What have been the person’s 
main problems over the past 
week? 
Q2. How has the patient been 
affected by each of the 
following symptoms over the 
past week: 
Replace term ‘patient’ 
with ‘person’ 
Q2. How has the person been 
affected by each of the following 
symptoms over the past week? 
Q2. Pain  None Q2. Pain 
Q2. Shortness of breath None Q2.Shortness of breath 
Q2. Weakness or lack of 
energy 
None Q2.Weakness or lack of energy 
Q2. Nausea (feeling like you 
are going to be sick) 
None Q2. Nausea (feeling like you are 
going to be sick) 
Q2. Vomiting (being sick) None Q2. Being sick 
Q2. Poor appetite None Q2. Poor appetite 
Q2. Constipation None Q2. Constipation 
Q2. Sore or dry mouth Include dental problems Q2. Mouth or dental problems 
Q2. Drowsiness None Q2. Drowsiness 
Q2. Poor mobility None Q2. Poor mobility 
 Include swallowing 
problems 
Q2. Swallowing problems 
 Include skin breakdown Q2. Skin breakdown 
 Include delusions Q2. Delusions 
 Include hallucinations Q2. Hallucinations 
Q2. Any other symptoms None Q2. Any other symptoms 
Q3. Has s/he been feeling 
anxious or worried about 
his/her illness or treatment?  
Amend to anxious or 
worried 
Q3. Has s/he been feeling 
anxious or worried 
Q4.  Have any of his/her 
family or friends been anxious 
or worried about the patient?  
None Q4. Have any of his/her family 
been anxious or worried about 
the person? 
Q5. Do you think that s/he felt 
depressed? 
None Q5. Do you think that s/he felt 
depressed? 
 Include depression 
screening item 
Q6. Do you think that s/he is 
still able to enjoy things in life? 
Q6. Do you think s/he has felt 
at peace? 
None  Q6. Do you think that s/he felt at 
peace? 
Q7. Has the patient been able 
to share how s/he is feeling 
with his/her family or friends 
as much as s/he wanted? 
Amend to interaction Q7. Has s/he been able to 
interact positively with others? 
Q8. Has the patient had as 
much information as s/he 
wanted? 
Amend to family 
information 
Q8. Has his/her family had as 
much information as wanted? 
 Include activities Q9. Does s/he have the 
opportunity to engage in 
enjoyable or pleasurable 
activities? 
Q9. Have any practical 
problems resulting from 
his/her illness being 
addressed? (such as financial 
or personal) 
Amend to reflect care 
home setting 
Q10. Have any practical matters 
been addressed [such as 
financial or personal] 
 Include care matters to 
incorporate other 
concerns such as vision 
or hearing problems 
Q10. Have any care matters 
been addressed [hearing aids, 
foot care, dental, glasses] 
 Include priorities and 
preferences for care 
Q11. Are priorities and 
preferences for care reviewed 
and documented? 
 




5.4 Summary and next steps 
This chapter presents the methods and results used to develop IPOS-Dem Version 1. The 
objectives were to identify items on IPOS that may be less relevant to people with dementia 
in care homes, and identify additional items to ensure that IPOS-Dem is comprehensive 
and therefore includes all important symptoms and concerns that people with dementia and 
multi-morbidities living in care homes may experience. IPOS-Dem Version 1 is presented 
in Appendix O, ready for further development, testing and refining in the next phase of this 
study, reported in Chapter 6: publication 2.
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6. Development/pre-implementation qualitative phase: 
development of IPOS-Dem Versions 2 and 3 
[PUBLICATION 2] 
This chapter presents findings from the development phase qualitative study addressing 
the study objectives two and three, which are presented again for convenience: 
2. To explore the content validity of IPOS-Dem Version 1 to identify additional 
relevant symptoms and concerns, and redundant items, and refine the measure 
resulting in IPOS-Dem Version 2. 
3. To determine the acceptability and ease of comprehension of IPOS-Dem  
Version 2 and its manual to care home staff and make necessary refinements 
based on the results, resulting in IPOS-Dem Version 3 ready for evaluation phase. 
 
6.1 Development of IPOS-Dem manual 
A manual was developed to support care home staff to use IPOS-Dem in routine care for 
people with dementia. This was developed from and informed by the theoretical model and 
from the exploration of context, mechanisms of action, and implementation requirements 
during the development/pre-implementation phase focus groups and interviews presented 
in the next chapter. More detailed presentation of overall themes and subthemes informing 
the manual development are presented in Appendix N. 
 
  
Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-









Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-











Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-









Chapter 6. Development/pre-implementation qualitative phase: development of IPOS-






6.2 Summary and next steps 
This chapter presents the further development and refinement of IPOS-Dem and its manual 
by examining its content validity, acceptability and comprehension. In the published paper, 
the result is called IPOS-Dem final version. This was requested by the editors of the journal. 
However, to reflect that IPOS-Dem is ongoing development work and that there are likely 
to be refinements resulting in future versions, this version is called Version 3 in the thesis. 
IPOS-Dem Version 3 and its manual is presented in Appendix P, ready for the evaluation 
in routine care of people with dementia in residential care homes.
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7. Development/pre-implementation qualitative and 
evaluation/post-implementation mixed methods phases: 
feasibility and process evaluation of IPOS-Dem 
[PUBLICATION 3] 
This chapter presents a manuscript which has been submitted to PLOS One and is 
currently under review (publication 3). The chapter presents results from a feasibility and 
process of evaluation of IPOS-Dem utilising results from the development/pre-
implementation and evaluation/post-implementation phases, addressing the study 
objectives four, five, six, and seven. Presented again here for convenience: 
 
IPOS-Dem development/pre-implementation objectives: 
4. To gain an understanding of the residential care home context, the likely 
mechanisms of action, implementation requirements, and acceptability and 
feasibility of IPOS-Dem in the development phase to inform its use in routine care 
in preparation for evaluation phase. 
 
IPOS-Dem evaluation/post-implementation objectives: 
5. To understand the mechanisms of action and potential benefit of IPOS-Dem used 
in routine care of people with dementia within the residential care home context. 
6. To gain an understanding of the implementation requirements of IPOS-Dem into 
routine care of people with dementia. 
7. To test the acceptability and feasibility of IPOS-Dem in routine care of people with 
dementia. 
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Background: Assessment of people with dementia is challenging; with undetected and 
under treated symptoms and concerns resulting in avoidable distress, and few evidence-
based interventions to support this. We aimed to understand the mechanisms of action of 
a measure to support comprehensive assessment of people with dementia in care homes; 
and its acceptability, feasibility, and implementation requirements.   
Methods: A mixed methods study in three residential care homes, underpinned by a 
theoretical model of mechanisms of action. The measure, the Integrated Palliative care 
Outcome Scale for Dementia (IPOS-Dem), was introduced into the care of residents with 
dementia for 12 weeks. Qualitative data comprised focus groups and semi-structured 
interviews with family members, care home staff, general practitioners and district nurses; 
and non-participant observations. Quantitative data comprised IPOS-Dem data. Directed 
content analysis for qualitative data, and descriptive statistics were used for quantitative 
data. 
Findings: Key mechanisms of action were: improved observation and awareness of 
residents, collaborative assessment, comprehensive ‘picture of the person’, systematic 
record keeping, improved review and monitoring, care planning and changes to care 
provision, and facilitated multi-agency communication. Potential benefit included improved 
symptom management, improved comprehensive care, and increased family 
empowerment and engagement. IPOS-Dem was found to be acceptable and feasible. It 
was perceived as quick and easy to use, with proportion of overall missing data decreasing 
from 2.1% to 1.1% from baseline to final time points. ‘Trust’ in the measure was important; 
and leadership essential to ensure integration into care processes.  
Conclusions: In a population with complex care needs, with challenges to assessment 
and barriers to multi-agency working, a measure introduced into routine care is feasible 
and acceptable, and supports assessment and management of symptoms and concerns. 
A theoretical model demonstrating the likely mechanisms of action was developed. Further 
evaluation is required to test its effectiveness. 
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Dementia is a progressive and terminal illness [1]. It is characterised by increasing 
dependence and disability [2, 3] meaning that 24-hour care is frequently required [4]. 
Worldwide demographic change of increasingly older population profiles will result in 
growing prevalence of dementia [5, 6]; with consequent increasing demand in care home 
provision, and increasing requirement for palliative care from non-specialist providers [6], 
including care home staff. 
 
People with dementia may experience high symptom burden [7, 8] due to dementia, multi-
morbidities [9] and side-effects of treatments. It is challenging to assess symptoms and 
concerns in people who may have difficulty verbally expressing their wishes and concerns. 
This impedes practitioners’ ability to assess symptoms and concerns and often leads to 
under detection and treatment; and increased distress, behavioural changes and reduced 
quality of life [10]. Practice guidelines recommend comprehensive assessment and non-
pharmacological interventions to identify and treat the underlying causes of behavioural 
changes such as agitation [11]. However there are few high-quality evidence-based 
interventions for care homes to improve comprehensive assessment and management of 
symptoms and concerns in this population [12-15]. Furthermore, in the UK particularly, 
there are barriers to accessing health care for residents in care homes that have no onsite 
nursing care and therefore rely on external providers, including General Practitioners (GPs) 
and community or district nurses (DNs), with inconsistencies in provision across the country 
and challenges to integrated working [16]. 
 
Measures used in routine clinical care can facilitate assessment and change care 
processes leading to improved patient outcomes [17]. However, little is known of their use 
in care home settings [17]. Measures used in this way are complex interventions [18, 19]. 
In developing and evaluating complex interventions it is important to understand the likely 
mechanisms of action, and potential harms and safety of the intervention [19, 20], how the 
intervention should be implemented, and any influencing contextual factors [21, 22]. This 
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is particularly the case in the residential care home sector where there are additional 
challenges of multi-agency, integrated working (including with family) [16, 17]. 
 
We aimed to explore the mechanisms of action, feasibility, acceptability and 
implementation requirements of a measure, the Integrated Palliative care Outcome Scale 
for Dementia (IPOS-Dem), used in routine care to support comprehensive assessment of 
symptoms and concerns of care home residents with dementia and their family members. 
 
Methods 
Study design  
We conducted a two phase pre-implementation and post-implementation qualitative study 
with a concurrent embedded quantitative component [24] (Fig 1), underpinned by a 
theoretical model of the likely mechanisms of action of a measure used in routine care for 
people with dementia in residential care homes [25-27]. 
 
Fig 1: Study design and research methods of pre-implementation and post-
implementation of IPOS-Dem 
 
 
IPOS-Dem was implemented into routine care of residents with dementia for 12 weeks. 
Qualitative data collection included pre-implementation focus groups and semi-structured 
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interviews with family members (including friends) and professionals (care home staff, GPs, 
DNs); and post-implementation (during and towards the end of implementation) focus 
groups and semi-structured interviews with family members and professionals, and non-
participant observations. Quantitative data collection comprised measures with residents 
at baseline and at 12 weeks. Throughout the planning, data collection and analysis of the 
study, we consulted with experts including service users and carers, and academics and 
health care professionals in palliative care, primary care and mental health. 
 
Setting  
Three residential care homes registered to provide care for people aged 65 and over in a 
London borough, United Kingdom. Unlike nursing homes, residential care settings are not 
required to employ professionally qualified nurses, and therefore have no onsite nursing. 
The main health care providers are GPs and DNs [28].  Settings were recruited to obtain a 
variety of funding types, ownership and dementia-registration [29].  
 
Participant recruitment 
Recruitment of residents was informed by the Mental Capacity Act [30]. Eligible residents 
were identified by senior staff in the care homes. The care home staff introduced residents 
to the research team. The research team met with residents to ascertain willingness to 
participate and assess mental capacity to consent for themselves. Those residents that 
had capacity gave written informed consent. As we anticipated that the majority of residents 
would only be able to consent in the moment, we took the approach of gaining the advice 
of consultees in addition to informed consent [31]. The care home therefore sent a letter 
on behalf of the research team to a close friend or family member to invite them to advise 
on whether the resident should participate in research (personal consultee). Two letters 
were sent. If no response was received after one week of the second letter being sent, a 
nominated consultee was asked to advise on resident participation [30]. The nominated 
consultee was independent from the research study and used all available information 
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(including meeting with the resident, reviewing case notes and speaking to care home staff) 
in order to give advice on resident participation. 
 
At each recruitment phase we advertised and held coffee mornings in the care homes to 
share study information with family (including friends) of residents with dementia (CES/CP) 
[32]. Interested family members shared their contact details with the research team. Post-
implementation, we contacted family members acting as personal consultees in the 
recruitment of residents lacking capacity [30] who had expressed interest in participating 
and shared their contact details. We made up to two attempts to contact family members 
to recruit them. Recruitment of care home staff for both phases involved formal and informal 
meetings with managers and care home staff.  GPs and DNs responsible for health care 
provision for the participating care settings were identified and invited to participate. All 
participants were provided with study information sheets at least 24 hours prior to 
participating, and gave written informed consent (CES/CP/LAH).  
 
Participant eligibility criteria 
Participants for the focus groups and semi-structured interviews comprised family 
members and professionals. Non-participant observations of meetings were conducted 
between GPs and/or DNs, and senior care home staff to discuss and review residents’ 
care. Managers or senior care home staff participated in repeat semi-structured interviews 
about feasibility and implementation requirements of using the measure. 
 
All care home staff working at the participating settings were eligible to participate. Eligibility 
criteria for family were 18 years or older, able to provide consent and English-speaking. 
Additionally, post-implementation, family members were relatives or friends of residents 
recruited to receive IPOS-Dem intervention.  Care home staff were purposively sampled to 
provide a range of seniority and care roles. GPs and DNs were eligible to participate if they 
were responsible for providing health care to the participating settings. All family and health 
care professionals (GPs and DNs) meeting the inclusion criteria were invited to participate. 
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Eligibility criteria of residents were a permanent resident of the care home, formal diagnosis 
of dementia or cognitive impairment of stages four to seven on Functional Assessment 
Staging (FAST) [2]. 
 
IPOS-Dem intervention  
IPOS-Dem [27] formed the intervention.  IPOS-Dem is developed from the Integrated 
Palliative care Outcome Scale [33]. IPOS-Dem was developed to support assessment of 
symptoms and concerns in care home residents with dementia by care home staff without 
a nursing qualification (unqualified care home staff) [27]. IPOS-Dem comprises twelve 
questions covering common symptoms and concerns experienced by people with dementia 
over the past week. Each item is rated on a five-point scale from 0 (no problem) to 4 (very 
severe). The first question is unscored and is a free text response option of the main 
problems experienced by the resident. IPOS-Dem can be accessed and downloaded for 
free [34]. 
 
An early version of IPOS-Dem [27] was examined pre-implementation to understand likely 
mechanisms of action, and understand how IPOS-Dem should be implemented into routine 
care, and an instruction manual developed based on the results [27, 35]. 
 
During implementation, participating care homes were given a refined version of IPOS-
Dem and asked to use it, according to the instruction manual with recruited residents. The 
instruction manual recommends that IPOS-Dem is used monthly at the time of care plans, 
or flexibly at times of resident change. Apart from at the baseline and final time points, the 
research team was not involved and did not prompt care home staffs’ use of IPOS-Dem 
through the course of the implementation phase. This was to understand the 
implementation of IPOS-Dem without the use of facilitation [36] which is frequently not 
available or sustainable in under-resourced care settings [37]. 
 
Chapter 7. Development/pre-implementation qualitative and evaluation/post-





Demographic and clinical data collection 
Family and professional demographic data: 
Demographic data on family and professional participants were collected using 
standardised data collection forms, collected by the research team from participants. 
Demographic data for family included relationship to resident, gender and age. 
Professional demographic data were profession or role, years of experience, gender, and 
ethnicity.  
 
Resident demographic and clinical data: 
We used a data collection form and extracted demographic and clinical data from case 
notes at baseline. Demographic and clinical data included resident age, diagnosis of 
dementia (yes/no), type of dementia, gender, ethnicity, FAST dementia staging (from case 
notes and care home staff), morbidities and medication. 
 
Qualitative data collection 
Pre and post-implementation focus groups and semi-structured interviews: 
Separate focus groups were conducted with family members and professionals. Focus 
groups were chosen as a method of data collection to obtain participant interaction data 
[38]. Semi-structured interviews were conducted to enhance data richness by alternative 
data collection methods [39]. The pre-implementation topic guide consisted of a 
PowerPoint [40] presentation on the purpose of IPOS-Dem. To stimulate discussion about 
how IPOS-Dem could benefit residents and family members, and requirements for its 
properties and implementation, we used case vignettes within the topic guides (S1 file) 
[41]. Post-implementation topic guides was informed by the findings of the previous phase 
and also included questions on IPOS-Dem mechanisms of action, measurement properties 
and implementation requirements. Topic guides for the manager interviews were similar, 
but included additional questions on implementation requirements and feasibility within the 
care home setting and the resources available. All topic guides were reviewed by expert 
members, and piloted and refined before being used in the main study. Given the potentially 
Chapter 7. Development/pre-implementation qualitative and evaluation/post-





sensitive nature of the focus groups and interviews, a distress protocol was developed. 
Focus groups and interviews were digitally recorded. All focus groups and the majority of 
semi-structured interviews were conducted in the care homes. One interview with a family 
member was conducted in her own home in accordance with her preference.    
 
Non-participant observations: 
Non-participant observations were conducted in the care homes of care home staff and 
health care professionals discussing and reviewing residents to further understand the 
process of integrated professional working, and a means of data triangulation. 
Observations of consultations between senior care home staff and visiting health care 
professionals occurred at regular intervals through the intervention period and field notes 
made. 
 
All qualitative data collection was conducted by CES (female; BSc, MSc), an Occupational 
Therapist with clinical experience in older adult mental health and dementia, who at the 
time of the study was a PhD Training Fellow. A second researcher (CP/LAH) was present 
for focus groups to record observations and implement the distress protocol if required. 
Data collection continued until data saturation was achieved. This was defined as the point 
where no new themes or subthemes were being generated from further data collection [42, 
43].  
 
Quantitative data collection 
Data collection time points (Fig 1): 
Resident baseline data collection occurred just prior to implementation of IPOS-Dem in 
routine care. Final time point data collection occurred at 12 weeks at the end of 
implementation of IPOS-Dem. Baseline data collection consisted of a measure of agitation, 
the Cohen-Mansfield Agitation Inventory (CMAI) [44] and a measure of function, the Barthel 
Index [45]. At both time points, IPOS-Dem with an attached utility questionnaire, were 
completed. 
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IPOS-Dem utility questionnaire: 
For the purposes of the study, a brief utility questionnaire was included at the end of each 
IPOS-Dem to be completed by care home staff using the measure. This comprised four 
brief questions regarding the acceptability and usefulness of IPOS-Dem (S2 file).  
 
Qualitative data analysis 
All recordings were transcribed verbatim and detailed field notes were made, and entered 
into Nvivo 10 [46] to aid data management and analysis. Transcripts were checked against 
the original recordings by CES to ensure accuracy. Data were analysed using directed 
content analysis [47]. A coding framework was developed informed by the theoretical 
model [27]. Additional codes were developed during analysis for relevant data that could 
not be coded into the existing framework [47]. One researcher conducted all coding (CES). 
A second researcher (CJE) coded a selection of interviews independently. Where coding 
differed, this was discussed and reviewed until consensus was reached and the coding 
framework was revised based on consensus. The full set of transcripts were then recoded 
using the finalised coding framework (CES). The codes were then inductively categorised 
into themes and subthemes. To triangulate the data, family and professional data, and pre-
implementation and post-implementation data were compared and contrasted [48]. All 
analysis was discussed in regular research supervision (CJE, BAD, IJH) to enhance 
reflexivity and ensure accurate representation of findings.  
 
Quantitative data analysis 
Quantitative data were analysed using simple descriptive statistics for demographic, 
clinical, IPOS-Dem and IPOS-Dem utility questionnaire data. To explore for patterns of 
missing baseline IPOS-Dem data [49] (all missing, ‘missing - cannot assess’, ‘missing – 
reason unknown’) across cases, we used X2 or Fisher’s exact test with a Bonferroni-
corrected alpha level of p<0.003. Assumptions (normality, outliers) were tested prior to all 
analysis. Pearson’s r and paired t-test (for parametric) or Spearman’s rho and Wilcoxon 
signed ranked test (for non-parametric data) were used to examine correlation and mean 
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difference between baseline and final time points scores respectively with Bonferroni-
corrected alpha level of p<0.004.  Analyses were conducted both without imputation and 
using two methods of imputation (mean item score and mean case score) [49].  All analyses 
were conducted using SPSS version 22 [50]. 
 
Ethics 
Ethical approval was obtained from the National Research Ethics Committee – London 
South East, a committee flagged for adults lacking capacity [NRES: 13/LO/1339], and Local 
Authority Research Governance Framework approval was obtained for research in social 
care settings. Where required, individual care home setting ethical approval was obtained. 
National Health Service (NHS) research governance approval was obtained for 




Recruited care home size ranged from 26-33 beds. No relationship existed between the 
research team and care homes prior to the study commencing. Pre-implementation data 
collection commenced in May 2014 and completed in July 2014. Resident recruitment 
commenced in July 2015 and finished in October 2015. Baseline data collection 
commenced in September 2015 and the study closed with final time point data collection 
in February 2016. 
 
Prior to implementation, one of the study sites had a change of management and high staff 
turnover, resulting in withdrawal from the study. As a result, only two settings participated 
in the post-implementation phase. 
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Pre-implementation, we conducted qualitative focus groups (n=4) and interviews (n=3) with 
six family members and 20 professionals comprising care home staff (n=15), GPs (n=3) 
and DNs (n=2) (S1 Table). Four family members who expressed interest and shared their 
contact details did not participate due to time commitments (n=1), non-contactable (n=1), 
did not arrive (n=2). All care home staff who were approached and available participated. 
Four GPs were approached, one declined citing workload reasons. Three DNs were 
approached and expressed interest but one was unavailable due to work commitments. 
 
During the IPOS-Dem implementation period, we conducted three non-participant 
observations with three senior care home staff and one GP in one care home. Also during 
the IPOS-Dem implementation phase we conducted two sequential interviews with both 
care home managers. Towards the end of the IPOS-Dem implementation period, we 
conducted focus groups (n=2) and qualitative interviews (n=7) with seven family members 
and five care home staff. For family members, thirteen expressed interest and shared their 
details to be contacted and were therefore sent details of the study. Eleven responded after 
two contact attempts. One declined due to his relative’s deteriorating health. Of the ten 
remaining family members, six and an additional family member of one participant took 
part. Four expressed interest but were unavailable to attend. Care home staff working and 
available at the time of the focus group participated in the focus group (n=4). One care 
home staff member was recruited to participate in a semi-structured interview. One GP was 
approached to participate in focus groups but could not be recruited due to time constraints 
[S1 Table].  
 
The mean length of focus groups was 77 minutes (range: 62-92), total 7 hours and 41 
minutes. The mean length of interviews was 49 minutes (range: 26-91), total 8 hours and 
5 minutes. In the post-implementation phase, none of the family members had awareness 
of IPOS-Dem being used with their relatives. All participating care home staff had used 
IPOS-Dem in the study, apart from the managers who had awareness of the care home 
staff’s use of IPOS-Dem.  
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Baseline and final time point data were collected for 32 residents and 30 residents 
respectively. One resident died and another moved to a nursing home due to complex care 
needs. S1 Fig. shows flow diagram of recruitment, including consenting process, and 
reasons for attrition.  Table 1 includes demographic and clinical data of participating 
residents. Care home staff completed utility questionnaires were returned for all 32 
baseline resident assessments and all 30 resident assessments and final time point.  
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Table 1: Baseline demographic and clinical characteristics of participating residents  
Variable Residents n=32 
(%) 
Socio-demographic details  
Age  
Mean (SD) 
Median (range)  
87.2  (8.3) 




 8 (25) 
24 (75) 
Ethnicity  
White British, Irish or other 
Black Caribbean 
28 (88) 
  4 (13) 
Clinical details 








Alzheimer’s disease – mixed type 






1   (3) 
9 (28) 
7 (22) 
Functional Assessment Staging dementia stage 
4-5: Mild dementia to moderate dementia 
6a- 6e: Moderately severe dementia  
7a-7f: Severe dementia  
  4 (13) 
24 (75) 
  3  (9)  
Agitation  
Mean (SD, range) Cohen-Mansfield Agitation Inventory (29-
203) 
50.3 (14.0, 29-93) 
Functional status  
Mean (SD, range) Barthel Index (scores 0-100)† 52.7 (24.7, 0-90) 
Morbidities (excluding dementia) [9]: Resident number of morbidities 
Mean (SD) 5.1 (2.1) 
Morbidities (excluding dementia) [9]: Morbidity by group 
Cardiovascular  
Musculoskeletal  










  8 
40 




5   















SD: standard deviation 
† Higher scores indicate greater independence 
¶ Higher scores indicate increased agitation 
$ Medication missing for 5 residents 
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Key findings from all the data are summarised here, and explored in more detail in the 
subsections that follow. Challenges to symptom identification and communication were 
identified. Key mechanisms of action of using IPOS-Dem were: (1) improved observation 
and awareness; (2) collaborative assessment; (3) comprehensive ‘picture of the person’; 
(4) systematic record-keeping; (5) improved monitoring and review; (6) care planning and 
changes to care provision; and (7) facilitated communication. Potential resident and family 
benefit were identified as: (1) improved symptom management; (2) comprehensive 
concerns being addressed; and (3) increased family empowerment and engagement in 
care. Measurement properties included: (1) acceptability of IPOS-Dem: easy to use with 
low missing scores and providing value to care, and relevant and comprehensive; (2) 
feasibility: perceived to be quick to complete, with flexible frequency. Important 
measurement properties were identified as: (1) ‘trusted’ as an assessment i.e. known 
validity and reliability and established as a recognised measure; (2) administered using 
touch-screen technology. Leadership was essential to ensure that the measure is 
integrated in care home processes, and that it is valued and recognised as a tool to improve 
care processes and outcomes. These findings are combined in Fig 2 to illustrate the 
theoretical model of mechanisms of action, measurement properties, and implementation 
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Fig 2: Theoretical model of a measure used in routine care of people with dementia 
in residential care homes 
 
Mechanisms of action 
Improved observation and awareness of resident symptoms 
and concerns 
In both phases, all participants reported that IPOS-Dem supported improved awareness of 
residents’ symptoms and concerns. Family participants expressed concern that IPOS-Dem 
may be less useful for experienced care home staff, and therefore less value for the time 
spent completing it, but would be a good training tool for new care home staff: 
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 ‘and I think this is a really good learning tool, this is what we’re looking for, this is 
the sort of thing that will affect people erm and some people will already know this, they will 
have sort of walked in maybe having already had erm, erm experience with dementia and 
they will know this; but most people need it breaking down and so I think the fact that it’s 
broken down into this level of detail must be really useful when you’re starting to work in 
the care environment but I, I imagine that some of the people who are, who have worked 
there for many years probably could recount this in their sleep, erm and to actually have to 
constantly reiterate it would be diffi – more difficult … it’s still time when you could be 
interacting with residents’ (Family A3004) 
 
Care home staff identified that it prompted them to think more about resident symptoms 
and concerns: 
‘We understood the questions but I think you have to think deeply about what may 
be the answer you might think of. As a resident, as an individual maybe you don’t quite 
think quite so deeply until someone asks you that question’ (Care home staff B3011)  
 
Collaborative assessment between family members and 
care home staff and between all care home staff 
Care home staff identified that sometimes they had gaps in their knowledge of residents, 
particularly regarding to residents’ earlier lives. Findings from both family and professional 
participants suggested that using IPOS-Dem could address this through facilitating 
consultation with family members in the assessment of residents:  
 ‘Isn’t this where we come in? As much as we can obviously give some history as 
to how our parents or whoever it is, um what their personality was, you know, and so we 
can contribute and say that prior to the diagnosis of dementia they were a difficult person 
anyway’ (Family B1009) 
Furthermore, completing IPOS-Dem prompted care home staff to discuss residents 
amongst themselves further improving assessment and awareness of resident concerns: 
‘Particularly if someone’s sitting near to somebody else when they’re completing it 
and they might just say ‘what do you think about this?’ so it’s actually prompting 
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conversation which maybe in some senses you’re saying the document is meant to be 
really clear but as a care manager, I think it’s brilliant that anything that prompts 
conversation between staff about a resident’ (Manager B3001.1) 
 
Comprehensive ‘picture of the person’ 
Pre-implementation, family and professional participants expressed concerns that IPOS-
Dem would not provide sufficiently detailed assessment, and that a much more 
comprehensive and thorough assessment could be obtained through written text in care 
plans. As a result, participants reported that time would be wasted by care home staff 
completing IPOS-Dem without the provision of any meaningful information. Conversely, 
post-implementation, IPOS-Dem was seen as comprehensive and enhancing the 
assessment process. Participants valued how IPOS-Dem provided a comprehensive 
overall ‘picture of the person’: 
 ‘Erm it sort of put you in the mind of, although we’re doing care plans and we’re 
doing report but it gives you a picture as well you know that you, you’re seeing a picture of 
a person when you’re doing this so yeah it do helps (Care home staff A3003) 
This provided benefit by allowing a comprehensive knowledge of any concerns about a 
resident from a brief look at IPOS-Dem. Participants reported this as much more favourable 
compared to going through lengthy case notes.  
 
Systematic record-keeping  
Participants in the post-implementation phase reported that IPOS-Dem would result in 
improved record-keeping. Completing IPOS-Dem and severity scoring, was reported as an 
efficient means of recording residents’ symptoms and concerns over time, and easier to 
access compared to existing case notes: 
 ‘Okay so say for instance, let’s go with the skin broken down. For weeks now Mrs 
So and So’s skin broken down, you’ve got a variance, you’ve got it’s changed, “not at all” 
to “moderately”. The moment you have something that maybe goes over 2 boxes, page so 
and so this is what we did … almost like yeah so you’re evidencing you’ve seen the change 
and you’ve actioned something’ (Manager B3001.2). 
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Improved review and monitoring of residents  
Participants in both phases identified the potential benefit of IPOS-Dem in monitoring 
residents over time. IPOS-Dem used regularly could facilitate early detection of symptoms 
and problems, ‘refresh the brain’ by enabling care home staff to review how residents have 
been over time, provide information on patterns of behaviour, and inform end-of-life care 
through knowledge of residents over time:  
 ‘or that would help them towards the end of life though because all that information 
you’ve got about that person could be used … yeah because if they suffer from depression 
or they’re particularly low or there’s different things you know about that person when it 
comes to the end of life you’d have more of an understanding about whether they’re in pain 
or… (Care home staff B3011). 
 
Care planning and timely changes to care provision 
Participants reported that IPOS-Dem could be used to inform care plans, and result in 
changes to care provision:  
 ‘And indeed [care home staff] using it to be an additional either reinforcement or 
even a step beyond, um and then to get into especially towards the end of life, and it does 
mean anticipating, it does mean early identification and action…’ (GP B1004) 
Participants also shared how IPOS-Dem could also result in improved access to health 
care through improved identification of symptoms and improved communication. A few 
participants identified the potential benefit of having an IPOS-Dem action plan, ensuring 
that any identified concerns trigger a change in care: 
 ‘that’s right so some way of dragging together the bits that are more worrying than 
other bits, putting them together into a co – what do you call them and email in sort of data 
terms but you know putting the data together and creating an answer which says, you know 
there’s a red light on this, you know giving red, orange and green lights really you know 
that patient or that care, or that care patient has got red lights we’ve got to keep an eye on 
him or her, she’s green she’s fine, she’s okay at the moment, that’s really the …’ (Family 
B3008) 
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However, some participants identified that there may be a risk of identifying problems but 
not acting upon them:  
‘You know if we are because we’re in the situation where we’re thinking 
everybody’s exactly the same and then suddenly the data comes back saying actually you 
aren’t identifying that there have been quite significant changes which are written down but 
nobody’s doing anything about. Because the problem with care plans is you write things 
down but you don’t necessarily act on them’ (Manager B3001.1) 
 
Facilitated communication between family members and 
care home staff  
All participants identified challenges of communication between family members and care 
home staff. Many family members identified problems with communication with care home 
staff, with challenges in accessing information in a timely manner. This was exacerbated 
by shift work. Information, when provided, was rushed and not adequately discussed: 
 ‘… I’m sure there is a record on my mum but even when I, you know I meet with 
them they don’t get it out and look at it you know, erm and I have said before now I’d like 
to come in and talk to you about her but they just say oh she’s taking all her tablets and …’ 
(Family A3002) 
 Care home staff identified challenges in communicating with family members. Barriers to 
communication were lack of confidence, concerns about causing distress to family, 
concerns about not giving accurate information, or not knowing the answers to family 
questions: 
 ‘One has to be very um polite see, in a case like that it’s crucial and one has to be 
very aware of the kind of information (Care home staff B3012)…information you give (Care 
home staff B3014) … how you give it and what you’re going to say, some are sensitive so 
it’s a very difficult (Care home staff B3012)…especially if someone’s at the end of life’ (Care 
home staff B3011) (Care home staff focus group) 
A tension was identified regarding whose role it is to communicate. Family members tended 
to prefer communication with managers. Care home staff referred family members to 
managers for any more complex information, while one manager in particular, considered 
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it important that care home staff are enabled and skilled to communicate with family 
members: 
 ‘One of the things that really frustrates me is when staff say well speak to the 
manager – no you’re looking after the person, you tell them, and with this tool [IPOS-Dem] 
you can’ (Manager B3001.2) 
 Family participants welcomed the potential opportunity of accessing information and 
overwhelmingly reported the wish for IPOS-Dem assessments to be shared with them, and 
the potential benefit to care as a result: 
‘If the staff were completing this on a weekly basis, can I come down and say, can 
I see what [they’ve] said about my mum? (Family A1006) … So would that be useful? (CES) 
…Oh God, yes (Family A1006) …Yeah (Family A1007)’ (Family focus group) 
While the majority of care home staff perceived IPOS-Dem as a means of easily conveying 
information to family members: 
 ‘but maybe with this [IPOS-Dem] they don’t have to go because some of them can’t 
be bothered to sit there all, going through the care plan, where this you could just say okay 
we’re using this now, as well as a care plan, if you don’t have time to go through, look 
through this and you can see why we’re saying that your dad or your mum needed more 
support you know so then they can look through and see what we’re going on about (Care 
home staff A3003) 
Post-implementation, participants discussed the possibility of family members disagreeing 
with care home staff assessment, and the potential negative impact of this. This was 
contrasted with perceived potential benefit as a result of improved dialogue: 
 ‘but you can always look through and you could always say to them if you not agree 
with what we’ve said in here then, with all means you could see a different picture from 
what we see because we are looking here looking after mum or dad, you could come in 
and see something else that we’ve missed so yeah you know so we could always say if 
you think that something I should add in then let us know and we could improve from that 
as well’ (Care home staff A3003) 
However, for this to occur, the importance of a culture of transparency and lack of 
defensiveness was highlighted by both family and care home staff participants: 
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 ‘I think you know I think anyone who’s looking after your parents have to be, have 
to be engaged, very engaged with you and have to be very honest with you and you have 
to be very honest with them really’ (Family A3004).  
Participants, particularly care home staff, expressed concern that sharing IPOS-Dem with 
family members may result in distress if the information was sensitive or unexpected. 
However, there was also recognition of the importance of transparent communication with 
family members. Family participants overwhelmingly identified the benefit of being able to 
access IPOS-Dem assessments, and did not identify any concerns about potential distress 
of seeing assessments. 
 
Facilitated communication between care home staff 
Participants post-implementation identified how IPOS-Dem could support communication 
between care home staff. IPOS-Dem was considered potentially useful for care home staff 
returning to work after time off as a means of quickly getting an update on resident changes 
or concerns: 
 ‘… and certainly one of the things I’ve considered is if somebody’s been on annual 
leave saying to them make sure you read the [IPOS-Dem]. I haven’t done it yet, but almost 
like on your first day back, the first thing you’ve got to, the thing you’ve got to achieve before 
the end of your first day is read – is just checking on every resident and you can’t do that 
with the normal care plans but I think you could do it with this’ (Manager B3001.2) 
Also post-implementation, participants identified the usefulness of IPOS-Dem in supporting 
communication between junior and senior care home staff: 
‘I’ve had more staff come to me regarding 2 residents having difficulty swallowing 
in the last 2 months than I think I’ve had in the last 2 years all of a sudden erm I don’t think 
she’s swallowing properly, I think she’s holding it in her mouth…’ (Manager B3001.1) 
Senior care home staff valued the potential ability to return from leave and quickly and 
easily get a resident update through looking at IPOS-Dem assessments. Senior care home 
staff and managers also identified how IPOS-Dem could support supervision. Participants 
suggested that IPOS-Dem could help them monitor the quality of junior care home staff 
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assessment, and ensure that care home staff are acting upon any symptoms or problems 
identified: 
 ‘supervising [junior care home staff] to see that they are actually knowing the clients 
that they’re looking after’ (Care home staff A3003) 
 One manager, however, expressed concern over the potential additional burden of 
supervising whether care home staff had accurately assessed residents and acted upon 
identified concerns. 
 
Facilitated communication between care home staff and 
external health care professionals 
All participants in both phases shared communication challenges between care home staff 
and external health care professionals. Barriers to communication were shift work, high 
health care professional turnover, time limitations, differing expectations, and lack of 
shared documentation. 
 
Participants in both phases identified how IPOS-Dem had potential to support 
communication with health and social care professionals. This was particularly the case in 
working with mental health professionals. However, as was evidenced by observations of 
GP consultations and expressed by participants in both phases, there was uncertainty as 
to whether GPs would have time to read documents: 
‘The real issue is whether I suppose in a way maybe the other thing to think about 
is whether there should be some trigger so that the care workers refer forms which they 
think the GP should see, to the GP so that they do the sifting because the GP won’t do it 
for sure, I mean you give him a pile of forms like this he’ll say forget it. Um but if the carers 
say well there’s 2 forms here that we think you should look at because this lady’s had 
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Potential benefit to residents and family members  
Improved symptom management 
Participants reported that symptoms identified through IPOS-Dem prompted treatment: 
 ‘Yeah I mean I can certainly think of one resident who erm has recently started to 
suffer with constipation and that was highlighted in this and now they’re on a laxative which 
you know so I know this was used for that so – ’ (Manager B3001.2) 
 
Improved care of comprehensive emotional, social and care 
concerns 
In both study phases, care home staff participants identified the usefulness of a 
comprehensive measure to detect resident concerns, and improve the care provided to 
residents: 
‘Because if you’re finding things out from this and you’re making the lives of clients 
better, whether it be in a health way, or whether it be mentally, physically, in whatever way, 
then that’s a good thing, something you might not have picked up on without this’ (Manager 
C1005) 
 
Increased family empowerment and engagement in care  
In the post-implementation phase some but not all participants identified how IPOS-Dem 
could help increase family member empowerment to advocate for the resident and help to 
engage in their care: 
‘Erm yeah I do because if maybe she had diarrhoea for - then I could possibly pick 
up on it you know and say to them have you done anything about this?’ (Family A3002) 
The same family member, however, reported that even using the measure would not help 
her overcome the challenges of communication: 
‘[sighs] I think some family members could, yes, I do I think as a whole family 
members could question it, it might make them think a bit more and I could just imagine I 
wouldn’t, I might not say anything because I’m that sort of person, I think I give up so, and 
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I shouldn’t, someone said something was done in the hospital recently, when I went to the 
hospital this week and someone said well didn’t you say and I thought what’s the point, if 
they’re in that profession and they don’t see that, you know my mum was supposed to be 
keeping this thing on her eye and she kept moving it and she went “put it back”, and you 
think don’t talk to her like that, but I thought, if, if I have to tell you then you’re not going to 
change you know what’s the point in having an argument you know with someone and I 
think maybe I don’t speak up when I should at times, you know and I think if this, if they 




Acceptability: ‘ease of use’ and ‘value to care’ 
Care home staff overwhelmingly reported that IPOS-Dem is easy to use and understand. 
IPOS-Dem was reported to provide value to care. The value was enhanced by care home 
staff understanding the purpose IPOS-Dem and valuing how it can help and contribute to 
improving and supporting care provision. Care home staff participants reported that all care 
home staff should use IPOS-Dem with residents and that it is sufficiently accessible for all 
care home staff providing care no matter what their seniority is:  
 ‘I should think so because I mean we’re all doing the same job, we all write care 
plans …’ (Care home staff B3013) 
Only one participant, a manager, expressed concerns about all care home staff using 
IPOS-Dem, due to time constraints and literacy skills: 
 ‘I think mostly it’s time because they are so involved in the practical needs of the 
residents you know, um plus a lot of them don’t have very good you know handwriting 
[literacy] skills and that kind of thing, they weren’t employed for their handwriting skills’ 
(Manager A3001.1) 
Care home staff participants discussed the challenges of assessing residents who have 
difficulties expressing their wishes and concerns, and that there is always a degree of 
uncertainty in the assessment of these residents:  
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 ‘I think sometimes when you’re talking about pain or you’re talking about the way 
that person might be feeling you have an idea of the way they might feel but you don’t really 
know how they are feeling because they can’t express themselves so …’ (Care home staff 
B3011) 
However, they spoke about the benefits of knowing residents well to inform assessment, 
and the requirement to closely observe behaviour to inform assessment: 
 ‘We are looking after the resident you see some who cannot express themselves 
but as a carer you notice that oh this resident, where he would try to um to behave you can 
see the face, the way he would do um the way he would make the face you know that oh 
this resident he have pain somewhere or he will hold, sometimes he will hold his stomach 
like that then you know oh maybe she got a pain in her stomach, maybe she constipated 
or maybe, so things like that they will make the sign that you, you feel that maybe she have 
pain’ (Care home staff B3014) 
A few items were considered potentially problematic. The usefulness and challenge of the 
item, ‘family information’ was discussed by participants. Family participants expressed the 
importance of this item, but concern that care home staff would not be able to accurately 
respond to this:  
 ‘They’re making a guess, that everybody in the family has had enough information 
as they want whether they’ve verbalised it or not; so they can only say have the family 
asked for more information and has it been provided, not that they want more’ (Family 
B1008) 
This was corroborated by care home staff participants: 
 ‘How do you know that families get enough information relayed to them as they 
should have? (Care home staff B3011) 
Quantitative data supported these findings. IPOS-Dem assessments were completed in full 
for 21 out of 32 (65.6%) residents at baseline. Completion improved over time to 25 out of 
30 (83.3%) complete assessments at final time point. Across all 28 items for 32 residents 
(896 items across all cases), IPOS-Dem had 19 (2.1%) missing items at baseline and this 
decreased to 9 (1.1%) for 30 residents (840 items across all cases) at the final time point. 
At baseline 14 out of the 28 IPOS-Dem items (50.0%) had no missing scores and this had 
increased to 21 out of 28 items (75.0%) at final time point (Table 2)





Table 2: IPOS-Dem scores at baseline (n=32) and final time point (n=30) 
 Baseline  Final time point at 12 weeks  
IPOS-Dem item N Missing 
N (%) 
Cannot 
assess N (%) 
Mean (SD) Range N Missing 
N (%) 
Cannot 
assess N (%) 
Mean (SD) Range 
Physical symptoms 
Pain 29 0 (0.0) 3 (9.4) 0.62 (0.82) 0-2 29 1 (3.3) 0 (0.0) 0.86 (0.92) 0-3 
Shortness of Breath 31 1 (3.1) 0 (0.0) 0.23 (0.62) 0-2 29 1 (3.3) 0 (0.0) 0.17 (0.38) 0-1 
Weakness or lack of energy 31 0 (0.0) 1 (3.1) 0.97 (1.08) 0-3 30 0 (0.0) 0 (0.0) 0.87 (1.0) 0-3 
Nausea 30 0 (0.0) 2 (6.3) 0.13 (0.57) 0-3 30 0 (0.0) 0 (0.0) 0.33 (0.84) 0-3 
Vomiting 31 1 (3.1) 0 (0.0) 0.13 (0.72) 0-4 30 0 (0.0) 0 (0.0) 0.20 (0.76) 0-3 
Poor appetite 32 0 (0.0) 0 (0.0) 0.63 (0.75) 0-2 30 0 (0.0) 0 (0.0) 0.63 (0.85) 0-3 
Constipation 30 0 (0.0) 2 (6.3) 0.37 (0.56) 0-2 30 0 (0.0) 0 (0.0) 0.30 (0.65) 0-3 
Dental Problems 31 0 (0.0) 1 (3.1) 0.10 (0.30) 0-2 30 0 (0.0) 0 (0.0) 0.13 (0.43) 0-2 
Sore or dry mouth 32 0 (0.0) 0 (0.0) 0.09 (0.39) 0-2 30 0 (0.0) 0 (0.0) 0.00 (0.00) 0-0 
Drowsiness 32 0 (0.0) 0 (0.0) 0.84 (0.88) 0-3 30 0 (0.0) 0 (0.0)  0.70 (0.92) 0-3 
Poor mobility 32 0 (0.0) 0 (0.0) 1.19 (1.36) 0-4 30 0 (0.0) 0 (0.0) 0.93 (1.26) 0-3 
Swallowing problems 32 0 (0.0) 0 (0.0) 0.22 (0.71) 0-3 30 0 (0.0) 0 (0.0) 0.07 (0.25) 0-1 
Skin breakdown 32 0 (0.0) 0 (0.0) 0.41 (0.71) 0-2 30 0 (0.0) 0 (0.0) 0.37(0.77) 0-3 
Diarrhoea 32 0 (0.0) 0 (0.0) 0.13 (0.55) 0-3 30 0 (0.0) 0 (0.0) 0.13 (0.43) 0-2 
Physical symptoms sub-
score: no imputation (14 
items) 
25 2 (0.5)$ 9 (2.0)$ 5.72 (4.92) 0-18 28 2 (0.5)$ 0 (0.0)$ 5.96 (4.99) 0-19 
22* 5.32 (4.38)* 22* 5.27 (4.36)* 
Physical symptoms sub-
score: imputation 1† 
32 n/a n/a 6.04 (4.63) 0-18 32 n/a n/a 5.70 (4.76) 0-19 
Physical symptoms sub-
score: imputation 2‡ 
32 n/a n/a 6.12 (4.74) 0-18 30 n/a n/a 5.67 (4.94) 0-19 
30* 5.69 (4.35)* 
Emotional, social and existential concerns 
Difficulty communicating 32 0 (0.0) 0 (0.0) 1.09 (1.23) 0-4 30 0 (0.0) 0 (0.0) 0.97 (1.00) 0-3 
Sleeping problems 31 1 (3.1) 0 (0.0) 0.13 (0.50) 0-2 28 0 (0.0) 2 (6.7) 0.07 (0.26) 0-1 
Hallucinations and 
delusions 
32 0 (0.0) 0 (0.0) 0.69 (1.06) 0-4 29 0 (0.0) 2 (6.7) 0.59 (0.91) 0-3 
Agitation 32 0 (0.0) 0 (0.0) 1.50 (1.27) 0-4 30 0 (0.0) 0 (0.0) 0.77 (0.97) 0-3 
Wandering 32 0 (0.0) 0 (0.0) 0.41 (0.62) 0-2 30 0 (0.0) 0 (0.0) 0.47 (0.78) 0-3 
Anxious or worried 32 0 (0.0) 0 (0.0) 1.06 (1.19) 0-4 29 0 (0.0) 1 (3.3) 0.86 (0.79) 0-2 
Depressed 30 1 (3.1) 1 (3.1) 0.80 (0.96) 0-4 30 0 (0.0) 0 (0.0) 0.53 (0.73) 0-2 
Lost interest 31 0 (0.0) 1 (3.1) 1.39 (1.23) 0-4 30 0 (0.0) 0 (0.0) 1.03 (1.03) 0-3 
Peace 31 0 (0.0) 1 (3.1) 1.00 (0.97) 0-4 30 0 (0.0) 0 (0.0) 0.83 (0.79) 0-3 





 Baseline  Final time point at 12 weeks  
IPOS-Dem item N Missing 
N (%) 
Cannot 
assess N (%) 
Mean (SD) Range N Missing 
N (%) 
Cannot 
assess N (%) 
Mean (SD) Range 
Positive interaction 32 0 (0.0) 0 (0.0) 0.94 (1.16) 0-4 30 0 (0.0) 0 (0.0) 1.30 (0.79) 0-3 
Enjoyment of activities 32 0 (0.0) 0 (0.0) 1.53 (1.34) 0-4 30 0 (0.0) 0 (0.0) 1.20 (1.06) 0-4 
Practical problems 31 1 (3.1) 0 (0.0) 0.23 (0.43) 0-1 30 0 (0.0) 0 (0.0) 0.17 (0.59) 0-3 
ESE concerns mean sub-
score: no imputation (12 
items) 
26 3 (0.8)$ 3 (0.8)$ 11.08 (7.91) 0-29 27 0 (0.0)$ 5 (1.4)$ 8.52 (5.91) 0-25 
21* 9.71 (6.90)* 21* 8.80 (6.47)* 
ESE concerns mean sub-
score: imputation 1† 
32 n/a n/a 10.76 (7.17) 0-29 32 n/a n/a 8.79 (5.48) 0-25 
ESE concerns mean sub-
score: imputation 2§ 
32 n/a n/a 10.77 (7.18) 0-29 30 n/a n/a 8.86 (5.71) 0-25 
30* 9.66 (5.86)* 
Family concerns 
Family anxious or worried 31 0 (0.0) 1 (3.1) 0.45 (0.89) 0-4 29 0 (0.0) 1 (3.3) 0.45 (0.74) 0-2 
Family information 31 0 (0.0) 1 (3.1) 0.13 (0.34) 0-1 29 0 (0.0) 1 (3.3) 0.07 (0.26) 0-1 
Family concerns sub-score: 
no imputation (2 items) 
30 0 (0.0)$ 2 (3.1) $ 0.60 (1.04) 0-4 29 0 (0.0)$ 2 (3.3)$ 0.52 (0.87) 0-3 
27* 0.59 (1.05)* 27* 0.48 (0.85)* 
Family concerns sub-score: 
imputation 1†  
32 n/a n/a 0.58 (1.01) 0-4 32 n/a n/a 0.52 (0.83) 0-3 
Family concerns sub-score: 
imputation 2‡ 
32 n/a n/a 0.56 (1.01) 0-4 29 n/a n/a 0.52 (0.87) 0-3 
29* 0.55 (1.02)* 
Total scores 
Total score: no imputation 
(28 items) 
21 5 (0.6) 14 (1.6) 18.14 (12.15) 0-44 25 2 (0.2) 7 (0.8) 14.56 (9.71) 0-42 
17* 15.47 (10.51)* 17* 15.82 (10.94)* 
Total score: imputation 1†  32 n/a n/a 17.38 (10.39) 0-44 32 n/a n/a 15.01 (9.05) 0-42 
Total score: imputation 2‡  32 n/a n/a 17.46 (10.46) 0-44 30 n/a n/a 15.05 (9.44) 0-42 
30* 15.89 (8.70)* 
SD: standard deviation 
* n= analysis for complete pairs only         
$ Denominator is number of items in sub or total score multiplied by number of resident assessments 
† Imputation 1: mean IPOS-Dem item score imputed 
‡ Imputation 2: case mean item (sub)-score imputed
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Missing data was either missing as it was rated as ‘Cannot assess’ by the care home staff, or 
items were not completed (i.e. reason unknown). At baseline 14 out of 896 (1.6%) items were 
rated ‘cannot assess’ and 5 out of 896 (0.6%) were missing with reasons unknown. ‘Pain’ had the 
highest number rated ‘cannot assess’ (n=3, 9.4%), followed by ‘nausea’ (n=2, 6.3%) and 
‘constipation’ (n=2, 6.3%). At the final time point, 7 out of 840 (0.8%) were rated ‘Cannot assess’ 
and 2 out of 840 (0.2%) were missing with reasons unknown. ‘Sleeping problems’ and 
‘hallucinations and delusions’ had the highest number rated ‘Cannot assess’ (n=2, 6.7%). We 
tested the null hypotheses that there is no relationship between missing IPOS-Dem items and 
dementia stage, agitation, function or care home; and were unable to reject any of the null 
hypotheses. It is likely that the missing data is related to some other unexplored factor such as a 
feature of care home staff.  
 
Thirty out of 30 (100%) of care home staff who responded at baseline (two missing responses) 
reported that the time spent completing IPOS-Dem had been worthwhile compared to 20 out of 
30 (66.7%) at final time point (no missing responses). At baseline 30 out of 31 (96.8) reported no 
challenges to completing IPOS-Dem (one missing response) and final time point 26 out of 28 
(92.9%) reported no challenges to completing IPOS-Dem (two missing responses). The following 
two reasons for challenges were provided (one care home staff did not provide a reason): 
‘Sometimes difficult to know if resident in pain due to low moods’, ‘Don’t know about family, don’t 
know how to assess hallucination’. At baseline 8 out of 31 (25.8%) (one missing response) of the 
care home staff reported that completing IPOS-Dem would result in changes to care. At final time 
point this had increased to 18 out of 30 (60.0%) (no missing responses). 
 
Acceptability: comprehensiveness and relevance  
Participants reported that the items of IPOS-Dem are relevant, comprehensive and important. 
Family participants in particular welcomed the comprehensive nature of the assessment: 
‘…so I think you know just the over the past week where you’ve got I think it’s question 3 
to – yes it’s question 3 onwards you know about their, how they are, how they’re feeling, and 
interacting with other people and staff and I think that’s really really important. Lots of people do 
interact and I feel my mum doesn’t, and my mum’s always been a party girl you know she was 
always get up and go,…’ (Family A3002) 
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And that it addressed important concerns, including their own: 
 ‘Anxious, has any of her [family been], anxious or worried about the person, I think that’s 
important really, I mean I think, [sigh] (Family A3003) 
There was some discussion amongst family members about the acceptability of the term 
‘palliative care’ with most, but not all participants finding the term acceptable and appropriate: 
 ‘but your mum’s been in homes for 8 years so I wouldn’t see her in the same sort of 
category, I wouldn’t see her as having palliative care would you? (Family B3008) … but it is really, 
it is the end of her life, isn’t it? (Family B3007) … yeah I suppose so (Family B3008) … it’s how 
long they can hang on for (Family B3010) … I think it’s also understanding that people do, as we 
said earlier, people do die from Alzheimer’s you know it’s not just a condition (Family B3007) …  
oh yeah (Family B3008) … they die from it (Family B3007)’ (Family focus group) 
Fig 3 shows prevalence and severity of symptoms and concerns experienced by residents at 
baseline, by symptom and/or concern subgroups comprising: (1) physical symptoms, (2) 
emotional, social and existential (ESE) concerns, and (3) family concerns. ESE concerns were 
the most prevalent and severe with a mean item score of 0.90 (SD 0.60) compared to physical 
symptoms with a mean item score of 0.44 (SD 0.44) and family concerns with a mean score of 
0.28 (SD 0.51). The full range of IPOS-Dem (0-4) scores for the majority of items were not used 
(Fig 3, Table 2). On question one (free text item), seven cases had three main problems reported, 
five cases had two main problems and eight cases had one main problem. The majority of these 
were classified as ‘agitation’ (n=11), followed by ‘poor mobility’ (n=4), ‘anxious’ (n=4), ‘wandering’ 
(n=4) and ‘pain’ (n=1). The remainder could not be classified into IPOS-Dem items as they were 
specific to the individual (S3 Table). 
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There were no significant differences between baseline and final time points for mean total scores 
and the three symptom/concerns subgroups with or without imputation. Areas of physical 
symptoms and ESE concerns appeared to remain stable across the time points with moderate 
correlation between baseline and final time points with all imputations (rho= 0.58-0.80). Family 
concerns were not correlated (rho=0.25-0.29) between baseline and final time points.  
 
Feasibility: brief and flexible use 
All participants reported the usefulness of completing IPOS-Dem at baseline. In both phases, the 
majority of participants identified that IPOS-Dem should be used routinely when reviewing care 
plans and at times of change in resident presentation (e.g. changes in behaviour, unstable or 
deteriorating physical health), with a minority of participants stating that IPOS-Dem should only 
be used at baseline and at times of change to identify potential symptoms or problems that could 
be contributing to a changed presentation.  
 
The majority of participants described its feasibility for use in routine care, as quick to complete, 
and that it became quicker to use over time. With few exceptions, professional participants 
reported that IPOS-Dem was best done monthly to inform care plans, but with flexibility and more 
frequently if required: 
 ‘For some people it might vary, some people you might need to do it every day (Care 
home staff C1007) … yeah (Manager C1005) …whereas some people you might do it once a 
month, while some you have to do it weekly (Care home staff C1007) 
One manager considered the potential benefit and usefulness of IPOS-Dem being used on a 
weekly basis: 
 ‘Erm do I think you should tell people how to – how – I think if you don’t give them a 
minimum timescale there will be those who will only use it when they know you need, they’ve got 
to, erm the thing with monthly which is, is only really coming to me as we’re talking, the thing with 
monthly is it’s only capturing one week in the month, but you can’t capture a month in one tick 
box and I’m just thinking to be honest this would be so much easier for every staff to have one of 
these every Monday to fill in for the previous week or you know one day for the previous week on 
their key residents and then when they come to do their care plan they’ve got the information 
there’ (Manager B3001.2) 
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Conversely, family participants expressed greater concern regarding the feasibility of IPOS-Dem 
and the potential time burden on care home staff and risk of taking from their caring role: 
 ‘I think, I mean I think what, what is always helpful if you have to do this kind of monitoring 
and tracking is for it to be as simplified as possible and that it can be incorporated in the work that 
[care home staff] do, … it’s very difficult I think these kinds of monitoring and tracking systems 
are just simply time consuming and sometimes do take away from the business of you know 
communicating and doing all the basic stuff’ (Family A3004) 
The mean time it took to complete IPOS-Dem at baseline was 8.48 minutes (SD 4.98) and at final 
time point was 5.60 minutes (SD 1.45). 
 
Validity and reliability; ‘trusted assessment’  
Participants in both phases identified the potential risk of inaccurate assessment, either as a result 
of poor assessment or the measurement properties of IPOS-Dem (i.e. reliability): 
‘… but to me poor appetite might be not eating for a week, for somebody else it is a 
different pers- they’ll say poor appetite is when you haven’t eaten for a couple of hours… (Family 
B1007) 
As such, participants discussed whether IPOS-Dem would provide them with useful and 
trustworthy information, and the requirement for health care professionals to trust the assessment 
of care home staff. Participants identified that a measure that is recognised across agencies and 
trusted would evidence their assessment and support communication with visiting health care 
professionals. This would also address the challenge of integrated working: 
 ‘and they’ve got the time to do it honestly, truthfully, then yes because anyone that needs 
to look at this whether it be GP, ambulance, consultant, relative, they know exactly what is going 
on’ (Family B3006) 
 
Touchscreen technology 
Use of touch-screen technology was identified by both family and professional participants as 
improving acceptability through improved ease of use, improved ease of monitoring, support in 
identifying areas of concerns and triggering action plans: 
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 ‘Erm, it’s a long way off but somebody’s got to start planning it, and this would fit perfectly 
with that touchscreen situation, and if it was done in such a way that you could identify one 
particular aspect as well and just get the swallowing for the last 6 months or the skin integrity for 
the last 6 months it would be brilliant’ (Manager B3001.1) 
 
Implementation requirements 
Managers and care home staff considered leadership as essential in implementing IPOS-Dem to 
facilitate integration into routine care processes through e.g. supervision, care planning. 
Leadership was seen as required to support adoption by all care home staff, ensuring that care 
home staff remember to use the measure, and ensuring they understand its purpose; thus 
ensuring that the measure is recognised as a valued tool to support care provision despite 
additional time burden: 
 ‘and I know it’s more work, but even if it’s only a little bit, it’s still more work regardless of 
a little or a lot but I think things like this which, I don’t mean this selfishly, doesn’t just look after 
the clients, it promotes us, it promotes the care we’re giving, it promotes the way in which we 
work, so you know, I don’t think it shouldn’t be done. I think it’s something that all homes should 
do’ (Manager C1005) 
Care home staff identified challenges of remembering and getting into the routine of using IPOS-
Dem on a monthly basis. Quantitative data supported this with the number of IPOS-Dem 
measures being completed increasing from zero (0.0%) in the first month to seven (23.3%) in the 
final month. Care home staff also identified the practical challenges of making IPOS-Dem 
accessible for family members and external health care professionals.  
 
Care home staff participants overwhelmingly reported that IPOS-Dem was easy to use and did 
not feel that training was required. Senior care home staff and managers, however, stated that 
online training or DVD training would support implementation of the measure, and that this would 
be important to understand the potential benefit of IPOS-Dem and how it may support care. 
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We found that it is possible to introduce a measure into the routine care of residents and that this 
may change care processes to improve resident and family outcomes.  We identified likely 
mechanisms of action within the residential care home context taking into account multi-agency 
working between family members, care home staff and health care professionals. Important 
measurement properties both to facilitate its use and support mechanisms of action were 
identified; as well as the requirements for implementation. Based on our findings, we developed 
a theoretical model (Fig 2). 
 
Our findings supported many of our expected mechanisms of action including improved 
observation and awareness, improved care planning and care provision, and facilitated 
communication and collaboration between all agencies; corroborating results of previous studies 
in clinical [18, 51, 52] and care home [53, 54] settings. We identified additional unexpected 
mechanisms of action reflecting the more complex care processes in residential care homes. The 
use of IPOS-Dem facilitated a comprehensive assessment of resident symptoms and concerns, 
which fostered a ‘picture of the person’. This ‘picture of the person’ was valued as a means of 
recording complex assessments of residents in a succinct and easily accessible format, which in 
turn supported  systematic records-keeping, monitoring, and improved knowledge of residents 
over time. Furthermore, the ‘picture of the person’ facilitated communication within care home 
settings, supporting a previous finding [53]. This included incorporating IPOS-Dem into 
supervision to monitor assessments and ensure that symptoms and concerns are acted upon. 
We identified challenges to communication between family members and care home staff. These 
resulted from care home staff confidence and skill, shift work and differing expectations of roles. 
IPOS-Dem was identified as a potentially useful tool to overcome some of these barriers, thus 
improving and empowering family engagement in care provision; important to family members 
[55]. In addition, the measure if trusted and recognised by both parties, could facilitate 
communication to external health care professionals. This is important as there are known 
challenges to integrated working between social and health care sectors [16] with barriers 
including a lack of trust between residential care homes and health care providers, and care home 
staff perceived lack of respect for their knowledge and skills [37, 56].  
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Participants reported that the measure was easy to use and provided value to care. Low missing 
data support this finding. However, qualitative and quantitative data suggest that there were 
challenges to assessing people who have difficulties expressing their wishes and concerns. All 
care home staff rated the time spent completing IPOS-Dem as worthwhile at baseline, which 
decreased at the final time point. The reason for this is unknown. However, it is possible that care 
home staff found the baseline assessment most useful, and that information subsequently 
obtained from IPOS-Dem was of less value as symptoms and concerns had already been 
identified. Conversely, care home staff ratings of whether using IPOS-Dem would change care 
processes increased from baseline to final time point. Again, while the reasons for this are not 
known, it is possible that over the course of the study, care home staff increasingly recognised 
the role of using IPOS-Dem to support care. We examined the use of IPOS-Dem without any 
support from the research team so as to understand its use and implementation without any 
additional resources, frequently unavailable. IPOS-Dem completion rates were low but continued 
to increase throughout the course of the implementation. Qualitative data suggest that care home 
staff required time to get into the routine of using and remembering to use IPOS-Dem, and put 
structures in place to support its use. This explains the low but increasing use of IPOS-Dem over 
the 12 week implementation period, and suggests that, with the right training resources, it might 
be possible to implement IPOS-Dem without the use of ‘high facilitation’ [36, 57]. 
 
Our participants identified the importance of the measure being comprehensive. This reflects the 
multiple symptoms and concerns that this population may experience due to dementia, multi-
morbidities and side-effects of treatments [9]. Family members welcomed that their own concerns 
were considered in the assessment, corroborating the importance of family concerns [58]. 
Touchscreen technology, while not essential, was identified as a potential key facilitator in 
completing IPOS-Dem, storing records, monitoring over time and communication including online 
access for family members. This technology is becoming increasingly common in using measures 
in routine care [17] and may support implementation particularly if it facilitates measure 
completion, storing, retrieving and analysis of scores [59]. However, it is not yet widely used in 
UK care homes. 
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We found that leadership engagement at all phases was essential in implementing IPOS-Dem, 
corroborating existing evidence [59, 60]. Our findings support results of previous reviews of 
implementation interventions [16, 61], that interventions that take into consideration time 
pressures and facilitate conversations between care home staff and health care professionals, 
and those that utilise structured resources and/or tools, are more likely to be implemented and 
effective in improving outcomes. 
 
In order to triangulate our data, we examined differences and similarities between family and 
professional participants. Family and professional participants identified similar mechanisms of 
action; and problems with communication although they expressed different perspectives and 
concerns. One surprising finding was the discrepancy between participant groups regarding the 
feasibility of using IPOS-Dem. Few professional participants expressed concern regarding 
feasibility with some considering the potential usefulness of using IPOS-Dem as frequently as 
weekly. Family participants, however, worried that care home staff may not have the motivation 
or time to use IPOS-Dem, and the potential for it detracting from their caring responsibilities.  
 
Our study also gained an understanding of potential risk of harm of using a measure in routine 
care. No risks of causing harm to residents or family members were identified. However, 
participants did identify risks of inaccurate assessment either due to poor assessment or lack of 
measurement reliability, corroborating a finding of a previous study [53]. Another potential risk 
was that even if care home staff identified symptom or concerns, they may not act, or may struggle 
to obtain health services required [16]. Factors that mitigated these risks were good leadership, 
use of the measure in supervision, and implementation involving health care professionals 
external to the care home. Furthermore, collaborative working with family may empower family 
members to challenge assessment and act upon identified concerns.  
 
Our findings indicate that further work is warranted. There are challenges to assessing people 
who have difficulties expressing their wishes and concerns. Training to support assessment 
particularly of the more challenging symptoms such as pain and hallucinations would improve 
acceptability. Our findings also suggest that a training component should incorporate information 
on the measure being ‘trusted’, how it can provide value to care, and how to support its integration 
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into care processes. Established validity and reliability is important and further psychometric 
testing is warranted. Finally, a larger feasibility trial is required to inform the research methods for 
a full trial to evaluate the effectiveness of IPOS-Dem in improving resident and family outcomes 
[19]. 
 
As with all studies, there are a number of strengths and limitations. Rather than just hypothesise 
the mechanisms of action pre-implementation, we examined the use of the measure during 
implementation into routine care, taking into consideration the residential care home context and 
implementation requirements. We incorporated family perspectives and compared and contrasted 
these to professionals thus gaining a much more detailed and insightful view into some of the 
contextual challenges and potential mechanisms of action. To triangulate our data, we used a 
number of different qualitative and quantitative data collection methods [48]. The limitations of the 
study are that the study settings are likely to be ‘good’ care homes and more receptive to 
implementing new initiatives. Our sample size of residents was small and there were challenges 
to identifying and recruiting family members. The implementation phase of the study was 12 
weeks, which limits the understanding of implementation and integration into care processes, and 
long-term sustainment in routine care.  
 
Conclusion 
In a population with dementia and complex care needs, characterised by multi-morbidity and high 
symptom burden, and with challenges in assessment and integrated working; IPOS-Dem 
introduced into routine care is feasible and acceptable, and can support comprehensive and 
assessment and management of symptoms and concerns. The theoretical model developed 
conceptualises the likely mechanisms of action of how the measure may change care processes 
and potentially benefit residents and family members, and the implementation requirements. 
Further psychometric testing and a full trial of effectiveness are indicated. 
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S2 File: IPOS-Dem utility questionnaire 
Thank you for using IPOS-Dem today.  In order for us to understand whether or not using IPOS-Dem is 
helpful and/ or practical when providing care, we would be grateful if you could answer the following 
questions.  There are no right or wrong answers.  The information you provide will help us know more 
about IPOS-Dem.  We would be grateful if you complete this questionnaire each time you use IPOS-Dem. 
 
You do not need to provide your name or any details about yourself.  The research team collecting and 
analysing this information will not be able to identify who you are.  If you have any questions or concerns 
about answering these questions, please feel free to contact [xxx] on the contact details below. 
 
Please state approximately how long it has taken you to complete this questionnaire: 
................................................ minutes 
Will completing IPOS-Dem result in any action or changes to care, please circle: 
YES / NO  
Was the information obtained by completing IPOS-Dem worth the time spent, please circle 
YES / NO 
Did you encounter any challenges or problems using IPOS-Dem? 
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S1 Table: Qualitative participants’ demographic data 
 Pre-implementation Post-implementation 
Number of family participants N=6 N=7 


















































Care home Care home A 
Care home B 







Number of professional participants N=20 N=11 

































































































































 7.0 (1-29)  
18.2 (10.7)* 
19.0 (1.5-30)* 
Care home Care home A 
Care home B 







SD: standard deviation 
* Missing data for three participants 
† Missing data for one participant 
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S2 Table: Model components with underpinning participant narratives 
 Family Professional  







‘that would be quite difficult for me 
because if I visit once a week, I don’t 
know whether she’s been in pain’ 
(Family B1009) 
 
‘It might help to exclude other things, like 
you’d go through it and try to find out 
whether she’s breathless, whether she’s 
sick or vomiting, sort of a symptom checker 
list really?’ (GP A1002) 
 
‘I think it’s interesting because in my head 
I’m thinking, well these are the thing we 
would do, you know if somebody became 
distressed, the first thing we’d say is are 
you in any pain? Are you… you know, so in 
a sense there it’s a good way of, of making 
you think about the questions to ask, you as 
opposed to, um just assuming you’ve asked 
all the questions’ (Manager B1005) 
Post-implementation 
‘and I think this is a really good 
learning tool, this is what we’re 
looking for, this is the sort of thing 
that will affect people erm and some 
people will already know this, they 
will have sort of walked in maybe 
having already had erm, erm 
experience with dementia and they 
will know this; but most people need 
it breaking down and so I think the 
fact that it’s broken down into this 
level of detail must be really useful 
when you’re starting to work in the 
care environment but I, I imagine 
that some of the people who are, who 
have worked there for many years 
probably could recount this in their 
sleep, erm and to actually have to 
constantly reiterate it would be diffi 
– more difficult … it’s still time when 
you could be interacting with 
residents’ (Family A3004) 
 
‘It makes you aware of things you, 
you know there’s so much to do in 
your job that when you’re focused 
on something you think actually she 
isn’t, you now she isn’t eating very 
well, she does leave her dinner every 
day whereas you know you’re in 
such a rush to give out the dinners, 
collect them in and, and move them 
back into their seats they may not…’  
(Family A3002) 
 
‘…but I don’t know how much 
training they have in order to 
become a care worker and so it 
‘We understood the questions but I think 
you have to think deeply about what may be 
the answer you might think of. As a resident, 
as an individual maybe you don’t quite 
think quite so deeply until someone asks you 
that question’ (Care home staff B3011)  
 
 ‘…or if it’s not any changes for the, the 
client you are dealing with that would be 
easy but if it’s a change that the person has 
um change then you have to be careful the 
way you are filling with not just to tick and 
tick and – (Care home staff B3014) 
 
‘I think maybe we don’t, you don’t always 
think really a lot about people being at 
peace do you until the question’s until 
you’re asked that question’ (Care home 
staff B3011) 
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doesn’t become part of you really so 
maybe, you know and I think 
ongoing training and prompts like a 
questionnaire that just make you 





care home staff 
and between all 
care home staff 
Pre-implementation 
‘Isn’t this where we come in? As 
much as we can obviously give some 
history as to how our parents or 
whoever it is, um what their 
personality was, you know, and so 
we can contribute and say that prior 
to the diagnosis of dementia they 




 ‘Particularly if someone’s sitting near to 
somebody else when they’re completing it 
and they might just say ‘what do you think 
about this?’ so it’s actually prompting 
conversation which maybe in some senses 
you’re saying the document is meant to be 
really clear but as a care manager, I think 
it’s brilliant that anything that prompts 
conversation between staff about a 
resident’ (Manager B3001.1) 
 
‘I think sometimes it helps to know more 
about their past which you don’t always 
know about, know what they’ve done within 
their life you know because sometimes that 
can, be a good thing to know you know 
sometimes when someone’s passed away 
you’ve suddenly found out more about them 
when they’ve passed away than when they 
were here’ (Care home staff B3011) 
Change in care processes 
Comprehensive 
‘picture of the 
person’  
Pre-implementation  
‘Has [resident] been feeling anxious 
or worried? She does all the time, 
sometimes when this happens, 
sometimes when that happens. You 
can gauge a lot more from that than 
from one tick box’ (Family A1006) 
‘It doesn’t actually tell us anything does it? 
Staff go on the care plan and they can, for 
staff going to the care plan they can read 




‘Well I mean it does look um nicely 
detailed, it looks like um I, what I 
imagine, um in terms of my own 
smaller capacity as carer, I um 
obviously do notice things about my 
mum and ask her questions and try 
and facilitate um information from 
her about how she’s feeling um but 
to actually have it detailed in this 
way with particular criteria must be 
very useful I would think for the care 
workers, um and for me as well as 
I’m looking through it, it seems very 
sensible and very relevant so yes I 
think it’s, I think it is a useful tool 
‘Erm it sort of put you in the mind of, 
although we’re doing care plans and we’re 
doing report but it gives you a picture as 
well you know that you, you’re seeing a 
picture of a person when you’re doing this 
so yeah it do helps (Care home  staff A3003) 
 
‘Okay, but nobody ever sits down and 
thinks, well I say nobody ever, that’s not 
true because they do but it would be so easy 
to say oh they just suffer with a sore mouth. 
What’s the link between oh they’re suffering 
with a sore mouth but actually they’ve got 
quite a lot of pain and they’ve been 
vomiting, have they got something that’s 
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just to concentrate the mind really 
(Family A3004) 
 
‘Erm but I think if, if they had 
something like this where they you 
know, where the question is about 
informing, I think that would be 
helpful’ (Family A3002) 
 
‘Yeah I think that’s really important 
um yes I mean I think all of those 
things are really important because 
I think definitely if there was 
anything, if any of these um came out 
negatively I know that my mum 
would be quite unwell and unhappy 
(Family A3004) 







 ‘I think you should do it regardless of the 
change, because then it’s all documented 
isn’t it? Because you want to have the 
documentation of the good changes as well 




‘Okay so say for instance, let’s go with the 
skin broken down. For weeks now Mrs So 
and So’s skin broken down, you’ve got a 
variance, you’ve got it’s changed, “not at 
all” to “moderately”. The moment you 
have something that maybe goes over 2 
boxes, page so and so this is what we did … 
almost like yeah so you’re evidencing 
you’ve seen the change and you’ve actioned 







‘Well I think um I, I’m looking at 
some of the um the problems that are 
identified, I imagine that a lot of 
these things happen occasionally 
anyway, I mean everybody probably 
does have sort of sleep problems and 
diarrhoea and vomiting or whatever 
from time to time because you know 
we’re human, but I suppose the 
important thing is, is to make sure 
that it’s monitored and that that 
monitoring, that the number of times 
things happen might, might erm 
alert people to when there is a real 
problem…’ (Family A3004) 
 
‘or that would help them towards the end of 
life though because all that information 
you’ve got about that person could be used 
… yeah because if they suffer from 
depression or they’re particularly low or 
there’s different things you know about that 
person when it comes to the end of life 
you’d have more of an understanding about 
whether they’re in pain or… (Care home 
staff B3011). 
 
‘Well no in the sense that having copies 
whether we would have access or having 
copies that is what I’m asking because at 
times these are important when you are just 
you know to refresh the brain about what 
you’ve just you know something (Care 
home staff B3012) 
 
‘I think what is interesting is it is making 
staff think because this constant question 
over the last week, over the last week and 
it’s making staff think about a time  span 
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changes to care 
provision 
Pre-implementation 
 ‘And indeed [care home staff] using it to be 
an additional either reinforcement or even 
a step beyond, um and then to get into 
especially towards the end of life, and it 
does mean anticipating, it does mean early 
identification and action…’ (GP B1004) 
 
‘… but it’s not enough to say that that 
person’s in pain. The minute you know that 
you have a responsibility and I suppose this 
is exactly the same. Is this person 
constipated? Yes. How often? Frequently. 
What are you going to do about it?’ 
(Manager B1005) 
 
‘Yeah I mean I think it could help the care 
plans because I think, because everything’s 
got to coincide doesn’t it, so there’s no 
point the care plan saying that you know 
someone’s fine, but this is saying that 
they’re not’ (Manager C1005) 
Post-implementation  
‘that’s right so some way of 
dragging together the bits that are 
more worrying than other bits, 
putting them together into a co – 
what do you call them and email in 
sort of data terms but you know 
putting the data together and 
creating an answer which says, you 
know there’s a red light on this, you 
know giving red, orange and green 
lights really you know that patient or 
that care, or that care patient has 
got red lights we’ve got to keep an 
eye on him or her, she’s green she’s 
fine, she’s okay at the moment, 
that’s really the …’ (Family B3008) 
 
‘I think, I think they yeah they would 
be more aware that is something 
they should be doing’ (Family 
A3002) 
 
‘You know if we are because we’re in the 
situation where we’re thinking everybody’s 
exactly the same and then suddenly the data 
comes back saying actually you aren’t 
identifying that there have been quite 
significant changes which are written down 
but nobody’s doing anything about. 
Because the problem with care plans is you 
write things down but you don’t necessarily 
act on them’ (Manager B3001.1) 
 
‘and as I said again to me um a method like 
this helps um for us to go through and see if 
these people needed more help from outside 
agents more than you know so um so yeah 
so that would be a part of we supervising to 
see what staff are putting in and see if we 
needed more help from outside’ (Care home 
staff A3003) 
 
‘Um, just what I’ve said you know their 
changes would be identified and um we 
could act upon it’ (Manager A3001.1) 
 
‘I think this would help us write the care 
plan much better’ (Care home staff B3013) 
 
‘mhmm, staff have expressed that it’s quite 
easy to use, which is good and that it 
doesn’t take them too long erm because 
they’re not having to actually write 
sentences, so they’ve found it useful in as 
much as they’ve done this and then they’ve 
gone to the longer care plan, using this so, 
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for instance if it’s, if somebody doesn’t 
normally have any pain and on this they’ve 
put that they’ve, you know they’ve got slight 
pain, it’s given them the thing to say what is 
going on that’s changed so it, it’s sitting 
with the longer care plans but it’s 
prompting the longer care plans to rather 
than just say no change, no change, 
everything’s the same, it’s now making 
them think about the individual questions so 
that’s been quite helpful’ (Manager 
B3001.2) 
 
‘well if we think people are getting very 
high scores, especially in pains and erm 
stuff we’d seek help from the doctors that 
obviously this person needs to be medicated 
for painkillers or you know um if it’s 
anything to do with their mental stages 
deteriorating then it help us to get in touch 
more with the erm mental health team so…’ 
(Care home staff A3003)  
 
‘Yeah I do think so, I think looking back at 
these tools can you know if staff do it 
because sometimes they might not report 
straight away, I know they do report but if 
you go, if we go though and look and think 
oh but we missed this, this person could get 
more help, then yeah we could look at it and 
seek help from, from just what we’re 
looking at I mean you do have staff that will 
discuss with their one another and they 
might not come in and say to us but if we 
look here and there’s, you know they’re 
thinking and doing it then we can look at it 
and think this person’s score is quite high 
and sometime again some people in here 
not recognises dementia and if you look 
back at this you can see you know we should 
seek help for this person, something else 
might help them to be more settled and you 
know’ (Care home staff A3003) 
 
‘I think you know the more I’ve thought 
about it today the more I’ve thought about 
it being a weekly tool and I do think it 
triggers the mind and once it triggers the 
mind it triggers the care’ (Manager 
B3001.2) 
 
‘and as I said again to me um a method like 
this helps um for us to go through and see if 
these people needed more help from outside 
agents more than you know so um so yeah 
so that would be a part of we supervising to 
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see what staff are putting in and see if we 
needed more help from outside’ (Care home 
staff A3003) 
 
‘I don’t think so, not with the staff that are 
doing, that are doing it I think they’re fairly 
confident and they, they feel sort of like 
fairly assured as to how to do it so I don’t 
think that is an issue, and one of the other 
things that’s come up is with the care plan 
that they write, they’re writing about how 
the person is, but this always asks them to 
look back over the last week’ (Manager 
B3001.2) 
 
‘It will, won’t it because you’ll have a better 
understanding of that person and will have 
thought more about that individual, you 
know, and about their health and about 
their wellbeing so if you’re more aware 
about that person, individual you should be 
able to treat them, treat them you know the 








care home staff 
Pre-implementation  
‘If the staff were completing this on 
a weekly basis, can I come down and 
say, can I see what [they’ve] said 
about my mum? (Family A1006) … 
So would that be useful? (CES) 
…Oh God, yes (Family A1006) 
…Yeah (Family A1007)’ 
 
‘I’ve also had slight problems in that 
when I want information it’s often 
not readily available’ (Family 
C1008) 
 
‘and it has been a problem so often 
I’ve just, if I’ve needed something 
I’ll ask her a question and give them 
an hour to try and look for it or a 
day. Um again this was about 
nobody to ask. If you go in there 
quite a bit at weekends, then you’ve 
got weekend staff who just say I 
don’t know’ (Family C1008) 
 
‘Yeah, yeah because it’s a two way – 
it should be a two way street it 
shouldn’t all be left to the care home 
people and it shouldn’t all be left to 
us – if we work hand in hand you’ll 
get along better. That’s an ideal 




‘… I’m sure there is a record on my 
mum but even when I, you know I 
‘One has to be very um polite see, in a case 
like that it’s crucial and one has to be very 
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meet with them they don’t get it out 
and look at it you know, erm and I 
have said before now I’d like to 
come in and talk to you about her but 
they just say oh she’s taking all her 
tablets and …’ (Family A3002) 
 
‘I think you know I think anyone 
who’s looking after your parents 
have to be, have to be engaged, very 
engaged with you and have to be 
very honest with you and you have to 
be very honest with them really’ 
(Family A3004).  
 
‘Erm some time ago and it was kind 
of 6 weeks and she still hadn’t seen 
the doctor so I said I would take her, 
and then the doctor said that they 
couldn’t see me and that they would 
come to the home but the home had 
to ring them and – and eventually 
the doctor came but they never even 
fed back to me what was going on’ 
(Family A3002) 
 
‘Communica – I can’t fault this 
home at all for its care because I 
know that he’s washed, fed, and 
looked after generally but erm 
[Manager] knows this because I’ve 
complained to [Manager], the 
communication here is terrible’ 
(Family B3006) 
 
‘I’d have to say it doesn’t happen at 
all, they would probably say they do 
inform us but I, I just, I just come in, 
see my mum and just believe that 
everything else is a big black hole 
because when I ask questions I don’t 
get answers’ (Family A3002) 
 
‘know that that’s the truth and it’s 
not the right thing to do and I know 
it isn’t and here I look and I think 
she gets her tablets on time, she erm 
is clean, and dressed well, she err 
has good food, they keep the place 
you know quite clean erm and she 
can’t get out so she’s safe, erm and 
you can’t have everything so there 
are lots of good things but I think 
communication is probably the 
biggest concern I have’ (Family 
A3002) 
 
‘I have trouble on the phone as well 
when I’ve phoned up to see how it is, 
aware of the kind of information (Care 
home staff B3012)…information you give 
(Care home staff B3014) … how you give it 
and what you’re going to say, some are 
sensitive so it’s a very difficult (Care home 
staff B3012)…especially if someone’s at the 
end of life’ (Care home staff B3011) 
 
‘One of the things that really frustrates me 
is when staff say well speak to the manager 
– no you’re looking after the person, you 
tell them, and with this tool you can’ 
(Manager B3001.2) 
 
‘but maybe with this [IPOS-Dem] they 
don’t have to go because some of them can’t 
be bothered to sit there all, going through 
the care plan, where this you could just say 
okay we’re using this now, as well as a care 
plan, if you don’t have time to go through, 
look through this and you can see why 
we’re saying that your dad or your mum 
needed more support you know so then they 
can look through and see what we’re going 
on about (Care home staff A3003) 
 
‘but you can always look through and you 
could always say to them if you not agree 
with what we’ve said in here then, with all 
means you could see a different picture 
from what we see because we are looking 
here looking after mum or dad, you could 
come in and see something else that we’ve 
missed so yeah you know so we could 
always say if you think that something I 
should add in then let us know and we could 
improve from that as well’ (Care home staff 
A3003) 
 
‘It depends on the kind of questions the 
relatives want to find out, is depends of the, 
the, the question, if it’s the question that you 
can refer the person to the manager you 
refer the person to the manager, you have 
to limit what you can tell the family, 
sometimes you are keyworker for so so so 
person, when you are key worker the 
relative walk out and ask you oh how my 
mum has been, sometimes they will ask oh 
who is so so so person who look after my 
mum, if you are not there or if you are there 
they will come and call you say how my 
mum has been, has she been okay? So you 
say oh yeah yeah yeah she has been fine but 
with the question sometimes is the things 
that if she want to find more, you refer the 
person to the manager’ (Care home staff 
B3014) 
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you never get, I know obviously they 
do shift and the shift patterns 
change’ (Family B3006) 
 
‘but I find anything to do with record 
keeping is done very hastily on the 
hoof so you’re just about to go out 
the door and someone says well will 
you sign this?’  (Family B3007) 
 
‘… but as I say it is always n, in a 
rush that you get pushed a piece of 
paper for you to sign and you really 
haven’t got time to look through it’ 
(Family B3007) 
 
‘I must say I’ve, I haven’t found it 
like you, I do a lot of emailing and I 
find that if I email and ask 
something, I get a response 
reasonably quickly back, I don’t 
know whether you use email do you 
to contact [Manager]?’ (Family 
B3008) 
 
‘Well erm yeah I mean I think that, I 
think that er obviously the 
information, all the information that 
um they can give me about what’s 
happening with my mum is really 
helpful, um I spend quite a lot of time 
with mum, she comes out here most 
Sundays for lunch, I take her out 
quite a lot walking so anything, I 
need to know what’s, how she is at 
any particular time whether I can 
take her out, whether she can erm 
whether she can come erm with me 
anywhere, erm and how she’s going 
to be so clearly I think it’s, the more 
information that staff can give me 
about her physical and mental 
wellbeing the more I’m able to make 
the time that we have together erm 
happy’ (Family A3003) 
 
‘Erm but I think if, if they had 
something like this where they you 
know, where the question is about 
informing, I think that would be 
helpful’ (Family A3002) 
 
‘see I think it should be the other 
way around, I don’t think that we 
should be thinking, are we 
embarrassed to ask, I think they 
 
‘Especially end of life if you’re in that 
situation where somebody’s seriously ill or 
it’s kind of, and they’re asking you like 
really explicit questions about that person 
you’ve got to know (Care home staff B3011) 
… what to say (Care home staff B3013) … 
you’re telling the correction information 
because that, that could be you that’s not 
(Care home staff B3011)’ 
‘So you have to think seriously (Care home 
staff B3011) … especially if the resident um 
not well, and going to the hospital and the 
relative is there  (Care home staff B3013) 
… mm (CES) … you are just trying to be 
cautious you don’t want to say something 
that, it might affect you later on (Care home 
staff B3013) … do not know (Care home 
staff B3014) … or you don’t know for sure 
(Care home staff B3013) … you might upset 
them by saying something (Care home staff 
B3011) … and then you might upset them by 
saying something so sometimes it’s best for 
them to talk and you listen and if there’s 
something you can say but say it in a very 
nice way (Care home staff B3013)’  
 
‘You don’t know, you don’t have a clue, you 
have to go and look for team leader to tell 
the team leader that such and such person 
wants to know about – (Care home staff 
B3013) …we’re in a bit of an awkward 
situation sometimes (Care home staff 
B3011)’ 
 
‘I’ve got some relatives who will never 
leave the building without coming to speak 
to me, even though I know they’ve had a 
conversation with somebody else’ 
(Manager B3001.2) 
 
‘Do you think that such a tool could support 
working with family members? (CES) No 
they, they’re not around enough really to 
um have an objective view on it’ (Manager 
A3001.1) 
 
‘Erm the risk for family members is that 
they will misunderstand the document erm 
and they will think that because it’s got a 
tick that’s the end of the answer, do you 
know what I mean? So there has to be open 
two way conversations. If a family member 
sees it they’ve got to be able to ask the 
questions, you can’t be defensive with a 
document like this, you’ve got to be able to 
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should be saying please look at the 
record, please have a look at it, I 
think that, that the emphasis of this 
tool should in writing be on it, this 
tool should be made available on a 
regular basis to the family, so it 
should be pushed from them, not, we 
shouldn’t feel ohh, I don’t know 
whether we should ask or not, it’s 
not the point, it’s the other way 
around, the, the um, the home should 
be pushing the information to us and 
saying you’re part of this, this 
journey, you must be with us all the 
way, it’s not a matter of them 
providing it all and we just 
observing, you know we are part of 
the journey’ (Family B3008) 
 
justify why you’ve written what you’ve 
written’ (Manager B3001.1) 
 
‘Yes, yeah you, if you want to fill up and you 
can, ever you want the family to be there 
and you see this is what your mother has 
been going through, she has been vomiting, 
I know you are aware of this that’s why I’m 
putting it down, you can be agree, she’s 
agree and you agree what you are doing it’s 
nothing to hide from the family, have to 
share’ (Care home staff B3014) 
 
‘No I think the thing is you’re absolutely 
right because some staff the moment they’re 
challenged see it as an attack and go into 
defence, whereas I, I work really hard with 
staff to say this is a question, they’re 
showing an interest in the person that 
you’ve been looking after, qualify your 
answer, tell them why you’ve done that, 
explain to them why you feel this, so instead 
of being all defensive what’s it got to do 
with them, it’s got everything to do with 
them erm and you need to be able to tell 
them how the money that their mum is 
paying for you to look after them is being 
spent wisely, qualify what you’ve done, you 






 ‘I’ve had more staff come to me regarding 
2 residents having difficulty swallowing in 
the last 2 months than I think I’ve had in the 
last 2 years all of a sudden erm I don’t think 
she’s swallowing properly, I think she’s 
holding it in her mouth…’ (Manager 
B3001.1) 
 
‘supervising [junior care home staff]to see 
that they are actually knowing the clients 
that they’re looking after’ (Care home staff 
A3003) 
 
‘… and certainly one of the things I’ve 
considered is if somebody’s been on annual 
leave saying to them make sure you read the 
[IPOS-Dem]. I haven’t done it yet, but 
almost like on your first day back, the first 
thing you’ve got to, the thing you’ve got to 
achieve before the end of your first day is 
read – is just checking on every resident 
and you can’t do that with the normal care 
plans but I think you could do it with this’ 
(Manager B3001.2) 
 
‘You notice that the person have erm that 
problem you have to report this to the 
senior care to the senior, then the senior 
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will come and look, if it’s nothing that the 
home can deal with they have to call um…’ 
(Care home staff B3014) ‘GP’ (Care home 
staff B3013) ‘…the doctor or emergency if 
it’s um…’ (Care home staff B3014) 
 
‘…because we have supervision with staff 
every six weeks so we will ask them about 
their residents so if we’ve got this document 
I noticed over the last couple of months 
you’ve noticed this what have you done 
about it? How have you identified it?’ 
(Manager B3001.2) 
 
‘or you can leave one of your colleagues 
you rely on to be observing the keyworker – 
the resident you know to see if there is 
anything important or necessary to say or 









 ‘yeah, yeah I’d glance at it particularly, 
mainly to see if they noted any changes from 
what is usual for them, that might be 
helpful’ (GP A1002) 
 
‘Another reason I’m saying that is that 
sometimes you have clients and you notice 
changes in them you’re not quite sure what 
it is and you send them to the hospital and 
they send them back to us saying there’s 
absolutely nothing wrong with them 
whereas if you send this they can see why 
you’ve thought there’s something wrong’ 
(Manager C1005) 
Post-implementation 
‘The real issue is whether I suppose 
in a way maybe the other thing to 
think about is whether there should 
be some trigger so that the care 
workers refer forms which they think 
the GP should see, to the GP so that 
they do the sifting because the GP 
won’t do it for sure, I mean you give 
him a pile of forms like this he’ll say 
forget it. Um but if the carers say 
well there’s 2 forms here that we 
think you should look at because this 
lady’s had diarrhoea and then you 
know been vomiting and that kind of 
stuff’ (Family B3008) 
 
‘Oh yeah, yeah and because if they 
want to say this has been happening, 
and they can look back on their 
notes and say actually you know it 
was noted that you know for the last 
4 times we’ve filled this form in that 
she’s had diarrhoea and so it would 
be a useful tool for … and being able 
to look at symptoms in order for the 
‘Absolutely no consistency and I don’t know 
if that is nationwide or whether that’s just 
London, but London is dreadful at the 
moment erm and so you can train one batch 
of district nurses and then next lot are going 
to come in in a month’s time and don’t know 
what it is you’re talking about so it is going 
to be tough, it is going to be really really 
tough but if it became an, a nationally 
recognised tool then it wouldn’t matter 
which [Clinical Commissioning Group] 
you work from this would be the thing, and 
it also says well this is what we’ve been 
assessing so we can say to the district nurse 
who says you know how long’s this pressure 
area been there? Well actually this tool was 
done last week and there was no pressure 
area last week, so before you start 
screaming that it’s been going for months 
and nobody’s done anything, you know’ 
(Manager B3001.1) 
 
‘No I think it can be helpful as well you 
know for the doctor come in and you’re 
quite busy you can say just look through this 
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doctor to work out what’s wrong’ 
(Family A3002) 
 
‘but this form is exactly what a GP 
would want to know isn’t it, it’s 
exactly what a GP would ask’ 
(Family B3008) 
 
‘Would there be any way of having a 
small front sheet that if there was 
any information that the home felt 
they needed, felt a doctor needed to 
know just put on it rather than him 
ploughing through it just put please 
see..?’ (Family B3010) 
 
 
in the meantime, I’m doing something and 
you’ll see what I’m trying to say about the 
dementia, especially if the mental health 
team come in and we want to give them a 
picture of what’s going on with this person 
then you could show them this and you 
know instead of sit there and explaining 
again they have that, they just go though 
and then they can ask you any question they 
want from it so’ (Care home staff A3003) 
 
‘um possibly if we contacted the mental 
health team um because we were concerned 
about certain changes in a resident’s 
behaviour and they might say oh well 
monitor them for a few days and document 
the changes, I think this would be an ideal 
tool to use to do that’ (Manager A3001.2) 
 
‘No they wouldn’t go to the doctor oh look 
doctor so and s, so and so but they might 
say oh [GP name] can you go and see so 
and so because, and it’s just information 
they’ve got there because they’ve seen it’ 
(Manager B3001.2) 
 
‘Not our business, erm when you get down 
to hallucinations, agitation and wandering 
then if this is a change, if somebody, if 
we’ve been saying for the last 6 months that 
somebody’s hallucinating severely, it 
actually says why didn’t you get in touch 
with us sooner, but it also says we’ve been 
monitoring to make sure it wasn’t a one off, 
and we can evidence that they have been 
hallucinating, that they have, I probably 
wouldn’t wait 6 months but, you know but 
just for explanations sake. So it is a way of 
saying this is, this isn’t new or this is new, 
this person never hallucinates and all of a 
sudden they are hallucinating, erm so yeah 
and you know we in [borough name] we use 
the care home interim, the care home 
support team’ (Manager B300.1.) 
 
‘Well I think um we have the booklet during 
this so there’s a lot of information from the 
booklet, um and also yeah this will help as 
well for the, the professionals to see and 
work from it as well to see you know 
because they could come in and you’ll miss 
something to tell them and if you have it all 
written down by the time they get here it’s 
already here so it’s um’ (Care home staff 
A3003) 
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‘I don’t think it’s worth doing on top of the 
care plan I mean you have sometimes you 
call the mental health team out and then 
they don’t shuffle through those things if 
they have something like this’ (Care home 
staff A3003) 
 
‘I think, I don’t think they use the document 
to communicate in as much as I don’t think 
they show [GP name] the document but I 
think it informs so if the staff are noticing 
something they’ll mention it to the team 
leader and the team leader will then put 
them down to see the doctor’ (Manager 
B3001.2) 





 ‘Yeah I mean I can certainly think of one 
resident who erm has recently started to 
suffer with constipation and that was 
highlighted in this and now they’re on a 
laxative which you know so I know this was 









 ‘Because if you’re finding things out from 
this and you’re making the lives of clients 
better, whether it be in a health way, or 
whether it be mentally, physically, in 
whatever way, then that’s a good thing, 
something you might not have picked up on 
without this’ (Manager C1005) 
Post-implementation 
 ‘Because it does make you stop and think 
and it makes you stop and ask yourself what 
am I doing? What am I doing, what have I 
done about this and I think the minute you 
see there’s a change and you see I’ve got to 
do something, that improves the life of a 








‘Erm yeah I do because if maybe she 
had diarrhoea for - then I could 
possibly pick up on it you know and 
say to them have you done anything 
about this?’ (Family A3002) 
 
‘[sighs] I think some family 
members could, yes, I do I think as a 
whole family members could 
question it, it might make them think 
a bit more and I could just imagine I 
wouldn’t, I might not say anything 
because I’m that sort of person, I 
think I give up so, and I shouldn’t, 
someone said something was done in 
the hospital recently, when I went to 
the hospital this week and someone 
said well didn’t you say and I 
thought what’s the point, if they’re 
‘Yeah it might be reassuring to them that 
you know we are watching because they 
might have noticed a change and you know 
it would be reassuring for them to see oh 
yeah they’ve realised too and they’re 
watching what’s going on’ (Manager 
A3001.2) 
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in that profession and they don’t see 
that, you know my mum was 
supposed to be keeping this thing on 
her eye and she kept moving it and 
she went “put it back”, and you 
think don’t talk to her like that, but I 
thought, if, if I have to tell you then 
you’re not going to change you 
know what’s the point in having an 
argument you know with someone 
and I think maybe I don’t speak up 
when I should at times, you know 
and I think if this, if they ticked that 
they’d communicated with me, I 
think there’s a chance I might not 
say anything (Family A3002) 
 
‘I think the staff could press more for 
the visitors to have a look at the tool 
and even perhaps a comment on it 
because that would help them to sort 
of respond to anything that the staff 
had spotted so I think that, I think 
that you know the danger of this kind 
of form filling is that it just gets put 
away and everybody thinks thank 
God I’ve filled in a form, that’s it 
you know finished, but it’s no good 
unless it’s actually a positive err 
useful piece of work really isn’t it so 
I actually think that, that the 
outcome of this would be to add to it 
you know erm comment of visitor, 
you know when visited, erm and it 
would also show the sort of 
regularity of visits and the difference 
in sort or who visits and the rest of it 
which might help in terms of care 




‘ease of use’ 




‘They’re making a guess, that 
everybody in the family has had 
enough information as they want 
whether they’ve verbalised it or not; 
so they can only say have the family 
asked for more information and has 
it been provided, not that they want 
more’ (Family B1008) 
 
‘It must be hard for staff in a care 
home working with people with 
Alzheimer’s dementia to know if 
those residents are in any discomfort 
or pain, going by when [resident of 
B3006 – BB3003] had his fall 
recently, when I got to the hospital 
erm to see him, he had a massive 
‘I should think so because I mean we’re all 
doing the same job, we all write care plans 
…’ (Care home staff B3013) 
 
‘I think mostly it’s time because they are so 
involved in the practical needs of the 
residents you know, um plus a lot of them 
don’t have very good you know handwriting 
[literacy] skills and that kind of thing, they 
weren’t employed for their handwriting 
skills’ (Manager A3001.1) 
 
‘I think sometimes when you’re talking 
about pain or you’re talking about the way 
that person might be feeling you have an 
idea of the way they might feel but you don’t 
really know how they are feeling because 
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erm swelling the side of his head and 
erm a big bruise, black going down 
towards his eye, and on the back of 
his head he’s taken the skin off but 
not once, and it must have been 
painful, not once did he sa – did he 




they can’t express themselves so …’ (Care 
home  staff B3011) 
 
‘We are looking after the resident you see 
some who cannot express themselves but as 
a carer you notice that oh this resident, 
where he would try to um to behave you can 
see the face, the way he would do um the 
way he would make the face you know that 
oh this resident he have pain somewhere or 
he will hold, sometimes he will hold his 
stomach like that then you know oh maybe 
she got a pain in her stomach, maybe she 
constipated or maybe, so things like that 
they will make the sign that you, you feel 
that maybe she have pain’ (Care home staff 
B3014) 
 
‘How do you know that families get enough 
information relayed to them as they should 
have? (Care home staff B3011) 
 
‘You know how dare you say you’ve given 
me enough information when actually you 
haven’t spoken to me…?’ (Manager 
B3001.2) 
 
‘So there is a point at which the value, the 
value of the document comes in the 
document being valued’ (Manager 
B3001.1) 
 
‘Because they can help you to answer it, 
especially pains and um depression, you 
ask these questions and they can answer to 
say yes or no how I feel where with the 
others some of them you got to sort of you 
use your own skill to find out what is 
happening so yeah’ (Care home staff 
A3003) 
 
‘Well especially if they are in pain you 
notice you know their face expression, you 
notice when you’re trying to do personal 
hygiene, if they scream, anything like that 
so you’ll recognise that this person’s in 
pain, um you know more sleepy, you can say 
they’re more tired looking, more 
withdrawn, if it’s severe or, you 
understand? So…’(Care home staff A3003) 
 
‘But for in that case probably occasionally 
I think um probably she’s a bit um anxious 
or having some fear that she’s going to be 
hurt so it’s sort of anticipating, thinking 
about that I hurt that is going to happen’ 
(Care home staff B3012) 
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‘I guess what I think you have to be 
observing more the resident as an 
individual more, probably within the care 
plans and get more information about that 
will help’ (Care home staff B3012) 
 
‘Yeah that’s the, one of the great benefits of 
staff being here long term, not flitting in and 
out because they actually know the 
residents and they would immediately spot 
any changes and know whether that was a 
concern or not’ (Manager A3001.2) 
 
 ‘So basically but then, but if you ask it like 
that then you’ve got to ask then why not and 
is it because I haven’t seen the family, or 
erm I haven’t had the information to give 
the family if I so it’s 2 ways it could be no I 
haven’t informed the family but only 
because I haven’t seen them, or it could be 
no I haven’t informed the family because I 
don’t know what to inform them’ (Manager 
B3001.1) 
 
‘How do you know if I’m at peace?’ (Care 
home staff B3012) … ‘I don’t really do I? 
You make an assessment you make a 
judgement about people but you don’t 
really know’ (Care home staff B3011) 
 
‘This one here, can she or he enjoy 
activities appropriate for his or her level of 
interests and abilities, that’s quite a hard 
one don’t you think?’ (Care home staff 
B3011) 
 
‘I think it is, I think it is and I think it is, I 
think that is one of the questions that is open 
to interpretation I really do, because for 
some people being at peace means they’re 
rest – they’re not rest, restless, but for 
actually for others they could be very 
restless but still be at peace, because some 
people don’t get that peace is an emotion as 
opposed to a s – a physical state, if, if you 
know where I’m going with that so it’s 
about helping people to understand that this 
is about their total wellbeing, are they at, 
are they at erm at the point of not 
necessarily acceptance, but are they 
embracing fully where they are? Are they 
fighting with where they are? Are they you 
know are they still saying I wish, I wish, I 
wish, you know I wish I could do this, I wish 
I could do that, because if somebody says 
oh I wish I could walk, they actually telling 
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you they’re sad that they can’t and so 
they’re not at peace because they’ve got 
that sense of not being able to do 
something, and I think, I think that question 
is going to be one that is interpreted very 






‘…so I think you know just 
the over the past week where you’ve 
got I think it’s question 3 to – yes it’s 
question 3 onwards you know about 
their, how they are, how they’re 
feeling, and interacting with other 
people and staff and I think that’s 
really really important. Lots of 
people do interact and I feel my mum 
doesn’t, and my mum’s always been 
a party girl you know she was 
always get up and go,…’ (Family 
A3002) 
 
‘Anxious, has any of her, anxious or 
worried about the person, I think 
that’s important really, I mean I 
think, [sigh] (Family A3003) 
 
‘but your mum’s been in homes for 8 
years so I wouldn’t see her in the 
same sort of category, I wouldn’t see 
her as having palliative care would 
you? (Family B3008) … but it is 
really, it is the end of her life, isn’t 
it? (Family B3007) … yeah I 
suppose so (Family B3008) … it’s 
how long they can hang on for 
(Family B3010) … I think it’s also 
understanding that people do, as we 
said earlier, people do die from 
Alzheimer’s you know it’s not just a 
condition (Family B3007) …  oh 
yeah (Family B3008) … they die 
from it (Family B3007)’ 
 
‘Definitely relevant because they 
don’t even really remember, will 
remember themselves, I know my 
mum wouldn’t remember any of 
these, she wouldn’t know that she 
hasn’t slept very well you know and 
I think they’re, them looking out for 
symptoms so the night staff are they 
here, because they must walk round 
at night and if they hear some noise 
in the room then they know you 
know, not sleeping at night is you 
know, erm and question 3, yeah I, I 
think they are all relevant [pause], 
but as I said you know lots of things 
‘There’s quite a lot, appetite, the mobility, 
wandering, yeah there is a lot here that 
would um indicate that things have changed 
and there’s a problem’ (Manager A3001.1) 
 
‘Um no they’re all quite relevant aren’t 
they you know have the family been anxious 
yeah I think they are all relevant’ (Manager 
A3001.2) 
 
Chapter 7. Development/pre-implementation qualitative and evaluation/post-implementation 




 Family Professional  
may go on but I’m not aware of them 





 ‘For some people it might vary, some 
people you might need to do it every day 
(Care home staff C1007) … yeah (Manager 
C1005) …whereas some people you might 
do it once a month, while some you have to 
do it weekly (Care home staff C1007) 
 
‘I think…if it’s going to be coinciding like 
and implementing what’s in the care plan 
then they all have to be done on a monthly 
basis and more regular if changes’ 
(Manager C1005)  
 
‘I mean, I suppose really the question was 
how often and who by and how would it 
help? … erm… we have a monthly 
assessment on their care, and I suppose 
really I would initially think that that is 
something we could use upon admission, 
and then monthly and then increase its 
usage if the level of change seemed to be 
more significant, or a tool that we could go 
back to, if we you know, we’ve done it and 
we might have done it last week, but all of a 
sudden we’re noticing a significant change, 
for it to be a tool to say well come on, let’s 
see what’s going on here’ (Manager 
B1005) 
Post-implementation 
‘I think, I mean I think what, what is 
always helpful if you have to do this 
kind of monitoring and tracking is 
for it to be as simplified as possible 
and that it can be incorporated in 
the work that [care home staff] do, 
… it’s very difficult I think these 
kinds of monitoring and tracking 
systems are just simply time 
consuming and sometimes do take 
away from the business of you know 
communicating and doing all the 
basic stuff’ (Family A3004) 
 
‘Erm [pause] I think weekly, the 
staff would not want to do that, and 
possibly, they probably wouldn’t 
want to do every 2 weeks either but I 
see things as 6 weeks as a teacher 
and you know if it was every 3 weeks 
or 4 weeks or every month you know 
that would be better than them not 
doing it but I can’t see that 
happening’ (Family A3002) 
 
‘Erm do I think you should tell people how 
to – how – I think if you don’t give them a 
minimum timescale there will be those who 
will only use it when they know you need, 
they’ve got to, erm the thing with monthly 
which is, is only really coming to me as 
we’re talking, the thing with monthly is it’s 
only capturing one week in the month, but 
you can’t capture a month in one tick box 
and I’m just thinking to be honest this would 
be so much easier for every staff to have one 
of these every Monday to fill in for the 
previous week or you know one day for the 
previous week on their key residents and 
then when they come to do their care plan 
they’ve got the information there’ 
(Manager B3001.2) 
 
‘I think you can use it like maybe for a 
resident that you see not having much 
change maybe every month or every 2 
months when we’re doing our care plan as 
well you just use that as well as part of our 
tool, um somebody that you see change 
more rapidly as the weeks go by I think it’s 
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good to use more as a 2 week or you know 
um monthly, it just depends on how, what 
we notice in their behaviour and changes’ 
(Care home staff A3003) 
 
‘Well as I said again it depends on the 
deterioration in some of our clients, some 
might deteriorate more rapidly and the ones 
that deteriorate more rapidly I could see I 
mean you could have it as a weekly but I 
think weekly might be a bit too much so say 
two weekly and the ones that is more slower 
erm deteriorating then that could be as our 
care plan because what we do we do 2 
monthly for the ones that not deteriorate 
and as time goes as well for example if we 
see somebody going downhill then you use 
it as a weekly erm method and work with it 
that way so’ (Care home staff A3003) 
 
‘It depends on the person, if the person has 
changed before erm you, you do it next 
month, if the person, I’m giving an example, 
if the person change this week you can’t 
wait for next month to do your book [IPOS-
Dem], you have to…’ (Care home staff 
B3014) 
 
‘But as a, you know as a one-off, um I think 
it could be quite a good tool, but not to be 
used every week’ (Manager A3001.1) 
 
‘Possibly, maybe you know if we notice 
some changes in the resident we might refer 
back to this’ (Manager A3001.1) 
 
‘Um, intermittently, if we notice a change in 
a resident then we would refer back to this, 
perhaps go through it again and then 
compare how it was and how it is now’ 
(Manager A3001.1) 
 
‘Erm I think initially once a month or where 
have you is, is good, as I said earlier I think 
it is something that particularly if you’ve 
got somebody who’s going through a 
change in their, their condition it could be 
used more frequently’ (Manager B3001.1) 
 
‘You know rather than let’s rewrite the care 
plan every time there’s a change which is 
the situation we’re in at the moment, if 
somebody has a change in their condition 
we have to update the care plan as the 
condition changes so you can be writing 
something in the care plan every day 
Chapter 7. Development/pre-implementation qualitative and evaluation/post-implementation 




 Family Professional  
because somebody’s changed whereas it 
would be brilliant if we would say we’re 
noticing changes, we’re going to use the 
[IPOS-Dem] on a weekly basis or a daily 
basis to monitor these changes, that would 
be so much easier’ (Manager B3001.1) 
 
‘Not really I mean as I said if we really put 
our mind to it and you do one a day really 
it’s, you know it’s not that we’re going to sit 
and do all 33 so you know if everyone really 
put their head to it I can see it going one a 
day, you know once a week somebody come 
in and take up this particular, especially key 
workers you know if one said I’ll do 2 of my 
clients and you know I think you know it 
could work really’ (Care home staff A3003) 
 
‘Yeah, so yeah I mean probably in the long 
term I would say yes it’s hard work to do 27 
of these every week but nobody’s doing 27, 
at the most they’re doing 4 because they 
only have 4 key residents so at the most 
they’re doing 4, so it, it’s not a huge thing. 
Now one of the big issues of course would 
be the amount of paperwork you would 
generate. Um but I do think  when you’ve 
got somebody who is changing or somebody 
who is unwell and you’re looking to see 
where those changes are, it could be, it 
could be a useful tool to do it weekly so 






‘… but to me poor appetite might be 
not eating for a week, for somebody 
else it is a different pers- they’ll say 
poor appetite is when you haven’t 
eaten for a couple of hours… 
(Family B1007) 
 
‘I’m not a fan of things like this 
because I don’t think they’re very 
helpful in the long run because you 
give them to people and they just 
think I’ve got to tick one so I’ll tick 
this’ (Family A1006) 
 
Post-implementation 
‘and they’ve got the time to do it 
honestly, truthfully, then yes 
because anyone that needs to look at 
this whether it be GP, ambulance, 
consultant, relative, they know 
exactly what is going on’ (Family 
B3006) 
 
‘no, I think that, I mean the harm 
could be that it’s filled in incorrectly 
‘Absolutely no consistency and I don’t know 
if that is nationwide or whether that’s just 
London, but London is dreadful at the 
moment erm and so you can train one batch 
of district nurses and then next lot are going 
to come in in a month’s time and don’t know 
what it is you’re talking about so it is going 
to be tough, it is going to be really really 
tough but if it became an, a nationally 
recognised tool then it wouldn’t matter 
which [Clinical Commissioning Group] 
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and then there’s some sort of 
medical intervention which might, 
for instance which might not be 
appropriate but it seems to be as you 
said, a GP if they read this at all 
would certainly not, not act on it 
without err second accounting and, 
and getting other information from 
other sources before say prescribing 
something or whatever for 
depression when she’s not 
depressed or he’s not depressed or 
whatever’ (Family B3008) 
 
‘I would say not that helpful for GPs. 
I’m not sure that they would tru – to 
be perfectly frank I don’t know 
whether they would trust that this 
had been filled in correctly, whether 
they’re talking about the same 
person, I don’t know, I just don’t feel 
they would use it (Family B3007) 
 
you work from this would be the thing, and 
it also says well this is what we’ve been 
assessing so we can say to the district nurse 
who says you know how long’s this pressure 
area been there? Well actually this tool was 
done last week and there was no pressure 
area last week, so before you start 
screaming that it’s been going for months 
and nobody’s done anything, you know’ 
(Manager B3001.1) 
 
‘and it’s got an NHS certificate on you 
know it, we had exactly the same with the 
integrated care plan. Once they’d been 
trained on the integrated care plan they 
were happy to use it. I, I get it they’re 
regulated as well and they’re petrified of 
doing anything outside their regulation’ 
(Manager B3001.1) 
 
‘The risk is, and you’re always going to 
have this when you’ve got a tick box, let’s 
just tick a box … and that risk can only be 
overcome by making sure that somebody is 
reading the document to make sure that it’s 




‘erm I mean you know we are in the 
modern world, I actually think that 
there’s no reason why each patient 
should not have a private folder 
which the family can access and so 
this is actually not just so that when 
I, I live a long way away as well and 
err I would like to know on a 
Tuesday what’s happening you 
know I mean B1009 comes in lots so 
she could ask to look at the 
documents, she wouldn’t want to 
access them online but you might 
want to access it on, you know those 
that use computers a lot I mean it 
would just be useful to, to see what’s 
been filled in this week so you’ve got 
a, a running log of what’s 
happening, I mean that’s not a, 
possibly the cheapest of options as it 
involves all sorts of security issues 
and all the rest of it but I definitely 
think that’s another way of 
communicating, namely that, and 
the staff could then say when, you 
know when they get a complaint 
about lack of, of a response they 
could actually say well it’s on the, 
you know people can look it up when 
‘Erm, it’s a long way off but somebody’s got 
to start planting it, and this would fit 
perfectly with that touchscreen situation, 
and if it was done in such a way that you 
could identify one particular aspect as well 
and just get the swallowing for the last 6 
months or the skin integrity for the last 6 
months it would be brilliant’ (Manager 
B3001.1) 
 
‘I mean I think it’s a little while before care 
homes are going to be all electronic, but 
we’re talking about a, a document with a 
future, not a document with a past so we 
have to you know think, this as it is fine, this 
as it is is fine but when the time comes that 
we’ve got touch screens in every communal 
area and what have you or tablets in our 
pockets, I mean I know some of the more 
affluent homes and have already got tablets 
in their pockets but you know it’s just a case 
of I’ve been in to see Mrs so and so and then 
it can be done far more often … and if it 
needs to be done every day it can be done 
every day. If it’s on a touchscreen it’s not 
actually, you know we’ve been talking in 
terms of once a month when their care plans 
are done’ (Manager B3001.1) 
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they like, it’s online’ (Family 
B3008) 
 
‘You know because if this could go onto a 
tablet and you could just bring it up, pain, 
last 6 months, and it gives you that picture 
for the pain for the last 6 months that would 






 ‘Erm for me, what I will do once the 
research if over you know if we continue 
with the document will be to say discuss it 
with them because we have supervision with 
staff every six weeks so we will ask them 
about their residents so if we’ve got this 
document I noticed over the last couple of 
months you’ve noticed this what have you 
done about it? How have you identified it?’ 
(Manager B3001.1) 
 
‘I do think it is purely by erm people being 
aware that there’s been changes and if this 
highlights it I, I don’t know I think, how can 
I, I don’t want to say big brother but 
somebody has to be looking at what other 
people are doing. There has to be a point at 
which staff are aware when – it’s twofold 
really, staff have to know when they’ve put 
it down somebody’s listening to it or 
reading it because otherwise they’ll just tick 
anything if they’re thinking oh they’re not 
going to take any notice so there is um there 
is a management responsibility to make 
sure we follow through when the staff put 
the effort in to do it and I think that then will 
complement the staff to make sure they’ve 
done it properly because they know the 
management’s going to look at it so it’s 
reciprocal really … erm if I know my boss 
is coming to look at something I know I’m 
going to do it properly because my boss is 
coming to look at it, if I think my boss isn’t 
interested.’ (Manager B3001.1) 
 
‘erm, just to compare you know this with the 
current care plan. That’s the only way 
you’d know if it was actually being 
implemented’ (Manager A3001.1) 
 
 ‘They just need that prompt from me have 
you done it, erm but again that, as I said 
earlier that just getting into the routine 
(Manager B3001.1) 
 
 ‘Yeah because I’m just not used to using it, 
you just have to get into that mind-set of 
thinking it’s got to be done at the end of 
every month’ (Care home staff B3011) 
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 ‘and I know it’s more work, but even if it’s 
only a little bit, it’s still more work 
regardless of a little or a lot but I think 
things like this which, I don’t mean this 
selfishly, doesn’t just look after the clients, 
it promotes us, it promotes the care we’re 
giving, it promotes the way in which we 
work, so you know, I don’t think it shouldn’t 
be done. I think it’s something that all 
homes should do’ (Manager C1005) 
Post-implementation 
 ‘I think a point of, a point of reference 
would be explaining to staff why it’s 
needed, you know what’s led to this, why 
have we introduced this document. That we 
haven’t just bought out this new document 
but actually that we’ve become aware that 
for, for you as a staff you have so many 
things to do where you have to write 
sentence after sentence and we’re, you 
know we’re trying to recognise that by 
giving you a document that basically is 
easier to do. I think it’s about selling it from 
you know why, why you’ve done it, why 
you’ve done it in this format, and how a 
resident will benefit from it’ (Manager 
B3001.1) 
 
‘I think I’ve been a motivator, I’ve had to 
motivate them and encourage them um I 
think, my role is, is to convince them a) that 
they’re able to do it, and b) the value of 
doing it, um I think those are the 2 key 
issues really you know to say you can do 
this, and this is why you’re doing it and I 
think I have to believe in it, if I don’t believe 
in it they won’t’ (Manager B3001.2) 
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S3 Table: Baseline IPOS-Dem question one main problems (n=32) 
Main problem (included in IPOS-Dem) Number 
Agitation 11 




Main problem (not included in IPOS-Dem) Number 
Refuses care 2 
Confused 2 
Sleepy and withdrawn 1 
Low mood, withdrawn 1 
Restless about how life has turned out to be 1 
Sometimes likes a lot of attention 1 
Losing his voice 1 
Unable to feed herself, needs prompting 1 
He will over and over asking question where he is 1 
Assistance at mealtimes, monitor food and fluid intake because of confusion 1 
Going into the cupboard in the kitchen 1 
Does not like to drink 1 
Extra close supervision with daily events 1 
Number of cases with no main problems 12 
Number of cases with one main problem 8 
Number of cases with two main problems 5 
Number of cases with three main problems 7 
Total number of main problems 39 
 
 




8. Integration and discussion 
8.1 Summary of main findings 
This thesis reports the development and preliminary evaluation of a measure to support 
comprehensive assessment and management of symptoms and concerns in people with 
dementia living in care homes. As no comprehensive measure had been developed for use in 
routine care of this population, the IPOS was adapted to form IPOS-Dem. Adaptation included 
identifying items of less relevance and additional important symptoms and concerns to ensure 
that the measure was comprehensive for people living with dementia and multi-morbidities. 
Cognitive interviews resulted in measurement refinement and IPOS-Dem Version 3. The 
mechanisms of action, feasibility, acceptability and implementation requirements within the 
residential care home context were explored and evaluated pre-implementation and post-
implementation of IPOS-Dem in routine care of recruited people with dementia. IPOS-Dem was 
found to have the potential to change care processes resulting in potential benefit for people with 
dementia and their family members. Furthermore, it was found to be acceptable and feasible for 
use in routine care, and implementation requirements were identified. The findings informed the 
development of a theoretical model that demonstrates the key mechanisms of action and potential 
benefit, and measurement and implementation requirements of a measure used in routine care 
of people with dementia in residential care homes to improve assessment and management of 
symptoms and concerns. 
 
8.2 A comprehensive assessment measure of symptoms and 
concerns (objectives one and two) 
The systematic review identified a gap of measures to support comprehensive assessment of 
symptoms and concerns experienced by people with dementia living in care homes. IPOS-Dem 
addresses this gap as a comprehensive measure developed for use by care home staff in routine 
care of people with dementia.  
  
Initial scoping of the literature identified common symptoms and concerns, which were included 
in IPOS-Dem Version 1. The development qualitative phase allowed further exploration of 
symptoms and concerns that may cause distress, and allowed identification of any items of less 




relevance in this population group. The result was IPOS-Dem Version 3, a comprehensive 
measure incorporating symptoms and concerns likely to cause distress. IPOS-Dem is therefore 
a measure to support systematic assessment through the identification of common symptoms 
and concerns in order to support management of these. There are many other measures that are 
used in dementia care. These include measures of quality of life, behaviours that challenge, 
cognition, or single symptoms. None have been developed to support comprehensive 
assessment of physical, emotional, social and existential symptoms and concerns experienced 
by older people with dementia and multi-morbidities living in care homes. 
 
8.2.1 A measure for older people with dementia and multi-morbidities 
IPOS-Dem is specifically tailored for the requirements of people with dementia with multi-
morbidities living in care homes. It incorporates symptoms and concerns of dementia such as 
hallucinations, delusions wandering and depression. However, key throughout the development 
of IPOS-Dem is the knowledge that many people with dementia have multi-morbidities common 
in older age (34), and therefore experience symptoms and concerns beyond those of dementia. 
This has informed what items should be included to ensure that it is comprehensive and relevant 
to this population. As such, IPOS-Dem is not just a measure of dementia symptoms, but 
incorporates all symptoms and concerns that older people with dementia living in care homes 
may experience.  
 
IPOS-Dem is developed for people with dementia throughout the disease trajectory, with the 
recognition that many may experience distressing symptoms and concerns related to dementia 
and multi-morbidities at any stage. There was some evidence from the results of the study that 
IPOS-Dem used in this way may support improved knowledge of the person over time, and 
therefore support comprehensive assessment particularly as dementia advances and towards the 
end of life, when there are increased challenges to assessment. Indeed, IPOS-Dem is developed 
with the recognition that many with dementia have challenges in expressing their wishes and 
concerns (40), and that proxy-completed measures are required (86). This is not to say that many 
people with dementia are not able to self-report symptoms and concerns, but rather to ensure 
that people who are not able to self-report are not excluded from assessment. IPOS-Dem manual 
instructs care home staff to use all available means to assess people with dementia and this 
includes, where possible, asking them during daily interactions. 




8.2.2 IPOS-Dem: a palliative care measure to assess comprehensive symptoms and 
concerns 
IPOS-Dem has clear overlap with quality of life, wellbeing, need and discomfort measures, yet 
does not measure any one of these constructs. Conceptually, IPOS-Dem assesses the aspects 
of quality of life, discomfort and wellbeing, and need that overlap. That is, IPOS-Dem assess 
aspects of quality of life that can benefit from intervention, such as physical symptoms, but not 
those that are beyond the remit or abilities of health and social care staff, such as characteristics 
of the individual or environment (74) which may be less amenable to change. Similarly, IPOS-
Dem assesses those aspects of need which affect quality of life, wellbeing and discomfort but not 
aspects of need such as risk which may be a greater priority for professionals, but may not directly 
cause distress for the person with dementia. As such, IPOS-Dem fits well within palliative care as 
an 
‘approach that improves the quality of life of patients and their families facing the problem 
associated with life-threatening illness, through the prevention and relief of suffering by means 
of early identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual’ (14) 
 
Understanding how IPOS-Dem relates to other measures used with people with dementia in care 
homes is important. This understanding can inform future validation work and constructing 
hypotheses to test construct validity. Understanding the relationship of IPOS-Dem with other 
measures will also help inform further testing of IPOS-Dem as an intervention and identifying 
potential primary and secondary outcome measures. 
 
8.2.3 IPOS-Dem in relation to measures of quality of life 
Quality of life measures have been used in routine clinical care as complex interventions in clinical 
settings (75, 222), and their use in routine care is advocated to support patient-centred care. 
Substantial work has been undertaken in measuring quality of life in people with dementia (107-
110, 223-225), and both self and proxy-reported measures of quality of life have been developed 
for people with dementia. In addition, a measure of social care related quality of life, with a proxy 
version has also been developed (226, 227). The WHO defines quality of life in older people as 
‘The product of the interplay between social, health, economic and environmental conditions 
which affect human and social development. It is a broad-ranging concept, incorporating a 
person’s physical health, psychological state, level of independence, social relationships, 
personal beliefs and relationship to salient features in the environment. As people age, their 
quality of life is largely determined by their ability to access needed resources and maintain 
autonomy and independence’ (73) 
 




IPOS-Dem aims to assess symptoms and concerns amenable to change which care home staff, 
along with family members and health care professionals, may be more able to address. As such, 
it does not measure the construct of quality of life, which constitutes multiple factors such as 
individual characteristics e.g. personality/motivation or environmental characteristics e.g. social 
and economic supports (74), which may have variable amenity to change through the provision 
of health and social care. Instead, used as an intervention, IPOS-Dem may contribute to improved 
quality of life by improved management of symptoms and concerns. Arguably, this enhances its 
use as an intervention as the information obtained from completing the assessment has direct 
relevance to care being provided. This, in turn, makes it more likely that the measure will be more 
acceptable to care home staff by providing information that can inform care and therefore add 
value to care provision.  
 
8.2.4 IPOS-Dem in relation to measures of wellbeing 
IPOS-Dem was not developed as a measure of wellbeing, but it is helpful to examine how IPOS-
Dem relates to wellbeing, and measures thereof. Different conceptual models of wellbeing exist 
and its relationship with quality of life is often confused (228). The terms are frequently used 
interchangeably (225). In dementia care, a number of wellbeing measures have been developed, 
all of which have a theoretical underpinning of psychological wellbeing (229-237). The most well-
established measure is Dementia Care Mapping (DCM). DCM has been described as a quality of 
life and quality of care measure (238), although it utilises scores of wellbeing (239). DCM is 
underpinned by Kitwood’s theory on person-centred care and was originally developed as a tool 
for supporting and developing person-centred care. It aimed to do so through collecting data for 
feedback to care teams in order to inform and improve care practice (238). Like IPOS-Dem, it is 
therefore both an intervention and a measure. However, IPOS-Dem aims to assess a different 
albeit complementary construct. Arguably, care cannot be person-centred if distressing symptoms 
and concerns are not addressed. IPOS-Dem fills this gap; and can potentially complement 
existing wellbeing measures. As wellbeing in dementia care is predominantly underpinned by 
psychological needs and subjective experiences (240), further work on how IPOS-Dem fits with 
our understanding of wellbeing in people with dementia could extend our understanding of what 
holistic wellbeing means for people with dementia.  
 




8.2.5 IPOS-Dem in relation to measures of need 
With the aim of assessing symptoms and concerns, IPOS-Dem could be considered a measure 
of need. The Oxford Dictionary defines need as  
‘[To] Require (something) because it is essential or very important rather than just desirable’ (241).  
 
Maslow (1943) proposed a hierarchy of needs that apply to all humans (242). However, some 
groups of people, such as people with dementia living in care homes, have additional and more 
specific needs, (243). A useful definition of health care need is that of Stevens and Raftery as the 
‘ability to benefit’ from health care provision (244, 245).  
 
The Camberwell Assessment of Need for the Elderly (CANE) is one of the best known measures 
of need for older people with mental health problems (246) and has been validated for people 
with dementia living in care homes (247). CANE was based on the definition of need as a ‘problem 
or difficulty requiring intervention or assessment’ (248). There is an obvious overlap between the 
construct of distressing symptoms and concerns, which IPOS-Dem aims to measure, and the 
construct of need. However, there are some differences too. CANE, for example, assesses the 
domains of ‘accommodation’, ‘looking after the home’, ‘food’, ‘self-care’, ‘caring for someone else’, 
‘daytime activities’, ‘memory’, ‘eyesight/hearing/communication’, ‘mobility/falls’, ‘continence’, 
‘physical health’, ‘drugs’, ‘psychotic symptoms’, ‘psychological distress’, ‘information’, ‘deliberate 
self-harm’, ‘inadvertent self-harm’, ‘abuse/neglect’, ‘behaviour’, ‘alcohol’, ‘company’, ‘intimate 
relationships’, ‘money/budgeting’, ‘benefits’, ‘carer’s need for information’, ‘carer’s psychological 
distress’ (249). As such, it incorporates a broad assessment of need, both from the person’s, 
carer’s (or family’s), and health care professionals’ perspectives (247), and therefore includes, for 
example, behaviours that challenge or risk. Conversely, IPOS-Dem provides a much more 
detailed assessment of physical symptoms, and emotional, social and existential concerns that 
people with dementia in care homes may experience but does not aim to assess all domains of 
need. As it was not developed to assess the full construct of need, it is not defined as or called a 
measure of need.  
 
8.2.6 IPOS-Dem in relation to measures of discomfort 
An alternative approach taken for people in people with advanced dementia who are no longer 
able to communicate, is to assess discomfort (250), operationalised as the presence of 




observable negative physical or emotional state (151). Discomfort measures have been 
developed as complex interventions for people with advanced dementia. The Serial Trial 
Intervention (STI), involving the assessment and treatment of discomfort in people with advanced 
dementia with behavioural changes has been developed and tested (40, 251). This intervention 
demonstrates the benefit of holistic assessment of people with dementia, and the importance of 
understanding potentially distressing symptoms and concerns that manifest as behavioural 
changes. Limitations of the intervention are that it targets only those people with dementia 
demonstrating behavioural changes, and so does not utilise systematic and regular 
comprehensive assessment of all people with dementia in care homes. Additionally, given the 
nature of the intervention, it requires nursing staff with a clinical qualification to assess for and 
treat symptoms (251). IPOS-Dem has different mechanisms of action. Instead of assessing 
discomfort in people who may be demonstrating signs of distress, IPOS-Dem encourages care 
home staff to consider whether all people with dementia may be experiencing symptoms or 
concerns, and use all methods of assessment. A person with dementia may not for example, not 
demonstrate overt signs discomfort but have poor food intake, weight loss, and on inspection of 
their mouth, show poor signs of oral health. IPOS-Dem prompts care home staff to consider all 
symptoms and concerns, and can therefore provide care home staff with an overall 
comprehensive ‘picture of the person’, which can in turn be communicated to family members 
and health care professionals.  
 
8.2.7 IPOS-Dem in relation to measures of agitation 
Agitation is common in dementia (33), with more than 50% of people with moderate to severe 
dementia in care homes experiencing agitation (252, 253). Agitation may often be a manifestation 
of underlying distress. Recommendations to manage agitation in dementia include 
comprehensive assessment to determine underlying causes including, for example, pain and 
physical health, depression, side effects of medication, psychosocial factors, the biography of the 
person including spiritual and cultural identity (254). Measures of agitation, such as the CMAI 
(255) are useful for quantifying the type and severity of agitation in people with dementia, however 
do not identify the potential underlying causes of agitation. IPOS-Dem with its aim to support 
comprehensive assessment of symptoms and concerns that may cause distress therefore 
complements assessment of agitation, and may be able to inform the assessment of underlying 
causes of agitation. 




8.3 The mechanisms of action and potential benefit, context and 
implementation requirements (objectives four, five and six) 
A key output of this study was a detailed understanding of how IPOS-Dem may support care 
processes to improve outcomes for, or potentially benefit people with dementia living in residential 
care homes and their family members. A detailed theoretical model was developed based on the 
findings. An understanding of the context and key mechanisms of action of this complex 
intervention were identified, including how components of the intervention may interact, what 
changes are expected as part of the intervention, how IPOS-Dem should be used and the degree 
of flexibility that can be accommodated in the use of IPOS-Dem to ensure that it is transferable 
to other care home settings (5). It has also allowed identification of likely outcomes. Finally, it has 
helped identify the structures, processes and resources required for implementation (5).This has 
important implications for how IPOS-Dem is further evaluated as an intervention and its 
implications for further training and its use in care. 
 
8.3.1 IPOS-Dem: the interactions of context, mechanisms of action and implementation 
requirements  
Key mechanisms of action of IPOS-Dem in routine care were identified. Importantly, an 
understanding of the residential care home context was gained and what is needed to support 
implementation. Consequently, IPOS-Dem as an intervention can now be detailed, including 
aspects which can be adapted to local context and those aspects which are crucial to ensure that 
IPOS-Dem is implemented in a way that facilitates the mechanisms of action to occur (3, 5).  
 
IPOS-Dem prompted care home staff to think about symptoms and concerns that people with 
dementia might be experiencing, and therefore improved their observations and awareness. To 
support this IPOS-Dem needs to be done routinely and regularly so that care home staff will be 
regularly prompted to assess symptoms and concerns. It is important to be explicit about how 
often IPOS-Dem should be completed. The original IPOS-Dem manual, developed from the pre-
implementation qualitative phase, advises that IPOS-Dem should be used monthly at times of 
care planning or at times of change in presentation. This finding was confirmed in post-
implementation findings, although a few care home participants reported that IPOS-Dem could 
be useful on a weekly basis to ensure ongoing assessment of people with dementia. Nonetheless, 




quantitative results revealed that care home staff ratings of ‘time spent doing IPOS-Dem being 
worthwhile’ decreased over the 12-weeks of implementation. This does suggest that IPOS-Dem 
used too frequently may be less useful and therefore less acceptable, corroborating a previous 
study of POS administered to people living in nursing home (157). Interestingly, in that study care 
home staff without a clinical qualification felt it more useful to use it weekly compared to the 
clinically qualified nursing staff who reported weekly was too frequent (157).  
 
An important mechanism of action was that IPOS-Dem provided a comprehensive ‘picture of the 
person’, corroborating findings from a study examining the use of MIDOS in people with dementia 
in care homes (97). This was key to supporting systematic record-keeping, improved review and 
monitoring, facilitated communication and care planning with timely changes to care provision. 
IPOS-Dem needs to be done routinely and regularly to ensure these mechanisms of action occur. 
At a minimum, IPOS-Dem should be done at times of care planning to ensure that it informs care 
plans and supports changes to care provision, and it should also be completed at times of change. 
 
Care home staff participants discussed the usefulness of using IPOS-Dem at times of change or 
deterioration. However, there was little data regarding what change would prompt IPOS-Dem to 
be completed. Care home staff appeared to demonstrate an implicit understanding of when a 
person with a dementia may be deteriorating or unstable, but did not articulate how they may 
present or be identified. Understanding this is important to ensure that people with dementia who 
are unstable or deteriorating are correctly identified. In palliative care clinical settings, a Phase of 
Illness measure has been used to identify and classify patients as stable, unstable, deteriorating, 
dying and deceased (256). Such a measure which is brief and easy to use may support 
identification of people with dementia who may be unstable, deteriorating or dying in care homes; 
and support care planning and referrals to additional services if required (85). A limitation, 
however, is that it has not been validated or tested in people with dementia living in care homes 
by care home staff without a clinical qualification.  
 
This study identified significant challenges to communication between family members and care 
home staff. Both groups of participants identified challenges but expressed different perspectives 
and causes. Family members identified a role of supporting assessment, advocating, engaging 
and accessing care, corroborating findings from previous studies (48, 50, 257-259). IPOS-Dem 




was perceived as supporting family involvement in assessment. The current IPOS-Dem manual 
states that care home staff should speak to family members to inform their assessment. However, 
the actual process of this occurring was less clear. Implicit in this process, was that care home 
staff would complete IPOS-Dem independently of family members, then utilise IPOS-Dem to 
communicate their assessments to family members. Both family members and care home staff 
perceived IPOS-Dem as a means of opening a dialogue about the assessment, providing the 
opportunity to discuss any areas of disagreement thus further informing assessment. It may not 
be practical or feasible for care home staff to speak to family members before each IPOS-Dem 
assessment is completed. Doing so may delay its completion, or result in IPOS-Dem not being 
completed at times of care plans. However, what is essential is that family members have the 
opportunity to read, comment and discuss IPOS-Dem assessments with care home staff, and 
agree any changes to care plans or action plans as a result; either through formal or informal 
discussions with family members. Given the identified challenges of communication between care 
home staff and family members and that family members may feel excluded from and 
disempowered in the caring role (48), this is a potentially important and novel intervention to 
support integrated working between care home staff and family members. 
 
Pre-implementation findings revealed that there were some challenges to communication 
between care home staff due to shift work and care home staff being on leave. This led to the 
IPOS-Dem manual stating that care home staff should consult other care home staff particularly 
those working different shifts, and read case notes to inform their assessment. The manual also 
states that care home staff should report symptoms and concerns to senior care home staff. 
These processes occurred during implementation of IPOS-Dem and post-implementation data 
revealed a much more detailed understanding of the process of communication between care 
home staff. In particular, care home staff reported how IPOS-Dem could be integrated into formal 
care processes, including supervision and to ensure that IPOS-Dem assessments are read on 
return from leave. This has implications for future IPOS-Dem training and the requirement for 
IPOS-Dem to be integrated into formal care processes to support this mechanism of action.  
 
IPOS-Dem intervention was identified as facilitating communication between care home staff and 
health care professionals. However, the qualitative interviews and focus groups, and non-
participant observations data were less revealing about how this should occur with challenges 




being identified to these processes. Participants reported that IPOS-Dem would be useful to 
communicate symptoms and concerns to GPs, DNs, and other health care professionals. 
However, concerns were raised that GPs would not have the time to read all IPOS-Dem 
assessments. Participants also identified that DNs may not acknowledge IPOS-Dem 
assessments unless it was recognised and accepted as an NHS assessment, and ratified by their 
organisation, and the importance of IPOS-Dem being ‘trusted’ as an assessment was therefore 
identified. This has important development and training implications for IPOS-Dem. Not only is it 
essential that psychometric properties are tested, but it is also important that care home staff, 
family members and health care professionals are aware of these properties so that IPOS-Dem 
is recognised as a ‘trusted’ assessment. This is likely to present a challenge to the future 
implementation of IPOS-Dem. While it may be possible to implement IPOS-Dem into residential 
care homes, a greater implementation challenge will be facilitating external health care 
professionals to accept and utilise IPOS-Dem assessments. Options to address this may include 
developing resources for health care professionals such as brief leaflets to provide information 
on the validity and reliability of IPOS-Dem and how it can support care provision to benefit people 
with dementia. 
  
There is no standard model of how health care services are provided to care homes, with a great 
deal of variation depending on how local services and working relationships have evolved (63, 
66). Indeed, each of the three participating care homes had different ways of working with GP 
providers. As such, it is not possible to be prescriptive about how IPOS-Dem is used to work with 
health care professionals. A previous study using POS found that nursing home staff found it 
useful to share POS scores and assessments with GPs during consultations (157). The current 
IPOS-Dem manual states that IPOS-Dem can be used to support communication between care 
home staff and health care professionals. It also advises care home staff of the importance of 
ensuring identified symptoms are treated, and that this may be urgent if a score is severe or 
overwhelming. However, it may not possible to dictate to care homes and health care providers 
how this is best done, and local arrangements will need to be agreed.  
 
The original theoretical model developed for this study hypothesised that scores on IPOS-Dem 
would support prioritisation of treatments and interventions, and support communication between 
all. Family and care home staff participants shared how scores could alert them to symptoms and 




concerns that needed acting upon, with some participants sharing how monitoring of scores over 
time could be useful, with change in scores being a useful prompt to action. There was little data 
on how participants may interpret scores, or how they would prioritise based on scoring. There 
was also little data on how participants may use scores to support communication. A key property 
of measures used in routine care is interpretability, detailed in Section 1.3.4, meaning that scores 
should be clinically interpretable (11). It is unclear whether the lack of data about scores relates 
to care home staff having no difficulty interpreting scores, whether participants paid little attention 
to scores, or whether over time as IPOS-Dem became more integrated into care processes, 
scores would be integrated into use and language of IPOS-Dem. The findings from the study 
examining implementation of POS in a nursing home and hospice found that participants wanted 
access to analysed data which was not easily available and beyond the resources of the sites. 
However, this appeared to be more of a barrier for the hospice setting who wanted the data to 
predict outcomes, while the nursing home site appeared to find access to summary scores 
sufficient (157). It may be that for use in routine care, the participants found no requirements for 
analysed IPOS-Dem data but if these data were identified for further use, then care home staff 
may wish to have access to resources to analyse and interpret data. Senior care home staff did 
identify the benefit of having scores for individual people with dementia over time, and the 
usefulness of receiving feedback of aggregate scores over time as a quality indicator of how well 
the care home is responding to symptoms and concerns addressed. 
 
Technology that can analyse individual scores as well as aggregate scores, and that can be easily 
used with the resources of care homes are likely to enhance acceptability and support 
implementation (157). Touchscreen technology was identified as facilitating completion of IPOS-
Dem, providing alerts of symptoms and concerns to prompt changes to care, overcome storage 
challenges, and support monitoring and communication. Family members would welcome online 
access to completed IPOS-Dem.  
 
The potential benefit of using IPOS-Dem for people with dementia and their family members were 
identified as improved symptom management, improved care of comprehensive emotional, social 
and existential concerns, and increased family empowerment and engagement in care. This 
study’s original theoretical model anticipated outcomes of reduced unmet need, improved quality 
of life and improved satisfaction with care. However, there was no data on whether addressing 




symptoms and concerns these may improve quality of life, wellbeing, reduce discomfort, reduce 
unmet need, or improve satisfaction with care in people with dementia or their family members; 
all of which might be anticipated. There is limited evidence on the effectiveness of measures used 
in routine care on quality of life and symptom burden outcomes (7). Another possible expected 
outcome of improved symptom and management and improved care of comprehensive concerns 
is reduced agitation, with evidence that improved pain management reduces agitation in people 
with advanced dementia (41). However, this was not identified as a potential outcome in this study 
either.  
 
Risks of using IPOS-Dem and implementation requirements mitigating risks 
None of the participants identified any risks of using IPOS-Dem to people with dementia. 
However, there were identified risks of mechanisms of action not occurring. These included risks 
of inaccurate assessment, risks of symptoms and concerns being identified but not acted upon, 
and risks of barriers in accessing health care due to health care professionals not accepting care 
home staff completed IPOS-Dem assessments.  
 
The IPOS-Dem manual was developed to minimise some of these risks with information on how 
IPOS-Dem may support care, instructions on how to assess people with dementia utilising all 
available information, what to do if symptoms and concerns are identified, and how IPOS-Dem 
can be used to support communication. The care homes were provided with copies of IPOS-Dem 
and the instruction manual. As the video version manual was not ready by the time this phase of 
the study started, this was not available to provide to care home staff. There was very little 
evidence of the care home staff reading or using the manual before starting to use it in care. This 
may be in part due to the fact that the majority of participants found reading and comprehending 
the manual challenging. However, Slade et al (1999) suggests that most health care professionals 
will start using a measure in routine care before reading the manual (13). Despite this, care home 
staff appeared to have a good understanding of how to assess symptoms and there was good 
evidence that symptoms and concerns were escalated to senior care home staff or managers. 
Care home participants appeared to intuitively understand how IPOS-Dem could support care, 
and how it should be best used to support care. Indeed, data collected from care home staff 
extended the understanding of how IPOS-Dem could support care processes. This corroborates 
earlier studies of comprehensive measures used in routine care of nursing home residents which 




demonstrated that care home staff understood the benefit of using a measure in routine care (97, 
157). There was little evidence in this study of managers or senior care home staff taking on a 
role of providing this information, although they did identify that resources for care home staff 
including how IPOS-Dem can support care, would support their implementation of IPOS-Dem.  
 
All participants identified how IPOS-Dem could support communication. Participants reported that 
this in turn could improve collaborative assessment with family members, and access to health 
care external from the care home. However, such a measure cannot change culture of care, and 
cannot change care home relationships with family members and health care professionals. In 
this study, participants demonstrated the desire to work together for the benefit of people with 
dementia. However, there was also evidence of some of the challenges of working with health 
care professionals. Participants also noted the requirement for a transparent and honest working 
relationship. An intervention such as IPOS-Dem cannot change working relationships, but may 
through shared documentation provide a shared language to support integrated working (260). A 
realist review of interventions to improve health care for people in care homes identified the 
requirements of care home staff being engaged from the outset and the intervention supporting 
the priorities and structures of the care home (260) in order to achieve expected outcomes. This 
study takes this a step further by developing an intervention which is (i) led by care home staff 
and implemented into routine care by care home staff, (ii) utilises care home staff skills and 
expertise in caring for people with dementia and their knowledge of residents, and (iii) is integrated 
into care home processes and structures by care home staff in order to facilitate integrated 
working between care home staff and health care professionals. This is important as interventions 
for care homes should ideally be developed in collaboration with care home staff, family members 
and where possible residents, to ensure an understanding of the care home context and that the 
intervention is tailored to context (176).  
 
Leadership was essential to support implementation, supporting existing evidence of 
implementing measures into routine care (261). Managers and senior care home staff identified 
their role in integrating IPOS-Dem into routine care processes, indicating the requirement for 
managers to have the motivation and understanding of the benefit of using IPOS-Dem in routine 
care. If this is done well, such as IPOS-Dem being incorporated into supervision, handover 
meetings, and processes are developed for working with family members and health care 




professionals, many of the risks will be mitigated. As one manager expressed, it is important that 
IPOS-Dem assessments are seen by managers and other care home staff, and that if care home 
staff believe that nobody will review their IPOS-Dem assessments, then they will not put sufficient 
effort into ensuring that it is accurate (Chapter 7, supplementary table 2 – Implementation 
requirements). This finding is similar to a previous one which demonstrated POS integrated into 
weekly team meetings at a nursing home by senior care home staff meant that care home staff 
could see the relevance of using POS to care (157). Another senior care home staff member 
expressed how despite the fact that she was using IPOS-Dem, recognised the benefit of all care 
home staff using it, and the benefit of integrating it into routine care processes, she felt that she 
was unable to do implement these changes without the support of the manager.  
 
Many health care interventions designed and developed for care homes require ‘high facilitation’ 
by health care professionals to be implemented and sustained (262, 263). Indeed, the realist 
review identified the importance for visiting health care professionals to provide ongoing support 
to care home staff to support how interventions were implemented and delivered (260). Another 
study, examining the implementation of a comprehensive admission assessment into hospice 
setting discussed the importance of interactional workshops, feedback sessions and opportunities 
for critical reflection to successfully change practice (264). This study found that care home staff 
identified how to integrate IPOS-Dem into routine care, recognised benefit to care processes, and 
used IPOS-Dem without external facilitation. This demonstrates IPOS-Dem may not require a 
high degree of external facilitation for its implementation into routine care. This is important for 
the implementation of IPOS-Dem to be accessible, scalable and feasible for implementation. 
However, it is important to take into consideration that the participating care homes agreed to 
participate in the research and were therefore likely more amenable to implementing a new 
intervention. The care home staff had also contributed to the development of IPOS-Dem and were 
therefore more invested in using and evaluating it. In addition, while I had not been involved in 
prompting or facilitating the use of IPOS-Dem in routine care, it is likely that my working 
relationship that developed over the course of the study may have influenced care home staff’s 
engagement in the use and implementation of IPOS-Dem. There is, therefore, a potential risk that 
without external facilitation, IPOS-Dem may not be implemented, or that symptoms and concerns 
may be assessed but not addressed. Working with an external facilitator, such as a palliative care 
team may support care home staff in their integration of IPOS-Dem into routine care, support 




them in accurate assessment of people with dementia, and identify means of addressing 
symptoms and concerns. This, in turn, would support collaborative and integrated working. 
 
8.4 Acceptability and feasibility of IPOS-Dem (Objectives three, four 
and seven) 
IPOS-Dem was found acceptable and feasible for use in routine care of people with dementia. 
Key to its acceptability was that participants recognised the value that it could provide to care. 
Participants identified a number of ways in which IPOS-Dem supported care and therefore its 
acceptability was enhanced. For this reason, the measurement properties of acceptability and 
feasibility were included in the theoretical model as they essential if the mechanisms of action are 
to occur, and for the measure to be successfully implemented (261). 
 
A central mechanism of action was the comprehensive ‘picture of the person’ that IPOS-Dem 
provided. Participants valued that IPOS-Dem assessed physical symptoms and emotional, social 
and existential concerns; and that this information was portrayed in concise and succinct format 
thus supporting care planning, record-keeping, monitoring of people with dementia, and 
communication. This was a finding of MIDOS being used in nursing home residents. In that study 
care home staff valued the comprehensive nature of MIDOS and also reported that it supported 
the same mechanisms of action (97). Participants also reported that IPOS-Dem was relevant to 
the care that is being provided, with no items being identified that were not important to people 
with dementia. These findings demonstrate the value of rigorous and significant developmental 
work of IPOS-Dem to ensure that it is a comprehensive and relevant measure; and that important 
symptoms and concerns were identified but items of less relevance were not retained. It also 
demonstrates how using an appropriate measure which has been developed for the purpose is 
important. A quality of life or needs assessment measure may not have been sufficiently relevant 
to be acceptable to care home staff. However, a measure to support a palliative care approach 
of comprehensive assessment and management of symptoms and concerns to reduce 
distressing symptoms and concerns, is one that family members and care home staff recognise 
as providing value to care. These findings also demonstrate the strength of adapting an existing 
measure that is established as a measure for use in routine clinical care (87), providing the 




opportunity to build upon the substantial research and development that has already been 
conducted internationally (85, 143, 158). 
 
IPOS-Dem is developed for care home staff without a clinical qualification, and it was important 
that this was taken into consideration as part of its development to ensure its ease of use. 
Cognitive interviewing proved essential in this process to ensure that the language used was 
comprehensible and acceptable to care home staff, and qualitative and quantitative results 
demonstrated that IPOS-Dem is easy to use. Nonetheless, there remain challenges to assessing 
people with dementia, particularly in those who have challenges verbally expressing their wishes 
and concerns. Care home staff are not able to rely on clinical examination to assess people with 
dementia and both in the development and evaluation of IPOS-Dem, there was data that 
demonstrated assessment challenges, particularly in people with more complex symptom 
presentation. Care home staff also expressed concerns and uncertainty about the accuracy of 
their assessment, corroborating findings from the study of MIDOS in people with advanced 
dementia (97); and missing data was for the most part attributable to the option ‘cannot assess’ 
being selected. This uncertainty could, however be a strength. It is certainly preferable that care 
home staff question and scrutinise their own assessments rather than confidently assume that 
their assessments are accurate. It is also reflected in the care home staff’s expression of how 
using IPOS-Dem ‘makes you think’ about symptoms and concerns that residents may be 
experiencing. However, it also does indicate that there are further training requirements to support 
care home staff in their assessment of people who may have challenges expressing the wishes 
and concerns. Many measures developed to assess symptoms and concerns in people with 
dementia are based on observations. There are therefore observable symptom indicators that 
people may have when experiencing a symptom. The systematic review (chapter two) identified 
that significant research has been conducted into the assessment of pain in people with dementia, 
but that further research is needed into care home staff assessment of other symptoms and 
concerns. 
 
IPOS-Dem was also found to be feasible. Flexibility of use supported feasibility, with care home 
staff expressing the benefit of using it regularly but also using their own judgement if IPOS-Dem 
needs to be used more frequently. Leadership integrating IPOS-Dem into routine processes will 
also enhance feasibility. Individual care homes would therefore benefit of deciding how frequently 




IPOS-Dem is used so that they are best integrated into care processes, with a minimum of IPOS-
Dem being used at times of care planning. It should be noted that it is likely that IPOS-Dem may 
be less acceptable if used too frequently as it may become burdensome and cease to provide 
valuable information in people with dementia who are stable. 
 
8.5 Strengths, challenges and limitations 
8.5.1 Recruitment, retention and attrition of residential care homes 
A strength of the study was that strong working relationships were developed and maintained with 
the care homes and that the work was seen as important by care home staff as a means to 
improve care for people with dementia. Maintaining a working relationship centred on the 
enthusiasm and commitment of the care home staff. Working with care home staff on the conduct 
of the study (265), understanding the priorities of the care homes, flexible working including 
evening and weekend working, and time and patience were also essential. Frequently, planned 
sessions had to be cancelled at the last minute due to an incident occurring at the care home or 
problems with staffing. Recognising the work priorities and challenges that care home staff faced, 
consulting them, and utilising their expertise was essential in maintaining good working 
relationships throughout (195). I believe that my own clinical background greatly assisted this, 
meaning that I had a good understanding of clinical and care priorities that care home staff face. 
However, there were challenges to conducting this study. 
 
An early challenge was identifying suitable residential care home sites. The limited resources and 
time constraints of the PhD meant that only one local authority was selected. This was to limit the 
number of Local Authority Governance approvals, and respective NHS site approvals for GP and 
DN participation required. This is a limitation as the care homes recruited were from the same 
area in London limiting the diversity of the population.  
 
A strength of the study was that recruitment of care homes was relatively successful. Only one 
care home approached declined participation stating that the home was undergoing managerial 
changes and the future of the care home was uncertain. Once permissions had been obtained 
from the care home providers to approach the care home staff directly. Managers and care home 
staff demonstrated interest and enthusiasm at participating in the study. This recruitment rate of 




care homes for this study is much higher than has been reported in literature with care home 
recruitment rates ranging from 27% to 73%, and researchers generally being required to approach 
40% more care homes than they require (195). However, a consequence of recruiting from one 
local authority was that the number of eligible residential care homes was limited.  This was further 
limited by recruiting residential care homes with a mix of funding types and ownership.  
 
Another challenge was the retention of care homes associated with changes in senior care home 
staff. Between the development and evaluation phases, the manager of Care Home C left and as 
a consequence there were many staff changes. Although good working relationships had been 
developed with the care home, there was evidently much uncertainty and low morale within the 
care home. It was therefore decided to suspend the care home’s participation in the study until 
the new manager had started. Once the new manager had commenced, I approached the 
manager on a few occasions but was unable to make contact; and eventually a decision had to 
be taken to not pursue this as any further delays would result in significant delays to the study. At 
the same time, the option of recruiting a fourth residential care home was considered, one whose 
manager had previously expressed interest in participating. However, this option was not 
progressed due to the requirement to get care home site approval from the ethics committee, and 
the consequent delays to the study. This resulted in the limitation that only two residential care 
homes participated in the final phase of the study, with the loss of a larger care home run by an 
organisation. Retaining this care home in the final phase of this study would have further 
enhanced the evaluation of IPOS-Dem by providing data of it being used in a third and different 
setting, and an increased sample size of people with dementia receiving the intervention.  
 
8.5.2 Recruitment and attrition of people with dementia 
This study rigorously adhered to ethical procedures and protocols in recruiting people who lack 
capacity (266). There are substantial challenges to recruiting people who lack capacity, and these 
were identified prior to the study commencing (197). As such, a detailed recruitment protocol was 
developed drawing upon previous research of recruiting adults lacking capacity (198) and living 
in care homes (197, 267). This included the methods of identifying eligible people with dementia, 
assessing capacity, gaining informed consent for adults with capacity or using a process of assent 
for adults lacking capacity, identification of a personal consultees, using nominated consultees 
when no personal consultee was available, and developing study information sheets accessible 




to people with dementia and their family members (169, 173, 197, 198, 267, 268). Despite this, 
there were some foreseeable but unavoidable complications which had a negative impact on the 
number of people with dementia recruited to the study. The main reason was the loss of Care 
Home C to the study which was registered to care for people with dementia and had 29 beds.  
 
Of the 47 identified eligible participants in Care Homes A and B, 36 (76.6%) were recruited. This 
is relatively high in comparison to previous studies which when adhering to the same rigorous 
ethical standards have achieved recruitment rates of 42% (269) and 62.1% (197). Successful 
recruitment was facilitated by the support of CRN SL Division 4 DeNDRoN in providing a 
nominated consultee who was both knowledgeable about the research but independent from the 
research study. 
 
Another unavoidable challenge to retention of resident participants was attrition due to death. 
Given the study’s population of older people with cognitive impairment and multi-morbidities, this 
was expected and demonstrates that the study had recruited the relevant population under 
question to the study (159). Nonetheless the number of deaths was higher than anticipated based 
on previous studies of people with dementia in care homes (41). In total, eight out of the eligible 
47 (17.0%) died. Three eligible resident participants died before being recruited, four out of the 
recruited 36 (11.1%) died before baseline data collection. Two more participants were lost during 
the course of the study due to death (n=1) and moving to a nursing home (n=1). As a 
consequence, the sample size of 32 at baseline and 30 at final time point is small, and limited the 
analysis that could be conducted and the conclusions that can be drawn from the analysis.  
 
A consequence of the high number of deaths which almost entirely occurred in one care home 
was the effect that this had on care home staff. It was clearly a challenging time for care home 
staff who lost an unprecedented number of people who they care for a short space of time. This 
needed to be handled sensitively, taking into account care home staff’s feelings, and giving them 
time to process their feelings. 
 
8.5.3 Recruitment of family members 
There were challenges to recruiting family members. A barrier was that family members could not 
be approached directly. This project therefore utilised methods used in previous studies, including 




posters to advertise the study and coffee mornings in each of the participating care homes (197, 
268). These were held during the weekends to facilitate family members’ attendance. Study 
materials were made available to family members, and they were given the opportunity to ask 
questions, and if they or the person with dementia wished, the opportunity to decline participation. 
Despite these processes, it was still difficult to recruit family members. The majority of family 
members attending the coffee morning were interested in participating, but attendance at the 
coffee mornings was limited. The evaluation phase had slightly better recruitment. This was 
mostly due to those family members who had acted as personal consultees, expressing interest 
in participating in their own right. Focus groups were conducted at care homes and during 
weekends at a time convenient for the majority participants, and interviews were conducted at the 
preferred time and location of participants to optimise recruitment. Nonetheless, while family 
members expressed interest and willingness to participate, the biggest challenge was their 
availability particularly as the evaluation phase data collection was shortly before Christmas. 
Despite this, data saturation was achieved; and no new themes were being generated from 
conducting further interviews. 
 
8.5.4 Recruitment of care home staff 
To facilitate engagement with care home staff, I met with the staff to discuss the study and consult 
with them regarding the process of conducting the study. The study was generally met with 
support and care home staff expressed interest in participating. Care home staff were purposively 
sampled to gain a range of seniority and care roles. Nonetheless, a limitation was the availability 
of willing care home staff due to shift work and care priorities in the care home, and dependency 
on managers or senior care home staff to release care home staff from their duties. To overcome 
some of these barriers and support care home staff attending, light meals and refreshments were 
provided to care home staff participants. 
 
Fewer care home staff participated in the evaluation phase. This was in the most part due to 
attrition of Care Home C. Another reason was the limited implementation in Care Home A. One 
senior staff member used IPOS-Dem in care of people with dementia, discussed the benefits of 
using it and of all care home staff using it, but felt unable to implement it across the care home 
due to the lack of the manager’s support. 
 




8.5.5 Recruitment of health care professionals 
Before the study commenced, it was identified that health care professionals may be a challenging 
participants to recruit to due clinical priorities. This proved to be the case. In the development 
phase, recruitment of GPs was reasonably successful. However, between the two phases, the 
GP working with Care Home A changed, and despite repeated attempts to contact the GP and 
practice manager, the new GP did not respond to approaches to participate in the study. In the 
evaluation phase, the GP working with Care Home B remained engaged in the study and 
interested in participating but clinical priorities resulted in an inability to participate in a focus 
groups or an interview. This GP did, however, participate in non-participant observations.  
 
Recruitment of DNs proved particularly challenging. Strategies utilised to recruit DNs involved 
meeting with the community nursing manager to discuss the study. With the support and 
agreement of the community nursing manager, the study was presented to all DNs in the borough 
in one of their meetings. Individual DNs working with participating care homes were then 
approached to participate. Using this approach was reasonably successful in the development 
phase with DNs from all three care homes expressing interest in participating, although one was 
unable to attend the focus group due to work commitments. However, between the two phases, 
there was a change in the community nursing manager, and it proved difficult to engage this 
manager in the research. Without the leadership support and approval, it was impossible to recruit 
DNs resulting in no DNs participating in the evaluation phase. 
 
8.5.6 Challenges, strengths and limitations of multiple methods of data collection 
A strength of this study was that it utilised multiple types of qualitative and quantitative data 
collection as a means of evaluating IPOS-Dem. This enhanced the understanding of its use in 
routine care, allowed for data to be triangulated and strengthened the overall findings. However, 
there were challenges to multiple types of data collection. In particular, for a novice researcher, 
there was much learning required in the different methods of data collection and data analysis.  
 
A challenge of the study was the planned analysis of the case note data extraction. Case note 
data extraction was resource intense. Data entry of these data was also extremely resource 
intense. It was a limitation of the study that the quality of the case note was generally poor. Health 
care professional consultations, care plans, medications, and medical histories were poorly 




documented. This is likely a reflection of that this is not a clinical setting, that care home staff have 
limited access to medical records, and that they do not hold a clinical qualification. However, it 
did mean that the case note data extraction was of limited value in evaluating IPOS-Dem, and the 
time and resources required into detailed analysis of the records was not warranted. Only baseline 
demographic and clinical data were utilised for the purpose of the study. This has ethical 
implications; as approval had been obtained to gain access to case notes, and resources had 
been used to extract these data. It is therefore important that the collection of these data is not 
wasted. As such, further analysis is planned but is not utilised for the purposes of this study. 
 
Another challenging aspect of data collection was non-participant observations. Using this 
method of data collection was a strength of the study, as it enhanced the understanding of how 
health care professionals worked with care home staff. A limitation is that only one health care 
professional could be recruited to non-participant observation, thus limiting the understanding of 
how health care professionals work with care homes to one GP who had good working 
relationships with the care home. The data from non-participant observations was also limited in 
providing insights into how IPOS-Dem may support integrated working between care home staff 
and health care professionals. Successful recruitment of health care professionals in the 
evaluation phase to participate in interviews or focus groups would have greatly enhanced the 
understanding of the this mechanism of action. 
 
8.5.7 Reflexivity and positionality 
I am an occupational therapist and have worked extensively with care homes in a clinical capacity. 
I was therefore aware that I was entering this field with a set of assumptions from my clinical 
experiences. These assumptions were about care home settings, the care provided, and about 
the care home staff, family members, and health care professionals. As a novice researcher, I 
had another set up of assumptions, partly informed by my clinical experiences, my knowledge of 
the literature and discussions with more senior colleagues.  
 
The requirement for me to deliver the PhD, meant that I worked hard to develop strong working 
relationships with potential participants. In particular, with care home managers and care home 
staff; and also with health care professionals and family members. This involved meetings, 
informal discussions, and emails. I quickly realised that I was learning much about the care home 




context, relationships, and that the recordings in my reflective diary were in fact a source of data. 
I had not gained ethical approval to analyse my own observations and reflections, and I was 
therefore not able to use the diary as a source of data. Nonetheless, the diary proved invaluable 
in both my own learning, skill development, understanding of the care home context and dynamics 
and relationships between participant groups. In addition, I was able to reflect in my diary on my 
own role and relationships with participants, and how this may have affected data collection and 
data analysis. The following is an extract from my diary from the first focus group of the study, 
and indeed the first ever study data collection I had conducted: 
 
I was very pleased at the eventual participation in the focus group.  Two GPs participated and a 
care home DN attended.  In the end, two care home staff also participated.  While I was really 
pleased that this number of healthcare staff attended (which exceeded [my] expectations) it did 
create an imbalance in the focus group.  This was further exacerbated by the fact that the two 
care home staff who did participate were very junior and not involved in the assessment of 
residents.   
 
On reflection I think that the power balance was wrong with the GPs being very vocal and the 
care home staff may have felt intimidated.  Also, healthcare staff definitely had their own priorities 
and care home priorities were not really considered.  I think that I could have better facilitated 
this and probed the care home staff more when they did contribute… 
 
I think that my key learning is that was too deferential.  I am not suggesting that I should not have 
been this as I think it is really important to show that you respect the participants input.  I could, 
however, questioned their input more and tried to get rationale for their suggestions…. 
 
My biggest criticism of my moderating is that I really did not allow or facilitate the care home 
staff’s participation.  I think that I should have probed much more and really encouraged their 
participation.  Again, I think my own anxiety means that I was being too deferential to the GPs at 
the cost of the care home staff. (PhD reflective diary, 13/05/2014) 
 
 
This reflection helped me recognise and consider the nature of working relationships and provided 
me with an insight of the care home context. The reflection also helped me consider my own role, 
my relationships with participants and the impact that this was having on the data collection. While 
I did not use the diary entries as study data, they facilitated my data analysis to be both more 
insightful and reflexive. This entry enabled to recognise some of the limitations to the data that I 
had collected, but also gave me deeper understanding of the relationships and the context that I 
was studying, which informed my data analysis. The diary also enabled my learning of the 
research processes, and through this learning, I was consciously able to improve my facilitation, 
including use of probing, ensuring quieter participants had the opportunity to contribute, and 
developing confidence to question participants more deeply. 
 




8.5.8 The study in relation to methods of measurement development, and the MRC 
guidance and MORECare statement 
A strength of this study, was that it was informed and underpinned by the MRC guidance (2, 93) 
and MORECare statement (159) and drew upon the more recent MRC process evaluation 
guidance (3) with the aim of understanding the mechanisms of action, acceptability, feasibility and 
implementation requirements of IPOS-Dem. The study was also informed by the methods of 
developing a measure (10) to ensure that rigorous methods in measurement development were 
employed. This meant there were challenges at times in combining the two approaches.  
 
Informed by the MRC guidance and MORECare statement, IPOS-Dem was developed as a 
complex intervention underpinned by a theoretical model. This proved essential in the 
development of IPOS-Dem as an intervention. As a consequence, a conceptual model of the 
construct that IPOS-Dem has been developed to measure was not developed, a potential 
limitation. However, the development of IPOS-Dem including the pre-clinical (Chapter 5) and the 
development phase qualitative focus groups and interviews (Chapter 6, publication 2) had the 
clear objectives of developing IPOS-Dem to measure symptoms and concerns experienced by 
people with dementia in care homes. Cognitive interviewing recommended in the development of 
measures were also utilised (Chapter 6, publication 2). IPOS-Dem therefore does have 
established content validity. With the focus on IPOS-Dem as an intervention, another limitation 
was that it was beyond the remit of this study to conduct a full psychometric evaluation of IPOS-
Dem, including testing its validity, reliability, responsiveness, and interpretability. 
 
The original MRC guidance proposes a linear approach to developing and evaluating 
interventions. More recent MRC guidance publications advise that the process may not be linear 
or even cyclical (2), with the importance of process evaluations being emphasised (3). In keeping 
with the newer MRC guidance, this study has not adhered rigidly to the linear approach. The 
development phase of this study aimed to develop IPOS-Dem with regards to its content validity, 
feasibility and acceptability, and also gain a pre-implementation understanding of the likely 
mechanisms of action and implementation requirements in the care home context so as to 
develop an instruction manual. The evaluation aimed to evaluate IPOS-Dem in routine care, to 
further understand the likely mechanisms of action, acceptability, feasibility and implementation 
requirements. Data collection for these study phases were conducted separately in two phases. 




For clarity and to aid more detailed understanding and comparison of the pre-implementation and 
post-implementation findings, the study findings are published and presented according to the 
study objectives; and not by study phase. While this is a strength of the study, the study could be 
criticised as not following a clearly ‘step-by-step’ approach. 
 
The MRC guidance and MORECare statement recommend that both the feasibility of the 
intervention and feasibility of methods for full scale evaluation of the intervention are evaluated in 
the feasibility study. Testing the methods of a full scale cluster-randomised trial, was beyond the 
remit of this study. Nonetheless, the findings of this study provides valuable insights into some of 
the challenges of such research, and which methods will require testing in a feasibility study. 
 
This study aimed to conduct a feasibility and process evaluation in order to understand how IPOS-
Dem works in the care home context, and the requirements of implementation. The MRC process 
evaluation guidance details key components of process evaluations. These include context, 
implementation and mechanisms of action (3). As this study was designed and was underway 
prior to the publication of the MRC process evaluation guidance, the guidance did not inform or 
underpin the study design. However, a strength of this study is that it aimed to examine in detail 
the residential care home context and how the mechanisms of action worked within this context. 
The implementation requirements of IPOS-Dem were also examined although implementation 
was not examined to the full extent recommended by the MRC guidance on process evaluations 
(3). At this stage of IPOS-Dem development and evaluation, the study aimed to understand what 
would be required to support implementation. The findings of this study informed and therefore 
allowed IPOS-Dem as an intervention to be detailed. This included which aspects were essential 
in order for the mechanisms of action to occur, which aspects can adapted to local context, the 
‘dose’ of IPOS-Dem or frequently it should be used, and how it should be integrated into routine 
care to support the mechanisms of action to occur. It was therefore too early in its development 
and evaluation, to evaluate fidelity, dose, adaptations and reach. However, as a result of this 








8.5.9 IPOS-Dem and its resources 
IPOS-Dem: what’s in a name? 
The name of IPOS-Dem changed through the course of the study, reflecting the rationale and 
thinking that occurred during the process of development. At the start of the study, and to reflect 
that IPOS-Dem was developed from the original and validated POS, the measure was called 
POS-Dem. During the course of the study and in response to feedback and potential criticism that 
POS-Dem was being developed as an intervention, and that no psychometric evaluation was 
being undertaken as part of the PhD, the name was changed to POS-Dem Assessment. This was 
to reflect the nature of POS-Dem Assessment as an assessment and not as an outcome measure. 
In the final stages of its development, in consultation with and at the request of the international 
POS development group, the name was changed to IPOS-Dem. This change was made to reflect 
that IPOS-Dem is a version of IPOS, and most closely aligned with IPOS in the POS family of 
measures. 
IPOS-Dem resources: guidance to support assessment of symptoms and concerns in 
people who have challenges expressing their wishes and concerns 
Accurate assessment of people who have difficulties in verbally expressing their wishes and 
concerns is challenging. Recognising this challenge, the systematic review was conducted to 
identify measures that had been developed to assess people with compromised verbal 
communication utilising symptom indicators. The original aim of the study was to develop IPOS-
Dem with symptom indicators (signs or behaviours indicating that a person may experience a 
symptom) to support assessment in people with dementia. However, it became evident that to 
achieve this with the methodological rigour required, would require substantial work beyond the 
resources and time permitted by the PhD. PhD supervision was important at this time to recognise 
the limits of what could be achieved with the available time and resources; and identify that this 
could be a development area for future research. It is therefore an unsurprising finding that care 
home staff found assessment of some people with dementia challenging, and that missing data 
was mostly due to the challenges of assessment in this population. The findings of the study are 
informative to identify areas that were particularly challenging for care home staff to assess 
including pain, nausea, constipation, sleeping problems, and hallucinations and delusions. In 
addition, the systematic review identified that it is challenging for care home staff to accurately 
detect depression in this population group. This is an important area for future development. 
 




IPOS-Dem resources: manual and video manual 
An important strength of this study was the in-depth understanding gained of how IPOS-Dem may 
support care in the residential care home context, and how it may be integrated into existing care 
processes in order to support implementation. To support care home staff understanding of this, 
and therefore support its implementation, a manual was developed (Appendix O). The findings 
from cognitive interviews demonstrated that care home staff had difficulties in reading 
comprehension of IPOS-Dem manual, and despite substantial effort to simplify language, a 
written manual was not a sufficient resource to support care home understanding of the purpose 
of IPOS-Dem and how it should be used to improve care. A prototype video version of the manual 
was developed, but it was not ready for testing by the time IPOS-Dem was implemented into 
routine care of residents. Further advancements in IPOS-Dem, in particular, the name change, 
rendered the video out of date quite quickly. This demonstrates the challenges of keeping 
resources current with ongoing developments. To optimise the resources available, the 
production of the video manual was not progressed. This was to allow for further understanding 
and awareness of potential training requirements of IPOS-Dem so that these could be 
incorporated into future video manuals and training. 
 
8.6 Research implications 
8.6.1 IPOS-Dem: defining the intervention 
IPOS-Dem can now be clearly detailed as an intervention to improve assessment and 
management of symptoms and concerns experienced by people with dementia and their family 
members. This includes how it should be integrated into care processes, how frequently it should 
be used, and aspects of IPOS-Dem that can be adapted to local context. 
 Essential components of IPOS-Dem are detailed as follows: 
(i) IPOS-Dem is completed by care home staff at baseline (on admission) of all people with 
dementia, and then at times of care planning, usually monthly. An option is that IPOS-
Dem can be used in routine care more frequently, but it is recommended that it is not 
used more frequently than weekly for people who are stable, as it is likely that IPOS-Dem 
would not provide further helpful information, become increasingly burdensome and lose 
its value. IPOS-Dem is used by care home staff more frequently at their own judgement, 
if they notice a change in presentation of the person with dementia.  




(ii) At a minimum, completed IPOS-Dem assessments should be made available to family 
members; and family members should be provided with the opportunity to comment and 
make changes to IPOS-Dem assessments. How this is done, will necessarily be 
according to individual care home processes. It is also recognised that not all family 
members may wish to engage in this process, but family members should be offered this 
opportunity. As an option, care home staff may choose to complete IPOS-Dem in 
consultation with family members. 
(iii) IPOS-Dem should be incorporated into care home staff supervision. This ensures that 
care home staff know that the assessments will be reviewed and seen by senior care 
home staff. Discussing IPOS-Dem assessments in supervision can facilitate monitoring 
of the accuracy of assessments by senior care home staff; and can support care planning 
by identifying any symptoms and concerns that need acting upon, and how best to 
address these. 
(iv) Symptoms and concerns rated three or four should be immediately escalated to senior 
care home staff. Senior care home staff should monitor in supervision whether they are 
being alerted to significant symptoms or concerns. 
(v) Care homes may consider the option of incorporating IPOS-Dem discussions into 
handover or any meetings. This will depend on existing processes of care homes and 
how IPOS-Dem may be best integrated into these. 
(vi) IPOS-Dem may be used to communicate symptoms and concerns to health care 
professionals. How this is done will depend on the working relationships care home staff 
have with health care professionals. It is likely that GPs will not have time to review IPOS-
Dem for all patients that they are reviewing. However, IPOS-Dem may be useful for 
patients with more complex presentation to inform GPs of symptoms and concerns, and 
thus inform GPs’ assessments. IPOS-Dem may also be used with other health care 
providers such as mental health teams and specialist palliative care to communicate care 
home staff assessment. 
 
8.6.2 Psychometric evaluation of IPOS-Dem 
Chapter one identified important measurement properties that are required for measures to be 
used in routine care. This study has evaluated the acceptability, comprehension, and feasibility 
of IPOS-Dem. Further testing is required to establish its validity, reliability, interpretability and 




responsiveness. These requirements were evident from the findings of this study. Establishing 
the psychometric properties of IPOS-Dem will facilitate its implementation through increasing its 
recognition as a ‘trusted’ measure, important if health care professionals are to recognise the 
IPOS-Dem assessments conducted by care home staff, and act upon the identified symptoms 
and concerns.  
 
Psychometric evaluation is challenging in proxy-completed measures; when there is an absence 
of a gold-standard to assess criterion validity. Psychometric evaluation should include 
assessment of construct validity through hypothesis testing of relationships, and strengths of 
relationships with other valid measures (106, 270), such as agitation; and through testing of 
structural validity through factor analysis. Reliability testing should include testing of internal 
consistency, test-retest reliability in groups of stable people with dementia, and inter-rater 
reliability (270). It is proposed that inter-rater reliability is assessed through evaluation of IPOS-
Dem completed by care home staff and specialist palliative care health care professionals to 
determine how care home staff assess in comparison to assessment by expert health care 
professionals. Responsiveness will be tested through longitudinal construct validity (270). Finally, 
given the potential usefulness of using IPOS-Dem in settings beyond residential care homes and 
its potential usefulness in supporting communication across health and social care sectors, 
psychometric testing across care settings (including, for example, nursing homes and inpatient 
wards) is warranted. This will extend accessibility of IPOS-Dem. 
 
8.6.3 IPOS-Dem intervention: identified areas for further developments 
Further areas of IPOS-Dem development have been identified from this study, which would 
support the implementation and use of IPOS-Dem into routine care: 
(i) Development of training resources and materials to support assessment in people who 
have challenges in expressing their wishes and concerns. Further research will need to 
be conducted as to what materials may best support assessment. One option is to utilise 
‘bolt-on’ validated measures that are already established to support assessment of 
symptoms such as PAINAD for pain. However, this will have an impact on the feasibility 
of using IPOS-Dem. Another option is to synthesise symptom indicators from the 
measures with the strongest psychometric properties to develop training resources and 
materials to support care home staff assess symptoms and concerns. 




(ii) IPOS-Dem manual: the video manual can now be further developed with guidance on 
how IPOS-Dem should be integrated into routine care, detailing the essential and optional 
components. IPOS-Dem training should also detail how IPOS-Dem may support care 
processes and provide value to care, by improving assessment and management of 
symptoms and concerns. 
(iii) As one of the findings of this study was the challenge of health care professionals 
recognising IPOS-Dem as a measure. Further development is required to determine what 
resources may support health care professionals to recognise and utilise IPOS-Dem in 
routine care. Further information materials and resources may be warranted for health 
care professionals, or a dissemination strategy to health care professionals developed. 
(iv) Previous POS developments have included a decision-support tool to facilitate and 
support health care professionals in managing identified symptoms and concerns, based 
on evidence-based interventions (105). To further develop IPOS-Dem as an intervention 
to improve person-centred care, it is proposed that a decision-support tool be developed. 
Such a tool will include established evidence-based person-centred interventions, and 
alert care home staff to referring to health care professionals when required. The 
decision-support tool will be based on scoring thus further supporting interpretability of 
scores (11, 105). 
(v) Finally, development of an electronic format of IPOS-Dem that can be used with 
touchscreen technology is warranted. This will increase IPOS-Dem acceptability and 
facilitate mechanisms of action of IPOS-Dem being used in routine care. 
 
8.6.4 Feasibility trial and full IPOS-Dem evaluation 
IPOS-Dem as an intervention needs testing to ascertain its effectiveness at improving outcomes 
for people with dementia and their family members through a cluster-randomised trial. An 
identified limitation of this study was that the methods for a full scale evaluation were not tested. 
A mixed-methods feasibility cluster-randomised trial will provide the opportunity to identify primary 
and secondary outcome measures, calculate the required sample size, and test methods for 
health economic evaluation (2, 93). A feasibility trial will also allow further process evaluation of 
IPOS-Dem including fidelity, reach, dose and implementation of training resources (3). 
 




8.6.5 Ethical implications for future research with people with dementia living in care 
homes 
A substantial amount of work was involved in applying the ethical and legal guidelines of 
conducting research in adults lacking capacity. The study drew upon the MCA (173), guidelines 
(169) and previous research (197-199). Identifying and contacting personal consultees proved 
challenging with only 15/44 (35.1%) of eligible residents having next-of-kin who were contactable 
and who responded stating they were prepared to act as consultees. Having an identified 
nominated consultee was essential in recruitment of people with dementia. This highlights the 
importance of identifying a nominated consultee who has dedicated time to speak to residents, 
care home staff and family members or friends, and read case notes in order to advise on 
participating in research. It is also essential that the nominated consultee has a good 
understanding about what participating in the research entails as well as the role of consultee in 
research. 
 
It was anticipated that those residents that had capacity to consent, may lose capacity over the 
course of the study. The MORECare statement on ethical issues in palliative and EoLC research 
(169) recommends that in conducting research in people who lack capacity or may lose capacity 
over the research study, consent is gained from the person and advice obtained from the 
consultee. In this way, the MCA (173), can be adhered to, if participants lose capacity. This 
approach is also less invasive as the participant is approached only once to assess capacity and 
gain informed consent, rather than at each data collection point.  Only one participant was 
assessed as having capacity and this participant preferred to meet with me with his next-of-kin 
and personal consultee. As such the study was discussed with them both, and they had the 
opportunity to discuss potential participation between them. The method therefore seemed to 
work well for them both. However, taking this approach may have presented challenges if they 
had disagreed about participation. It is less certain what the most ethical course of action may 
have been under these circumstances. Future studies considering this approach, should have 
clear plans about what steps should be taken under these circumstances. 
 




8.7 Implications for care 
IPOS-Dem is developed for care home staff assessment and management of symptoms and 
concerns for people with dementia living in residential care homes, addressing an identified gap. 
As such it has generated clinical interest, with a number of requests and enquiries having been 
received regarding its implementation into care. This presents a challenge and a dilemma. IPOS-
Dem requires further testing. On the other hand, judging by the interest that IPOS-Dem has 
generated, there evidently appears to be an important need; and withholding IPOS-Dem while 
further testing is conducted will mean there will continue to be unaddressed care need for a 
substantial period of time. A decision was therefore taken to make IPOS-Dem publicly and freely 
available for use in care and IPOS-Dem with its instruction manual is now available on the POS 
website (154).  
 
IPOS-Dem has generated interest beyond residential care homes; and it has now been 
implemented in clinical care by specialist palliative care teams in residential and nursing homes, 
hospices and community settings for people with dementia. A Clinical Commissioning Group is 
conducting a six-month audit of a pilot implementation of IPOS-Dem in nursing homes, residential 
care homes, an acute hospital ward, mental health ward, and community settings with the plan of 
extending to all commissioned sites by the end of the audit period. A mental health trust is 
currently considering its use for patients with dementia and a national dementia charity has 
expressed plans to implement IPOS-Dem in a number of services that it funds both to support 
care and as a service evaluation. 
 
This interest has resulted in opportunities to further understand IPOS-Dem in routine care. 
Collaborations have been developed and data sharing agreements have been agreed and signed 
between organisations so that IPOS-Dem data generated in routine care can be analysed, in 
conjunction with demographic and clinical data (such as medical conditions), as well as measures 
of phase of illness (256), FAST (32), Australia-modified Karnofsky Performance Status (271). This 
is of benefit to both parties as analysed data can be shared with clinical/care teams; and further 
IPOS-Dem data can be accessed. This will inform understanding of IPOS-Dem acceptability and 
feasibility, and potential benefit through data on numbers of measures completed, missing scores, 
scores over time, and IPOS-Dem in relation to demographic and clinical data. It is anticipated that 




these data, in conjunction with the results of this study will support future funding applications for 
further development and testing of IPOS-Dem. 
 
8.8 Next steps 
At the time of writing, a grant application to Dunhill Medical Trust had been submitted to secure 
funding for developing IPOS-Dem training resources, and further psychometric evaluation of 
IPOS-Dem. This has gone through to the final stage and a full application has therefore been 
submitted. This is a priority given IPOS-Dem is already being implemented into routine care of 
people with dementia. Translation and psychometric evaluation has commenced in Germany and 
due to be commenced in Switzerland, with groups from the Netherlands and Sweden also having 
expressed interest in translating IPOS-Dem. 
 
8.9 Personal reflections and learning 
This PhD was my first research job. Prior to commencing it I had worked clinically. I am passionate 
about interventions to improve the lives of people with dementia and knew that this was the 
research topic for my PhD. Improving the lives of people with dementia in care homes seemed to 
me a particularly important topic. In preparing my PhD question, I read much about the challenges 
of conducting research with care homes and with people with dementia who lack capacity. I 
believed that this, along with my understanding of the care home environment from my clinical 
experience prepared me well for conducting the research. I quickly learnt of the real-life 
challenges of conducting research despite my careful preparation. I learnt of the importance of 
developing and maintaining good strong working relationships, and ensuring that the care needs 
of the residents and supporting the care home staff to meet these needs, had to be prioritised 
over my study. I therefore learnt that it is important to make compromises and that it is essential 
to be flexible. In the earlier stages of the PhD, I saw every compromise as a failure on my part to 
deliver a high-quality research, and struggled with the uncertainty of further challenges. Through 
supervision and as I progressed and developed, I was to learn that all research has limitations 
and that it is important to recognise and acknowledge these, and how they may affect the study 
results and interpretation of results. Nonetheless, this newly acquired knowledge has helped me 
in planning future research. When I recently prepared a grant application, this understanding was 




essential in helping me think about the time and funding required to support such research, and I 
was able to write the grant application taking these considerations into account.  
 
8.10 Contribution to the science of developing and evaluating 
measures for clinical/care use 
PCOMs or measures used in routine care has been recognised as a means of improving person-
centred care for people with advancing illness or palliative care needs (7, 84, 272). However, the 
majority of evidence for their use is with patients with cancer (75, 222). There is little evidence of 
their use in care homes, in people with dementia who may not be able to verbally communicate 
their wishes and concerns, or in populations with multi-morbidities (7). This is important as with 
an ageing population, there is likely to be a growing population of people who may have complex 
symptoms and concerns as a result of dementia and/or multi-morbidities (27, 34) and who may 
require care in a care home (55). Assessing and addressing their symptoms and concerns is an 
essential part of providing person-centred care, and PCOMs provide a means of doing so (7). 
However, we need to understand how such measures may work best for this population and this 
setting, and ensure that they are developed to take into account the population and setting 
requirements.  
 
This thesis contributes to the science of developing and evaluating measures in clinical/care use 
in the following ways: 
(i) Essential to this was adapting an existing measure rather than developing a new 
measure. Choosing a measure that had been developed for clinical use and that was 
already well-established meant that I could build upon existing evidence and science. It 
was also important not to add to the multiple measures used in advanced illness (84, 
121), but rather contribute and build upon an existing one thus extending its use for this 
population and setting. The approach of having a core palliative care measure with 
additional symptom and setting items combines the requirement for standardisation with 
the flexibility for use across population settings (272). The result of this study is a proxy-
reported measure developed for use in routine care of people with dementia living in 
residential care homes to support systematic assessment and management of symptoms 
and concerns. 




(ii) The study identifies the measurement properties required for use in routine care and 
ensures that these are taken into consideration from the outset of development. This 
ensures that the measure is developed to be acceptable and feasible for use in routine 
care. Essential to this was the involvement in care home staff who would be using it. Care 
home staff were consulted on its development and how it should be used to support 
routine care during the development phase of the study (272). Involving family members 
proved essential in ensuring that the requirements of them and residents were 
incorporated. 
(iii) This study focuses on identifying the key mechanisms of action of using a measure in 
routine care. It therefore extends our understanding of how measures may work, 
particularly proxy-reported measures for people with dementia in care homes. This study 
supported and builds upon previous findings that measures used in routine care may 
improve comprehensive detection of symptoms, facilitate communication and lead to 
changes in care provision (7). However, this study provided a more in-depth 
understanding of how a measure may support communication, and particularly multi-
agency working through provision of a comprehensive and complex assessment in a 
succinct and easily accessible format. This is important and potentially has implications 
beyond the residential care home setting to all people with complex and multiple care 
needs cared for multiple agencies, and their family members. This study also identified 
that such measures may support regular review, monitoring, and systematic record-
keeping, and by doing so, may support provision of end of life care. Again, this has 
implications beyond the population of dementia living in residential care homes to 
populations with chronic or progressive diseases.  
 
8.11 Conclusion 
IPOS-Dem is a measure developed for care home staff assessment and management of 
symptoms and concerns of people with dementia in residential care homes and their family 
members, addressing an important gap. It has been developed to support comprehensive 
assessment, incorporating important and relevant symptoms and concerns experienced by 
people living with dementia and multi-morbidities and their family members. In addition, it has 
been developed with an understanding of the care home context, and an understanding of care 




home staff knowledge, skills and remit in providing care for people with dementia. IPOS-Dem 
used in routine care may change care processes including improved observation and awareness 
of symptoms and concerns, and improved collaborative assessment; thus providing a ‘picture of 
the person’. This ‘picture of the person’ in turn supports systematic record-keeping, monitoring, 
care planning and multi-agency communication. It therefore addresses important challenges in 
the care of this population by supporting comprehensive assessment of people with dementia, 
and supporting integrating working between care home staff, family members and health care 
professionals. The potential benefit of IPOS-Dem includes improved symptom management, 
improved care of emotional, social and existential concerns, and increased family empowerment 
and engagement in care. IPOS-Dem was found to be acceptable and feasible for use in routine 
care, with findings that it is easy to use and provides value to care. The implementation 
requirements of IPOS-Dem have been identified, particularly the importance leadership in 
enabling care home staff to recognise the value of using IPOS-Dem and ensuring it is integrated 
into care processes. Important areas for further research are the psychometric evaluation of 
IPOS-Dem in care homes and across care settings, and testing of the research methods for a full 
trial on the effectiveness of IPOS-Dem to improve outcomes of care for people with dementia 






1. Care Quality Commission. Care Quality Commission: Care homes; 2016. Available from: 
http://www.cqc.org.uk/content/care-homes. Accessed 5 August 2016. 
2. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and 
evaluating complex interventions: the new Medical Research Council guidance. BMJ. 
2008;337(sep29_1):a1655-a. 
3. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation 
of complex interventions: Medical Research Council guidance. BMJ. 2015;350. 
4. Power R, Langhaug LF, Nyamurera T, Wilson D, Bassett MT, Cowan FM. Developing 
complex interventions for rigorous evaluation--a case study from rural Zimbabwe. Health 
Education Research. 2004;19(5):570-5. 
5. Moore G, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of 
complex interventions: UK Medical Research Council (MRC) guidance. Available from: 
https://www.mrc.ac.uk/documents/pdf/complex-interventions-guidance/. Accessed 29 
March 2017. 
6. Donabedian A. The quality of care. The Journal of the American Medical Association. 
1988;260(12):1743-8. 
7. Etkind SN, Daveson BA, Kwok W, Witt J, Bausewein C, Higginson IJ, et al. Capture, 
Transfer, and Feedback of Patient-Centered Outcomes Data in Palliative Care Populations: 
Does It Make a Difference? A Systematic Review. J Pain Symptom Manage. 2015;49:611-
24. 
8. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported 
outcome measures in healthcare settings. British Medical Journal. 2010;340:c186. 
9. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN 
study reached international consensus on taxonomy, terminology, and definitions of 
measurement properties for health-related patient-reported outcomes. Journal of Clinical 
Epidemiology. 2010;63(7):737-45. 
10. de Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine. Cambridge: 
Cambridge University Press; 2011. 






12. Bausewein C, Simon ST, Benalia H, Downing J, Mwangi-Powell FN, Daveson BA, et al. 
Implementing patient reported outcome measures (PROMs) in palliative care–users’ cry for 
help. Health and Quality of Life Outcomes. 2011;9(27):1-11. 
13. Slade M, Thornicroft G, Glover G. The feasibility of routine outcome measures in mental 
health. Social Psychiatry and Psychiatric Epidemiology. 1999;34(5):243-9. 
14. World Health Organization. World Health Organization definition of palliative care 2017. 
Available from: http://www.who.int/cancer/palliative/definition/en/. Accessed 25 May 2017. 
15. World Health Organization and Alzheimer's Disease International. Dementia: a public health 
priority. Geneva, Switzerland: World Health Organization; 2012. 
16. Alzheimer's Disease International. The global voice on dementia; 2014. Available from: 
http://www.alz.co.uk/. Accessed 7 June 2017. 
17. Mitchell SL, Black BS, Ersek M, Hanson LC, Miller SC, Sachs GA, et al. Advanced dementia: 
state of the art and priorities for the next decade. Annals of Internal Medicine. 2012;156:45-
51. 
18. Mitchell SL, Kiely DK, Hamel MB. Dying with advanced dementia in the nursing home. 
Archives of Internal Medicine. 2004;164(3):321-6. 
19. World Health Organization. Dementia Fact Sheet: World Health Organization; 2017. 
Available from: http://www.who.int/mediacentre/factsheets/fs362/en/. Accessed 1 August 
2017. 
20. Department of Health. Living well with dementia: a national dementia strategy. Crown 
Copyright; 2009. 
21. Department of Health. End of life care strategy. Crown Copyright; 2008.  
22. van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, et al. White 
paper defining optimal palliative care in older people with dementia: A Delphi study and 
recommendations from the European Association for Palliative Care. Palliative Medicine. 
2014;28(3):197-209. 
23. Alzheimer's Disease International. World Alzheimer Report 2015: the global impact of 
dementia. London: Alzheimer's Disease International; 2015. 
24. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of 
multimorbidity and implications for health care, research, and medical education: a cross-





25. Todd S, Barr S, Roberts M, Passmore AP. Survival in dementia and predictors of mortality: 
a review. International journal of geriatric psychiatry. 2013;28(11):1109-24. 
26. Office for National Statistics. Deaths registered in England and Wales (Series DR): 2015: 
Office for National Statistics; 2016. Available from: 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/
bulletins/deathsregisteredinenglandandwalesseriesdr/2015. Accessed 29 May 2017. 
27. Etkind SN, Bone AE, Gomes B, Lovell N, Evans CJ, Higginson IJ, et al. How many people 
will need palliative care in 2040? Past trends, future projections and implications for services. 
BMC Med. 2017;15(1):102. 
28. World Health Organization. International statistical classification of diseases and related 
health problems 10th Revision. 2010. 
29. Stephan B, Brayne C. Prevalence and projections of dementia. In: Downs M, Bowers B, 
editors. Excellence in dementia care: research into practice. New York: Open University 
Press; 2008. 
30. Molloy DW, Alemayehu E, Roberts R. Reliability of a standardized mini-mental state 
examination compared with the traditional mini-mental state examination. The American 
Journal of Psychiatry. 1991;148(1):102-5. 
31. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment 
of primary degenerative dementia. The American Journal of Psychiatry. 1982;139(9):1136-
9. 
32. Reisberg B. Functional assessment staging (FAST). Psychopharmacology Bulletin. 
1988;24(4):653. 
33. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of 
neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the 
cardiovascular health study. Journal of the American Medical Association. 
2002;288(12):1475-83. 
34. Public Health England. Dying with Dementia: National Dementia Intelligence Network and 
National End of Life Care Intelligence Network Briefing. Crown Copyright; 2016. 
35. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet. 
2013;381(9868):752-62. 
36. Johnell K. Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A 





37. Parsons C. Polypharmacy and inappropriate medication use in patients with dementia: an 
underresearched problem. Therapeutic Advances in Drug Safety. 2017;8(1):31-46. 
38. National Institute for Health and Clinical Excellence. Multimorbidity: clinical assessment 
and management; 2016. Available from: 
https://www.nice.org.uk/guidance/ng56/chapter/Recommendations. Accessed 15 May 
2017. 
39. Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, et al. 
Assessment and treatment of pain in people with dementia. Nature Reviews Neurology. 
2012;8(5):264-74. 
40. Kovach CR, Cashin JR, Sauer L. Deconstruction of a complex tailored intervention to assess 
and treat discomfort of people with advanced dementia. Journal of Advanced Nursing. 
2006;55(6):678-88. 
41. Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce 
behavioural disturbances in residents of nursing homes with dementia: cluster randomised 
clinical trial. British Medical Journal. 2011;343:d4065. 
42. Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. 
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimer's & dementia : the journal of 
the Alzheimer's Association. 2011;7(5):532-9. 
43. Knapp M, Chua K-C, Broadbent M, Chang C-K, Fernandez J-L, Milea D, et al. Predictors of 
care home and hospital admissions and their costs for older people with Alzheimer's disease: 
findings from a large London case register. BMJ Open. 2016;6(11). 
44. Luppa M, Luck T, Weyerer S, König H-H, Brähler E, Riedel-Heller SG. Prediction of 
institutionalization in the elderly. A systematic review. Age and Ageing. 2010;39(1):31-8. 
45. Yaffe K, Fox P, Newcomer R, Sands L, Lindquist K, Dane K, et al. Patient and caregiver 
characteristics and nursing home placement in patients with dementia. Journal of the 
American Medical Association. 2002;287(16):2090-7. 
46. Hébert R, Dubois M-F, Wolfson C, Chambers L, Cohen C. Factors Associated With Long-
term Institutionalization of Older People With Dementia Data From the Canadian Study of 
Health and Aging. The Journals of Gerontology: Series A. 2001;56(11):M693-M9. 
47. Knapp M, Prince M, Albanese E, Banerjee S, Dhanasiri S, Fernandez JL, et al. Dementia 





48. Moyle W, Edwards H, Clinton M. Living with loss: dementia and the family caregiver. 
Australian Journal of Advanced Nursing. 2002;19(3):25-31. 
49. Hennings J, Froggatt K. The experiences of family caregivers of people with advanced 
dementia living in nursing homes, with a specific focus on spouses: A narrative literature 
review. Dementia. 2016. 
50. Davies S, Nolan M. ‘Making it better’: Self-perceived roles of family caregivers of older people 
living in care homes: A qualitative study. International Journal of Nursing Studies. 
2006;43(3):281-91. 
51. Lievesley N, Crosby G, Bowman C. The changing role of care homes. London: Bupa and 
Centre for Policy on Ageing; 2011. 
52. Van den Block L, Smets T, van Dop N, Adang E, Andreasen P, Collingridge Moore D, et al. 
Comparing Palliative Care in Care Homes Across Europe (PACE): Protocol of a Cross-
sectional Study of Deceased Residents in 6 EU Countries. Journal of the American Medical 
Directors Association. 2016;17(6):566.e1-.e7. 
53. Care Quality Commission. The state of adult social care services 2014-2017. Newcastle 
upon Tyne: Care Quality Commission; 2017. 
54. National Audit Office. The adult social care workforce in England. London: National Audit 
Office; 2018. 
55. Bone AE, Gomes B, Etkind SN, Verne J, Murtagh FEM, Evans CJ, et al. What is the impact 
of population ageing on the future provision of end-of-life care? Population-based projections 
of place of death. Palliative Medicine. 2018; 32(2): 329-36. 
56. Skills for Care. Care homes without nursing in the adult social care sector 2016/2017. Leeds: 
Skills for Care; 2017. 
57. Skills for Care. The state of the adult social care workforce in England. Leeds: Skills for Care; 
2017. 
58. Gov.UK. What qualification levels mean: Crown Copyright; 2018. Available from: 
https://www.gov.uk/what-different-qualification-levels-mean/list-of-qualification-levels. 
Accessed 6 April 2018. 
59. Skills for Health. The Care Certificate 2018. Available from: 






60. Goodman C, Robb N, Drennan V, Woolley R. Partnership working by default: district nurses 
and care home staff providing care for older people. Health & Social Care in the Community. 
2005;13(6):553-62. 
61. Luff R, Ferreira Z, Meyer J. Care homes. London: NIHR School for Social Care Research; 
2011.  
62. Owen T, Meyer J, Bentley J, Heath H, Goodman C. Better partnership between care homes 
and the NHS: Findings from the My Home Life programme. Journal of Care Services 
Management. 2008;3(1):96-106. 
63. Davies S, Goodman C, Bunn F, Victor C, Dickinson A, Iliffe S, et al. A systematic review of 
integrated working between care homes and health care services. BMC Health Services 
Research. 2011;11(1):320. 
64. Gage H, Dickinson A, Victor C, Williams P, Cheynel J, Davies SL, et al. Integrated working 
between residential care homes and primary care: a survey of care homes in England. BMC 
Geriatrics. 2012;12(1):71. 
65. Goodman C, Woolley R, Knight D. District nurses' experiences of providing care in residential 
care home settings. Journal of Clinical Nursing. 2003;12(1):67-76. 
66. Iliffe S, Davies SL, Gordon AL, Schneider J, Dening T, Bowman C, et al. Provision of NHS 
generalist and specialist services to care homes in England: review of surveys. Primary 
Health Care Research & Development. 2016; 17(2): 122-137. 
67. British Geriatrics Society. Quest for quality: A joint working party inquiry into the quality of 
healthcare support for older people in care homes. London: British Geriatrics Society; 2011. 
68. Hancock GA, Woods B, Challis D, Orrell M. The needs of older people with dementia in 
residential care. International Journal of Geriatric Psychiatry. 2006;21(1):43-9. 
69. Glendinning C, Jacobs S, Alborz A, Hann M. A survey of access to medical services in 
nursing and residential homes in England. British Journal of General Practice. 
2002;52(480):545-8. 
70. Mann AH, Schneider J, Mozley CG, Levin E, Blizard R, Netten A, et al. Depression and the 
response of residential homes to physical health needs. International Journal of Geriatric 
Psychiatry. 2000;15(12):1105-12. 
71. Moriarty J, Rutter D, Ross PDS, Holmes P. End of life for people with dementia living in care 





72. Gillick MR. Adapting advance medical planning for the nursing home. Journal of Palliative 
Medicine. 2004;7(2):357-61. 
73. World Health Organization. Ageing and health technical report Volume 5 Geneva: World 
Health Organization Centre for Health Development; 2004. Available from: 
http://www.who.int/kobe_centre/ageing/ahp_vol5_glossary.pdf. Accessed 3 July 2017. 
74. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. Journal of 
the American Medical Association. 1995;273(1):59-65. 
75. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of 
life in routine oncology practice improves communication and patient well-being: a 
randomized controlled trial. Journal of Clinical Oncology. 2004;22(4):714-24. 
76. Hill N. Use of quality-of-life scores in care planning in a hospice setting: a comparative study. 
International Journal of Palliative Nursing. 2002;8(11):540-7. 
77. Quill TE, Abernethy AP. Generalist plus Specialist Palliative Care — Creating a More 
Sustainable Model. The New England Journal of Medicine. 2013;368(13):1173-5. 
78. Hendrix CC, Sakauye KM, Karabatsos G, Daigle D. The use of the Minimum Data Set to 
identify depression in the elderly. Journal of the American Medical Directors Association. 
2003;4(6):308-12. 
79. van der Steen JT, Goodman C. What research we no longer need in neurodegenerative 
disease at the end of life: the case of research in dementia. Palliative Medicine. 
2015;29(3):189-92. 
80. Hall S, Kolliakou A, Petkova H, Froggatt K, Higginson IJ. Interventions for improving palliative 
care for older people living in nursing care homes (review). Cochrane database of systematic 
reviews. 2011(3):CD007132. doi:10.1002/14651858.CD007132.pub2. 
81. Murphy E, Froggatt K, Connolly S, O'Shea E, Sampson EL, Casey D, et al. Palliative care 
interventions in advanced dementia. Cochrane database of systematic reviews (Online). 
2016;12: CD011513. doi:10.1002/14651858.CD011513.pub2. 
82. Higginson IJ, Carr AJ. The clinical utility of quality of life measures. In: Carr AJ, Higginson 
IJ, Robinson PG, editors. Quality of life. London: BMJ Books; 2003. 
83. Department of Health. Equity and Excellence: Liberating the NHS. London: The Stationery 
Office; 2010. 
84. Harding R, Simon ST, Benalia H, Downing J, Daveson BA, Higginson IJ, et al. The PRISMA 





Palliative and Advanced Disease Care: Too Many Tools in Practice. Journal of Pain and 
Symptom Management. 2011;42(4):493-500. 
85. Witt J, Murtagh FE, de Wolf-Linder S, Higginson IJ, Daveson BA. Introducing the Outcome 
Assessment and Complexity Collaborative (OACC) suite of measures. London: King's 
College London; 2014. 
86. Smith S, Lamping D, Banerjee S, Harwood R, Foley B, Smith P, et al. Measurement of 
health-related quality of life for people with dementia: development of a new instrument 
(DEMQOL) and an evaluation of current methodology. Health Technology Assessment. 
2005;9(10):1-93, iii-iv. 
87. Hearn J, Higginson I. Development and validation of a core outcome measure for palliative 
care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. 
Quality in Health Care. 1999;8(4):219-27. 
88. McPherson CJ, Addington-Hall JM. Judging the quality of care at the end of life: can proxies 
provide reliable information? Social Science & Medicine. 2003;56(1):95-109. 
89. Lichtner V, Dowding D, Esterhuizen P, Closs S, Long A, Corbett A, et al. Pain assessment 
for people with dementia: a systematic review of systematic reviews of pain assessment 
tools. BMC Geriatrics. 2014;14(1):138. 
90. Weiss CH. Nothing as practical as a good theory: exploring theory-based evaluation for 
comprehensive community inititiatives for children and families. In: Connell JP, Kubisch AC, 
Schorr LB, Weiss CH, editors. New Approaches to Evaluating Community Initiatives Volume 
1 Concepts, Methods and Contexts. Washing D.C.: The Aspen Institute; 1995.  
91. De Silva MJ, Breuer E, Lee L, Asher L, Chowdhary N, Lund C, et al. Theory of Change: a 
theory-driven approach to enhance the Medical Research Council's framework for complex 
interventions. Trials. 2014;15:267. 
92. Mason P, Barnes M. Constructing Theories of Change: Methods and Sources. Evaluation. 
2007;13(2):151-70. 
93. Medical Research Council. A framework for development and evaluation of RCTs for 
complex interventions to improve health,  2000. Available from: 






94. Gilissen J, Pivodic L, Gastmans C, Van der Stichele R, Deliens L, Breuer E, et al. How to 
achieve the desired outcomes of advance care planning in nursing homes: a theory of 
change. BMC Geriatrics. 2018;18(1):47. 
95. Blamey A, Mackenzie M. Theories of change and realistic evaluation peas in a pod or apples 
and oranges? Evaluation. 2007;13(4):439-55. 
96. Fuchs-Lacelle S, Hadjistavropoulos T, Lix L. Pain assessment as intervention: a study of 
older adults with severe dementia. The Clinical Journal of Pain. 2008;24(8):697-707. 
97. Krumm N, Larkin P, Connolly M, Rode P, Elsner F. Improving dementia care in nursing 
homes: Experiences with a palliative care symptom-assessment tool (MIDOS). International 
Journal of Palliative Nursing. 2014;20(4):187-92. 
98. Evans BC, Coon DW, Ume E. Use of Theoretical Frameworks as a Pragmatic Guide for 
Mixed Methods Studies. Journal of Mixed Methods Research. 2011;5(4):276-92. 
99. Tashakkori A, Creswell JW. Exploring the nature of research questions in mixed methods 
research. Journal of Mixed Methods Research. 2007;1(3):207-11. 
100. Slade M. Routine outcome assessment in mental health services. Psychological Medicine. 
2002;32(08):1339-43. 
101. Worldwide Palliative Care Alliance. Global atlas of palliative care at the end of life. London: 
Worldwide Palliative Care Alliance; 2014. 
102. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine 
clinical practice: lack of impact or lack of theory? Social Science & Medicine. 2005;60(4):833-
43. 
103. Aveyard B, Davies S. Moving forward together: evaluation of an action group involving staff 
and relatives within a nursing home for older people with dementia. International Journal of 
Older People Nursing. 2006;1(2):95-104. 
104. van Soest-Poortvliet MC, van der Steen JT, Zimmerman S, Cohen LW, Reed D, Achterberg 
WP, et al. Selecting the Best Instruments to Measure Quality of End-of-Life Care and Quality 
of Dying in Long Term Care. Journal of the American Medical Directors Association. 
2012;14(3):179-86. 
105. van Vliet LM, Harding R, Bausewein C, Payne S, Higginson IJ. How should we manage 
information needs, family anxiety, depression, and breathlessness for those affected by 
advanced disease: development of a Clinical Decision Support Tool using a Delphi design. 





106. Terwee CB, Bot SD, de Boer MR, van der Windt DlA, Knol DL, Dekker J, et al. Quality criteria 
were proposed for measurement properties of health status questionnaires. Journal of 
Clinical Epidemiology. 2007;60(1):34-42. 
107. Ettema T, Droes R, de Lange J, Mellenbergh G, Ribbe M. A review of quality of life 
instruments used in dementia. Quality of Life Research. 2005;14(3):675 - 86. 
108. Moyle W, Murfield JE. Health-related quality of life in older people with severe dementia: 
challenges for measurement and management. Expert Review of Pharmacoeconomics & 
Outcomes Research. 2013;13(1):109-22. 
109. Perales J, Cosco T, Stephan B, Haro J, Brayne C. Health-related quality-of-life instruments 
for Alzheimer's disease and mixed dementia. International Psychogeriatrics. 2013;25(5):691 
- 706. 
110. Ready RE, Ott BR. Quality of life measures for dementia. Health and Quality of Life 
Outcomes. 2003;1(11). 
111. Mahoney RI, Barthel DW. Functional Evaluation: the Barthel Index (BI). Maryland State 
Medical Journal. 1965(14):56-61. 
112. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in 
dementia: development of the Bristol Activities of Daily Living Scale. Age and Ageing. 
1996;25(2):113-20. 
113. Voigt-Radloff S, Leonhart R, Schutzwohl M, Jurjanz L, Reuster T, Gerner A, et al. Interview 
for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in 
patients with mild to moderate dementia. International Psychogeriatrics. 2012;24(3):382-90. 
114. Teri L, Truax P, Logsdon R, Uomoto J, Zarit S, Vitaliano PP. Assessment of behavioral 
problems in dementia: the revised memory and behavior problems checklist. Psychology and 
Aging. 1992;7(4):622-31. 
115. Allen RS, Burgio LD, Roth DL, Ragsdale R, Gerstle J, Bourgeois MS, et al. The Revised 
Memory and Behavior Problems Checklist-Nursing Home: Instrument Development and 
Measurement of Burden Among Certified Nursing Assistants. Psychology and Aging. 
2003;18(4):886-95. 
116. Iverson GL, Hopp GA, DeWolfe K, Solomons K. Measuring change in psychiatric symptoms 
using the Neuropsychiatric Inventory: Nursing Home version. International Journal of 





117. Cummings JL. The Neuropsychiatric Inventory Assessing psychopathology in dementia 
patients. Neurology. 1997;48(5 Suppl 6):10S-6S. 
118. Reisberg B, Auer SR, Monteiro IM. Behavioral Pathology in Alzheimer's Disease (BEHAVE-
AD) rating scale. International Psychogeriatrics. 1996;8:301-8. 
119. Rosen J, Burgio L, Kollar M, Cain M, Allison M, Fogleman M, et al. The Pittsburgh agitation 
scale: A user-friendly instrument for rating agitation in dementia patients. The American 
Journal of Geriatric Psychiatry. 1994;2(1):52-9. 
120. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. 
The Journals of Gerontology. 1989;44(3):M77-M84. 
121. Parker D, Hodgkinson B. A comparison of palliative care outcome measures used to assess 
the quality of palliative care provided in long-term care facilities: a systematic review. 
Palliative Medicine. 2011;25(1):5-20. 
122. van Soest-Poortvliet MC, van der Steen JT, Zimmerman S, Cohen LW, Klapwijk M, Bezemer 
M, et al. Psychometric properties of instruments to measure the quality of end-of-life care 
and dying for long-term care residents with dementia. Quality of Life Research: An 
International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation. 
2012;21(4):671-84. 
123. van Soest-Poortvliet MC, van der Steen JT, Zimmerman S, Cohen LW, Munn J, Achterberg 
WP, et al. Measuring the quality of dying and quality of care when dying in long-term care 
settings: a qualitative content analysis of available instruments. Journal of Pain and 
Symptom Management. 2011;42(6):852-63. 
124. Evans CJ, Benalia H, Preston NJ, Grande G, Gysels M, Short V, et al. The selection and use 
of outcome measures in palliative and end-of-life care research: the MORECare international 
consensus workshop. Journal of Pain and Symptom Management. 2013; 46(6):925-937. 
125. Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of End-of-Life Care in Dementia. 
Alzheimer Disease & Associated Disorders. 2001;15(4):194-200. 
126. Casarett D, Pickard A, Bailey FA, Ritchie CS, Furman CD, Rosenfeld K, et al. A nationwide 
VA palliative care quality measure: the family assessment of treatment at the end of life. 
Journal of Palliative Medicine. 2008;11(1):68-75. 
127. Vohra JU, Brazil K, Hanna S, Abelson J. Family Perceptions of End-of-Life Care in long-term 





128. Curtis JR, Patrick DL, Engelberg RA, Norris K, Asp C, Byock I. A measure of the quality of 
dying and death. Initial validation using after-death interviews with family members. Journal 
of Pain and Symptom Management. 2002;24(1):17-31. 
129. Munn JC, Zimmerman S, Hanson LC, Williams CS, Sloane PD, Clipp EC, et al. Measuring 
the Quality of Dying in Long‐Term Care. Journal of the American Geriatrics Society. 
2007;55(9):1371-9. 
130. Pang SM, Chan KS, Chung BP, Lau KS, Leung EM, Leung AW, et al. Assessing quality of 
life of patients with advanced chronic obstructive pulmonary disease in the end of life. Journal 
of Palliative Care. 2005;21(3):180-7. 
131. Chan H, Pang S. Applicability of the modified Quality-of-Life Concerns in the End of Life 
Questionnaire (mQOLC-E) for frail older people. Asian Journal of Gerontology & Geriatrics. 
2008;3(3):17-26. 
132. Teno JM, Clarridge B, Casey V, Edgman-Levitan S, Fowler J. Validation of Toolkit After-
Death Bereaved Family Member Interview. Journal of Pain and Symptom Management. 
2001;22(3):752-8. 
133. Steel K, Ljunggren G, Topinkova E, Morris J, Vitale C, Parzuchowski J, et al. The RAI-PC: 
an assessment instrument for palliative care in all settings. American Journal of Hospice and 
Palliative Medicine. 2003;20(3):211-9. 
134. Casarett D, Shreve S, Luhrs C, Lorenz K, Smith D, De Sousa M, et al. Measuring families' 
perceptions of care across a health care system: preliminary experience with the Family 
Assessment of Treatment at End of Life Short form (FATE-S). Journal of Pain and Symptom 
Management. 2010;40(6):801-9. 
135. Biola H, Sloane PD, Williams CS, Daaleman TP, Williams SW, Zimmerman S. Physician 
Communication with Family Caregivers of Long‐Term Care Residents at the End of Life. 
Journal of the American Geriatrics Society. 2007;55(6):846-56. 
136. Aminoff BZ, Purits E, Noy S, Adunsky A. Measuring the suffering of end-stage dementia: 
reliability and validity of the Mini-Suffering State Examination. Archives of Gerontology and 
Geriatrics. 2004;38(2):123-30. 
137. Zimmerman S, Cohen L, Reed D, Sloane P, Hanson L, Cagle J, et al. End of life in long term 






138. Schols R, Schipper R, Brabers A, Schols J. The Mini-Suffering State Exam (MSSE) has been 
studied in a Dutch nursing home. Tijdschrift voor Verpleeghuisgeneeskunde. 2003;27:14-8. 
139. Cohen LW, Van Soest-Poortvliet M, Van der Steen J, de Vet HC, Reed D, Zimmerman S. 
Differences in the end-of-life experience in the United States and Netherlands. The 
Gerontologist. 2009;49(Suppl_2):58. 
140. Aminoff BZ, Adunsky A. Dying dementia patients: too much suffering, too little palliation. 
American Journal of Hospice & Palliative Medicine. 2005;22(5):344-8. 
141. Aminoff BZ, Adunsky A. Their last 6 months: suffering and survival of end-stage dementia 
patients. Age and Ageing. 2006;35(6):597-601. 
142. Bausewein C, Fegg M, Radbruch L, Nauck F, von Mackensen S, Borasio GD, et al. 
Validation and clinical application of the german version of the palliative care outcome scale. 
Journal of Pain and Symptom Management. 2005;30(1):51-62. 
143. Brandt HE, Deliens L, van der Steen JT, Ooms ME, Ribbe MW, van der Wal G. The last days 
of life of nursing home patients with and without dementia assessed with the Palliative care 
Outcome Scale. Palliative Medicine. 2005;19(4):334-42. 
144. Cohen LW, van der Steen JT, Reed D, Hodgkinson JC, van Soest-Poortvliet MC, Sloane 
PD, et al. Family perceptions of end-of-life care for long-term care residents with dementia: 
differences between the United States and the Netherlands. Journal of the American 
Geriatrics Society. 2012;60(2):316-22. 
145. Eisenchlas JH, Harding R, Daud ML, Perez M, De Simone GG, Higginson IJ. Use of the 
palliative outcome scale in Argentina: a cross-cultural adaptation and validation study. 
Journal of Pain and Symptom Management. 2008;35(2):188-202. 
146. Kiely DK, Volicer L, Teno J, Jones RN, Prigerson HG, Mitchell SL. The validity and reliability 
of scales for the evaluation of end-of-life care in advanced dementia. Alzheimer Disease and 
Associated Disorders. 2006;20(3):176-81. 
147. van der Steen JT, Gijsberts MJ, Muller MT, Deliens L, Volicer L. Evaluations of end of life 
with dementia by families in Dutch and U.S. nursing homes. International Psychogeriatrics. 
2009;21(2):321-9. 
148. van der Steen J, Gijsberts M, Knol D, Deliens L, Muller M. Ratings of symptoms and comfort 






149. Volicer L, Hurley AC, Blasi ZV. Characteristics of dementia end-of-life care across care 
settings. American Journal of Hospice & Palliative Medicine. 2003;20(3):191-200. 
150. Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS. The quality of life in 
late-stage dementia (QUALID) scale. Journal of the American Medical Directors Association. 
2000;1(3):114-6. 
151. Hurley A, Volicer B, Hanrahan P, Houde S, Volicer L. Assessment of discomfort in advanced 
Alzheimer patients. Research in Nursing & Health. 1992;15(5):369 - 77. 
152. Warden V, Hurley AC, Volicer L. Development and Psychometric Evaluation of the Pain 
Assessment in Advanced Dementia (PAINAD) Scale. Journal of the Medical Directors 
Association. 2003;4(1):9-15. 
153. Collins ES, Witt J, Bausewein C, Daveson BA, Higginson IJ, Murtagh FEM. A Systematic 
Review of the Use of the Palliative Care Outcome Scale and the Support Team Assessment 
Schedule in Palliative Care. Journal of Pain and Symptom Management. 2015;50(6):842-
853. 
154. Cicely Saunders Institute. Palliative care Outcome Scale: Cicely Saunders Institute; 2012. 
Available from: https://pos-pal.org/. Accessed 16 May 2017. 
155. Harding R, Selman L, Agupio G, Dinat N, Downing J, Gwyther L, et al. Validation of a core 
outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale. 
Health and Quality of Life Outcomes. 2010;8:10. 
156. Bausewein C, Le Grice C, Simon S, Higginson I. The use of two common palliative outcome 
measures in clinical care and research: A systematic review of POS and STAS. Palliative 
Medicine. 2011;25(4):304-13. 
157. Dunckley M, Aspinal F, Addington-Hall JM, Hughes R, Higginson IJ. A research study to 
identify facilitators and barriers to outcome measure implementation. International Journal of 
Palliative Nursing. 2005;11(5):218-25. 
158. Schildmann EK, Groeneveld EI, Denzel J, Brown A, Bernhardt F, Bailey K, et al. Discovering 
the hidden benefits of cognitive interviewing in two languages: The first phase of a validation 
study of the Integrated Palliative care Outcome Scale. Palliative Medicine. 2016;30(6):599-
610. 
159. Higginson IJ, Evans CJ, Grande G, Preston N, Morgan M, McCrone P, et al. Evaluating 





generated by a synthesis of transparent expert consultations and systematic reviews. BMC 
Medicine. 2013;11(1):111. 
160. Hardeman W, Sutton S, Griffin S, Johnston M, White A, Wareham NJ, et al. A causal 
modelling approach to the development of theory-based behaviour change programmes for 
trial evaluation. Health Education Research. 2005;20(6):676-87. 
161. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and 
evaluating complex interventions to improve health care. British Medical Journal. 
2007;334(7591):455-9. 
162. Oakley A, Strange V, Bonell C, Allen E, Stephenson J. Process evaluation in randomised 
controlled trials of complex interventions. British Medical Journal. 2006;332(7538):413-6. 
163. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and Statistics in 
Medicine. Statistics in Medicine. 2007;26(1):2-19. 
164. Shiell A, Hawe P, Gold L. Complex interventions or complex systems? Implications for health 
economic evaluation. British Medical Journal. 2008;336(7656):1281-3. 
165. Hawe P, Shiell A, Riley T. Complex interventions: how “out of control” can a randomised 
controlled trial be? British Medical Journal. 2004;328(7455):1561-3. 
166. Bumbarger B, Perkins D. After randomised trials: issues related to dissemination of 
evidence‐based interventions. Journal of Children's Services. 2008;3(2):55-64. 
167. Bonell C, Fletcher A, Morton M, Lorenc T, Moore L. Realist randomised controlled trials: a 
new approach to evaluating complex public health interventions. Social Science & Medicine. 
2012;75(12):2299-306. 
168. National Institutes of Health. NIH State-of-the-Science Conference Statement on improving 
end-of-life care. NIH consensus and state-of-the-science statements. 2004;21(3):1-26. 
169. Gysels M, Evans CJ, Lewis P, Speck P, Benalia H, Preston NJ, et al. MORECare research 
methods guidance development: Recommendations for ethical issues in palliative and end-
of-life care research. Palliative Medicine. 2013;27(10):908-17. 
170. Preston NJ, Fayers P, Walters SJ, Pilling M, Grande GE, Short V, et al. Recommendations 
for managing missing data, attrition and response shift in palliative and end-of-life care 
research: Part of the MORECare research method guidance on statistical issues. Palliative 
Medicine. 2013; 27(10):899-907. 
171. Farquhar M, Preston N, Evans CJ, Grande G, Short V, Benalia H, et al. Mixed Methods 





of-Life Care: Report on the MORECare Consensus Exercise. Journal of Palliative Medicine. 
2013;16(12):1550-60. 
172. Preston N, Short V, Hollingworth W, McCrone P, Grande G, Evans C, et al. MORECare 
research methods guidance development: recommendations for health economic 
evaluations in palliative and end of life care research. Palliative Medicine. 2012;26(4):541. 
173. Mental Capacity Act. London: HMSO; 2005.   
174. Forbes S, Bern‐Klug M, Gessert C. End‐of‐Life Decision Making for Nursing Home Residents 
with Dementia. Journal of Nursing Scholarship. 2000;32(3):251-8. 
175. Anderson RA, Issel LM, McDaniel Jr RR. Nursing homes as complex adaptive systems: 
relationship between management practice and resident outcomes. Nursing Research. 
2003;52(1):12. 
176. Froggatt K, Davies S, Meyer J. Research and development in care homes: setting the scene. 
In: Froggatt K, Davies S, J. M, editors. Understanding Care Homes: A Research and 
Development Perspective. London: Jessica Kingsley Publishers; 2009. p. 9-22. 
177. National Care Home Research and Development Forum. My Home Life - quality of life in 
care homes: a review of the literature. London: Help the Aged; 2007. 
178. Goodman C, Davies SL, Dickinson A, Gage H, Froggatt K, Morbey H, et al. A study to 
develop integrated working between primary health care services and care homes. NIHR 
Service Delivery and Organisation programme. 2013. 
179. Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman AD. Methods of consumer 
involvement in developing healthcare policy and research, clinical practice guidelines and 
patient information material. Cochrane database of systematic reviews (Online). 2006;3. 
CD004563. Doi:10.1002/14651858.CD004563.pub2. 
180. Creswell JW. Research design: Qualitative, quantitative, and mixed methods approaches. 
Los Angeles: Sage; 2009. 
181. Miles MB, Huberman AM, Saldana J. Qualitative Data Analysis: a methods sourcebook. 
Third ed. Thousand Oaks, California: Sage Publications; 2014. 
182. O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in 
health services research in England: a mixed methods study. BMC Health Services 
Research. 2007;7:85. 
183. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd ed. 





184. O’Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods 
studies. British Medical Journal. 2010;341. 
185. Foster RL. Addressing Epistemologic and Practical Issues in Multimethod Research: A 
Procedure for Conceptual Triangulation. Advances in Nursing Science. 1997;20(2):1-12. 
186. Erzberger C, Prein G. Triangulation: Validity and empirically-based hypothesis construction. 
Quality and Quantity. 1997;31(2):141-54. 
187. McEvoy P, Richards D. A critical realist rationale for using a combination of quantitative and 
qualitative methods. Journal of Research in Nursing. 2006;11(1):66-78. 
188. Pawson R, Tilley N. Realistic evaluation. London: Sage Publications; 1997.  
189. Bhaskar R. A Realist Theory of Science. London: Taylor & Francis Group; 2008.  
190. Parlour R, McCormack B. Blending critical realist and emancipatory practice development 
methodologies: making critical realism work in nursing research. Nursing Inquiry. 
2012;19(4):308-21. 
191. Blackwood B, O'Halloran P, Porter S. On the problems of mixing RCTs with qualitative 
research: the case of the MRC framework for the evaluation of complex healthcare 
interventions. Journal of Research in Nursing. 2010;15(6):511-21. 
192. Coyle J, Williams B. An exploration of the epistemological intricacies of using qualitative data 
to develop a quantitative measure of user views of health care. Journal of Advanced Nursing. 
2000;31(5):1235-43. 
193. Berger R. Now I see it, now I don’t: researcher’s position and reflexivity in qualitative 
research. Qualitative Research. 2015;15(2):219-34. 
194. National Institute for Health Research. ENRICH: enabling research in care homes 2017 
Available from: http://www.dendron.nihr.ac.uk/enrich/index.php. Accessed 1 September 
2017. 
195. Davies SL, Goodman C, Manthorpe J, Smith A, Carrick N, Iliffe S. Enabling research in care 
homes: an evaluation of a national network of research ready care homes. BMC Medical 
Research Methodology. 2014;14:47. 
196. Froggatt K, Davies S, Meyer J. Understanding Care Homes: A research and development 
perspective. London: Jessica Kingsley Publishers; 2009. 
197. Goodman C, Baron NL, Machen I, Stevenson E, Evans C, Davies SL, et al. Culture, consent, 
costs and care homes: enabling older people with dementia to participate in research. Aging 





198. Scott S, Jones L, Blanchard M, Sampson E. Study protocol: The behaviour and pain in 
dementia study (BePAID). BMC Geriatrics. 2011;11(1):61. 
199. Handley M, Goodman C, Froggatt K, Mathie E, Gage H, Manthorpe J, et al. Living and dying: 
Responsibility for end-of-life care in care homes without on-site nursing provision - a 
prospective study. Health and Social Care in the Community. 2014;22(1):22-9. 
200. Collins ES, Witt J, Bausewein C, Daveson BA, Higginson IJ, Murtagh FEM. A Systematic 
Review of the Use of the Palliative Care Outcome Scale and the Support Team Assessment 
Schedule in Palliative Care. Journal of Pain and Symptom Management. 2015;50(6):842-
853. 
201. De Roo ML, Albers G, Deliens L, de Vet HC, Francke AL, Van Den Noortgate N, et al. 
Physical and Psychological Distress Are Related to Dying Peacefully in Residents With 
Dementia in Long-Term Care Facilities. Journal of Pain and Symptom Management. 
2015;50(1):1-8. 
202. Black B, Finucane T, Baker A, Loreck D, Blass D, Fogarty L, et al. Health problems and 
correlates of pain in nursing home residents with advanced dementia. Alzheimer Disease & 
Associated Disorders. 2006;20(4):283 - 90. 
203. Di Giulio P, Toscani F, Villani D, Brunelli C, Gentile S, Spadin P. Dying with advanced 
dementia in long-term care geriatric institutions: a retrospective study. Journal of Palliative 
Medicine. 2008;11(7):1023-8. 
204. Lloyd-Williams M. An audit of palliative care in dementia. European Journal of Cancer Care. 
1996;5(1):53-5. 
205. Mitchell SL, Morris JN, Park PS, Fries BE. Terminal care for persons with advanced dementia 
in the nursing home and home care settings. Journal of Palliative Medicine. 2004;7(6):808-
16. 
206. Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, et al. The clinical 
course of advanced dementia. The New England Journal of Medicine. 2009;361(16):1529-
38. 
207. Brandt HE, Deliens L, Ooms ME, van der Steen JT, van der Wal G, Ribbe MW. Symptoms, 
signs, problems, and diseases of terminally ill nursing home patients: A nationwide 
observational study in the netherlands. Archives of Internal Medicine. 2005;165(3):314-20. 
208. Sloane PD, Zimmerman S, Williams C, Hanson LC. Dying with dementia in long-term care. 





209. Buchanan RJ, Choi M, Wang S, Huang C. Analyses of nursing home residents in hospice 
care using the minimum data set. Palliative Medicine. 2002;16(6):465-80. 
210. Hall P, Schroder C, Weaver L. The last 48 hours of life in long-term care: a focused chart 
audit. Journal of the American Geriatrics Society. 2002;50(3):501-6. 
211. Hanson LC, Eckert JK, Dobbs D, Williams CS, Caprio AJ, Sloane PD, et al. Symptom 
experience of dying long-term care residents. Journal of the American Geriatrics Society. 
2008;56(1):91-8. 
212. Reynolds K, Henderson M, Schulman A, Hanson LC. Needs of the dying in nursing homes. 
Journal of Palliative Medicine. 2002;5(6):895-901. 
213. Parker D, Grbich C, Brown M, Maddocks I, Willis E, Roe P. A Palliative Approach or 
Specialist Palliative Care? What Happens in Aged Care Facilities for Residents With a 
Noncancer Diagnosis? Journal of Palliative Care. 2005;21(2):80-7. 
214. Mor V, Angelelli J, Jones R, Roy J, Moore T, Morris J. Inter-rater reliability of nursing home 
quality indicators in the U.S. BMC Health Services Research. 2003;3:20. 
215. Morris JN, Hawes C, Fries BE, Phillips CD, Mor V, Katz S, et al. Designing the national 
resident assessment instrument for nursing homes. The Gerontologist. 1990;30(3):293-307. 
216. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for 
the Minimum Data Set for nursing home resident assessment and care screening (MDS). 
The Gerontologist. 1995;35(2):172-8. 
217. Morris J, Murphy K, Nonemaker S. Long-term care resident assessment user's manual, 
version 2.0. Baltimore, MD: Health Care Financing Administration; 1995. 
218. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: 
Fourth Edition (DSM 4). American Psychiatric Association; 1994. 
219. Robinson L, Dickinson C, Rousseau N, Beyer F, Clark A, Hughes J, et al. A systematic 
review of the effectiveness of advance care planning interventions for people with cognitive 
impairment and dementia. Age and Ageing. 2012;41(2):263-9. 
220. Hemingway D, MacCourt P, Pierce J, Strudsholm T. Together but apart: Caring for a spouse 
with dementia resident in a care facility. Dementia. 2016;15(4):872-90. 
221. Mullin J, Simpson J, Froggatt K. Experiences of spouses of people with dementia in long-





222. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-
life assessments and patient-physician communication. The Journal of the American Medical 
Association. 2002;288(23):3027-34. 
223. Scholzel-Dorenbos C, Ettema T, Bos J, Boelens-van der Knoop E, Gerritsen D, Hoogeveen 
F, et al. Evaluating the outcome of interventions on quality of life in dementia: selection of 
the appropriate scale. International Journal of Geriatric Psychiatry. 2007;22(6):511 - 9. 
224. Selai C, Trimble MR. Assessing quality of life in dementia. Aging & Mental Health. 
1999;3(2):101-11. 
225. Algar K, Woods RT, Windle G. Measuring the quality of life and well-being of people with 
dementia: A review of observational measures. Dementia. 2016;15(4):832-57. 
226. Malley JN, Towers AM, Netten AP, Brazier JE, Forder JE, Flynn T. An assessment of the 
construct validity of the ASCOT measure of social care-related quality of life with older 
people. Health and Quality of Life Outcomes. 2012;10:21. 
227. Rand S, Caiels J, Collins G, Forder J. Developing a proxy version of the Adult social care 
outcome toolkit (ASCOT). Health and Quality of Life Outcomes. 2017;15(1):108. 
228. Langlois A, Anderson DE. Resolving the quality of life/well-being puzzle: toward a new 
model. The Canadian Journal of Regional Science. 2002;25(3):501-11. 
229. Burgener SC, Twigg P, Popovich A. Measuring psychological well-being in cognitively 
impaired persons. Dementia. 2005;4(4):463-85. 
230. Lawton MP, Van Haitsma K, Klapper J. Observed affect in nursing home residents with 
Alzheimer's disease. Journal of Gerontology: Psychological Sciences. 1996; 51B(1):3-14. 
231. Kolanowski A, Hoffman L, Hofer SM. Concordance of self-report and informant assessment 
of emotional well-being in nursing home residents with dementia. Journal of Gerontology: 
Psychological Sciences and Social Sciences. 2007;62(1):20-7. 
232. Snyder M, Ryden MB, Shaver P, Wang J, Savik K, Gross CR, et al. The Apparent Emotion 
Rating Instrument: assessing affect in cognitively impaired elders. Clinical Gerontologist. 
1998;18(4):17-29. 
233. Lawton MP, Van Haitsma K, Perkinson M, Ruckdeschel K. Observed affect and quality of 
life in dementia: Further affirmations and problems. Journal of Mental Health and Aging. 
1999; 5(1):69-81. 






235. Bradford Dementia Group. The Bradford Well-being Profile. Bradford: University of Bradford; 
2008. 
236. Rentz CA. Memories in the making: outcome-based evaluation of an art program for 
individuals with dementing illnesses. American Journal of Alzheimer’s Disease & Other 
Dementias. 2002;17(3):175-81. 
237. Brooker DJ, Surr C. Dementia Care Mapping (DCM): initial validation of DCM 8 in UK field 
trials. International Journal of Geriatric Psychiatry. 2006;21(11):1018-25. 
238. Brooker D. Dementia care mapping: a review of the research literature. Gerontologist. 
2005;45 Spec No 1(1):11-8. 
239. University of Bradford. Introduction to Dementia Care Mapping (DCM); 2015. Available 
from:http://www.bradford.ac.uk/health/dementia/dementia-care-mapping/file-
downloads/Introduction-to-Dementia-Care-Mapping.pdf. Accessed 3 July 2017. 
240. Kaufmann EG, Engel SA. Dementia and well-being: A conceptual framework based on Tom 
Kitwood’s model of needs. Dementia. 2016;15(4):774-88. 
241. Oxford University Press. English Oxford Living Dictionaries 2017. Available from: 
https://en.oxforddictionaries.com/definition/need. Accessed 7 July 2017. 
242. Maslow AH. A theory of human motivation. Psychol Rev. 1943;50(4):370-96.  
243. Hancock G, Orrell M. Introduction. In: Orrell M, Hancock G, editors. CANE - Camberwell 
Assessment of Need for the Elderly: A needs assessment for older mental health service 
users. London: Gaskell 2004. 
244. Stevens A, Gillam S. Needs assessment: from theory to practice. British Medical Journal. 
1998;316(7142):1448-52. 
245. Higginson IJ, Hart S, Koffman J, Selman L, Harding R. Needs Assessments in Palliative 
Care: An Appraisal of Definitions and Approaches Used. Journal of Pain and Symptom 
Management. 2007;33(5):500-5. 
246. Orrell M, Hancock G. CANE: Camberwell assessment of need for the elderly: Gaskell 
London; 2004. 
247. Reynolds T, Thornicroft G, Abas M, Woods B, Hoe J, Leese M, et al. Camberwell 
Assessment of Need for the Elderly (CANE). Development, validity and reliability. British 
Journal of Psychiatry. 2000;176:444-52. 
248. Reynolds  T, Hancock G, Woods B, Thornicroft G, Orrell M. Development of the Camberwell 





Camberwell Assessment of Need for the Elderly: A needs assessment for older mental 
health service users. London: Gaskell; 2004. 
249. Hancock G, Orrell M. CANE instruction manual. In: Orrell M, Hancock G, editors. CANE - 
Camberwell Assessment of Need for the Elderly: A needs assessment for older mental 
health service users. London: Gaskell; 2004. 
250. Kovach CR, Noonan PE, Griffie J, Muchka S, Weissman DE. The assessment of discomfort 
in dementia protocol. Pain Management Nursing. 2002;3(1):16-27. 
251. Kovach CR, Logan BR, Noonan PE, Schlidt AM, Smerz J, Simpson M, et al. Effects of the 
Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia. 
American Journal of Alzheimer’s Disease & Other Dementias. 2006;21(3):147-55. 
252. Cohen-Mansfield J, Libin A. Verbal and physical non-aggressive agitated behaviors in elderly 
persons with dementia: robustness of syndromes. Journal of Psychiatric Research. 
2005;39(3):325-32. 
253. Testad I, Aasland AM, Aarsland D. Prevalence and correlates of disruptive behavior in 
patients in Norwegian nursing homes. International Journal of Geriatric Psychiatry. 
2007;22(9):916-21. 
254. National Institute for Health and Clinical Excellence/Social Care Institute for Excellence. 
Dementia: Supporting people with dementia and their carers in health and social care; 2011. 
Available from: http://www.nice.org.uk/nicemedia/live/10998/30320/30320.pdf. Accessed 14 
July 2017. 
255. Cohen-Mansfield J. Assessment of agitation. International Psychogeriatrics. 1996;8(2):233-
45. 
256. Masso M, Allingham SF, Banfield M, Johnson CE, Pidgeon T, Yates P, et al. Palliative Care 
Phase: inter-rater reliability and acceptability in a national study. Palliative Medicine. 
2015;29(1):22-30. 
257. Powell C, Blighe A, Froggatt K, McCormack B, Woodward-Carlton B, Young J, et al. Family 
involvement in timely detection of changes in health of nursing homes residents: a qualitative 
exploratory study. Journal of Clinical Nursing. 2018; 27(1-2):317-327. 
258. Hennings J, Froggatt K, Payne S. Spouse caregivers of people with advanced dementia in 





259. van der Steen JT, Lemos Dekker N, Gijsberts MHE, Vermeulen LH, Mahler MM, The BA. 
Palliative care for people with dementia in the terminal phase: a mixed-methods qualitative 
study to inform service development. BMC Palliative Care. 2017;16(1):28. 
260. Goodman C, Dening T, Gordon AL, Davies SL, Meyer J, Martin FC, et al. Effective health 
care for older people living and dying in care homes: a realist review. BMC Health Services 
Research. 2016;16(1):1-14. 
261. Antunes B, Harding R, Higginson IJ. Implementing patient-reported outcome measures in 
palliative care clinical practice: a systematic review of facilitators and barriers. Palliative 
Medicine. 2014;28(2):158-75. 
262. Kinley J, Stone L, Dewey M, Levy J, Stewart R, McCrone P, et al. The effect of using high 
facilitation when implementing the Gold Standards Framework in Care Homes programme: 
A cluster randomised controlled trial. Palliative Medicine. 2014;28(9):1099-109. 
263. Hockley J, Watson J, Oxenham D, Murray S. The integrated implementation of two end-of-
life care tools in nursing care homes in the UK: an in-depth evaluation. Palliative Medicine. 
2010;24(8):828-38. 
264. O'Reilly M, Larkin P, Conroy M, Twomey F, Lucey M, Dunne C, et al. The Impact of a Novel 
Tool for Comprehensive Assessment of Palliative Care (MPCAT) on Assessment Outcome 
at 6- and 12-Month Follow-Up. Journal of Pain and Symptom Management. 2016;52(1):107-
16. 
265. Froggatt K, Davies S, Atkinson L, Aveyard B, Binney S, Kent Y, et al. The joys and 
tribulations of partnership working in care homes for older people. Quality in Ageing and 
Older Adults. 2006;7(3):26-32. 
266. DiazOrdaz K, Slowther A-M, Potter R, Eldridge S. Consent processes in cluster-randomised 
trials in residential facilities for older adults: a systematic review of reporting practices and 
proposed guidelines. BMJ Open. 2013;3(7):e003057. 
267. Hall S, Longhurst S, Higginson IJ. Challenges to conducting research with older people living 
in nursing homes. BMC Geriatrics. 2009;9(1):38. 
268. Evans C, Goodman C. Changing practice in dementia care for people in care homes towards 
the end of life. Dementia. 2009;8(3):424-31. 
269. Zermansky AG, Alldred DP, Petty DR, Raynor DK. Striving to recruit: the difficulties of 






270. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN 
checklist manual. Amsterdam: VU University Medical Center. 2009. 
271. Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC. The Australia-modified 
Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative 
care clinical practice]. BMC Palliative Care. 2005;4(1):7. 
272. Simon ST, Higginson IJ, Harding R, Daveson BA, Gysels M, Deliens L, et al. Enhancing 
patient-reported outcome measurement in research and practice of palliative and end-of-life 
care. Supportive Care in Cancer. 2012;20(7):1573-8. 





  Appendix A. Scoping review methods 
308 
 
Appendix A. Scoping review methods 
Aim: 
To identify palliative care measures developed for or used with people with dementia, to gain an 
understanding of the construct of palliative care for people with dementia including domains 
assessed, and to identify the populations of dementia that palliative care measures are used for 
including dementia severity and settings. 
 
Methods: 
The Cochrane Library, PsycINFO and EMBASE were searched in July 2012 using terms palliative 
care AND dementia OR Alzheimer’s disease AND outcome OR measurement OR assessment 
for articles published in the last ten years. Reference and citation searches of included articles 
were conducted using Scopus. Systematic reviews or original articles that reported the 
development, psychometric evaluation or use of palliative care measures in people with dementia 
in any care setting were included. Measures were those used to assess palliative care need or 
measure palliative care outcomes, including those that assessed multiple or individual symptoms 
and concerns, quality of care, and carers’ concerns. Conference abstracts and theses were 
excluded. As this was a scoping review to determine established measures used in dementia, 
grey literature was not searched. Titles and abstracts were reviewed by one reviewer and those 
clearly not meeting the inclusion criteria were excluded. The remaining full texts were reviewed 
by one reviewer to determine whether the articles met the inclusion criteria.  
 
One reviewer extracted all the data. Data extraction included (1) lead author and date of 
publication, (2) study design, (3) name of measure(s), (4) construct(s) of the measure(s), (5) 
population (including dementia stages) and setting, (6) any details of original development of 
measure including original reference, and population that measure was originally developed for. 
As the aim of the review was to identify what palliative care measures had been used for people 










Appendix B. The Palliative care Outcome Scale, POS-Symptom 
and Integrated Palliative care Outcome Scale 
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Appendix G. Care home ethics application 
 
 






































































Appendix H. Coffee morning advertisement 
 




Appendix I. Examples of participant information sheets from 
each data collection phase 
 
  






























































































































































































































































































































































































































































































































































































































































































































Appendix O. IPOS-Dem Versions 
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